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ABSTRACT 
Almost half of all cases of heart failure have a preserved ejection fraction. 
However, therapy targeting the mechanisms of this disorder has not improved 
outcomes. Left ventricular (LV) diastolic dysfunction is a characteristic feature of 
heart failure with a preserved ejection fraction. A more sound understanding of the 
mechanisms responsible for LV diastolic dysfunction produced by risk factors may 
lead to better approaches to preventing this syndrome. 
Although obesity is thought to be a major risk factor for LV diastolic 
dysfunction, this does not occur in all obese individuals. In the present thesis I have 
demonstrated in 737 randomly recruited participants from a community sample of 
African ancestry, that the relationship between insulin resistance (homeostasis 
model) and LV diastolic function, as assessed from trans-mitral velocity (E/A) and 
tissue Doppler imaging of the lateral and septal walls of the LV (e’ and E/e’), is 
markedly altered by the presence of a more concentrically remodelled LV (as 
indexed by LV relative wall thickness [RWT]). Importantly, insulin resistance was only 
associated with LV diastolic function or dysfunction in those with an RWT above a 
threshold value.  In contrast no interactive effects on LV diastolic function between 
either blood pressure or age and RWT were noted. These data therefore suggest 
that obesity will only translate into LV diastolic dysfunction if it is associated with 
insulin resistance and a concentrically remodeled LV. 
Although hypertension is thought to play an important role in contributing to 
LV diastolic dysfunction, the pulsatile hemodynamic change primarily responsible for 
this effect is uncertain. In 524 randomly selected individuals from a community 
sample I have demonstrated that independent of confounders including left 
ventricular mass and RWT, aortic backward wave pressure effects (as determined 
using wave separation analysis), antedate the impact of aortic stiffness (indexed by 
aortic pulse wave velocity) or the factors determined by aortic stiffness (the time of 
backward wave return or forward wave pressures) on LV filling pressures (E/e’). 
These data therefore suggest that to adequately prevent LV diastolic dysfunction, 
targeting aortic backward wave pressures may be required. 
 As conventional risk factors account for only a portion of the inter-individual 
variations in LV diastolic function, it is thought that the genetic factors may play a 
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significant role. In 694 randomly recruited participants of African ancestry belonging 
to nuclear families, I demonstrated that independent of conventional risk factors, 
heritability accounts for approximately 50% of the variation in LV RWT, an important 
LV structural determinant of LV diastolic function. Moreover, in 442 randomly 
recruited individuals of African ancestry belonging to nuclear families, I also 
demonstrated that heritability accounts for approximately 50% of the variation in the 
index of LV filling pressures, E/e’, independent of LV mass or RWT remodeling and 
aortic function. These data provide strong evidence that genetic factors responsible 
for LV diastolic dysfunction and the structural determinants thereof should be sought. 
 In conclusion, the results provided in the present thesis have advanced our 
knowledge of possible pathophysiological mechanisms that play a role in the 
development of LV diastolic dysfunction and hence possibly heart failure with a 
preserved ejection fraction. 
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PREFACE 
 
Globally the prevalence of cardiovascular risk factors linked to the 
development of heart failure has become a burden to healthcare systems. Previously 
heart failure with reduced ejection fraction was the most common form of heart 
failure. However, over the past few decades heart failure with a preserved ejection 
fraction (HFpEF) has been reported to account for half of all cases of heart failure. 
However, the results of clinical trials employing therapy targeting the mechanisms of 
HFpEF have been disappointing. In this regard, cardiac diastolic dysfunction 
characterizes HFpEF and can precede the development of overt heart failure. 
Although several risk factors for HFpEF are well recognized, including obesity and 
hypertension, the exact mechanisms through which these risk factors mediate 
cardiac diastolic dysfunction is still uncertain. Moreover, the extent to whuich genetic 
mechanisms play a role in contributing to cardiac diastolic dysfunction is unclear. 
In the present thesis I set out to better identify the factors associated with 
obesity that contribute to cardiac diastolic dysfunction. Moreover, I further evaluated 
aspects of aortic function which contribute to pulsatile load and hence in-part explain 
the impact of increases in blood pressure on cardiac diastolic function. I also 
identified the intra-familial aggregation and heritability of aspects of cardiac diastolic 
function and the structural determinants thereof that had at the time of conducting the 
present thesis, been unclear. Overall the findings of the present thesis provide novel 
insights into the metabolic, haemodynanmic and genetic determinants of cardiac 
diastolic dysfunction and hence possibly a better understanding of the risk factors 
that lead to heart failure with a preserved ejection fraction.  
In the present thesis, in chapter 1 I review the current understanding and 
controversies related to cardiac diastolic function, thus arguing in favor of conducting 
the studies described herein. In chapters 2-5 I describe each of the studies, their 
results and the implications thereof. These chapters are constructed as semi-
independent chapters and each includes its own abstract, introduction, methods, 
results and discussion sections. The present thesis concludes with a chapter 
(chapter 6), which provides a summary of the findings reported; highlights the novelty 
of these findings and places them in context of our current understanding of the 
mechanisms responsible for cardiac diastolic dysfunction and heart failure with a 
preserved ejection fraction. 
In support of this thesis, the data provided in chapter 2 has been published in 
the International Journal of Cardiology (Petersonb et al 2016); chapter 3 and 4 have 
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been published in the the American Journal of Hypertension (Petersonc et al 2016; 
Peterson et al 2015); and chapter 5 has been published in the Journal of the 
American Society of Hypertension (Petersona et al 2016).  
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CHAPTER 1 
  
 
 
 
 
INTRODUCTION 
 
 
 
 
Current Understanding and Controversies Related to Left Ventricular 
Diastolic Function 
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1.1 Introduction 
 
Cardiovascular disease is a major healthcare burden and a leading cause of 
death in low, middle and high-income countries (Bradshaw et al 2003; Bhatia et al 
2006; Borlaug & Redfield 2011; Mozaffarian et al 2015). A number of factors increase 
the risk of developing cardiovascular disease. These factors include hypertension, 
obesity, diabetes mellitus, smoking, dyslipidaemia, a sedentary lifestyle and excess 
alcohol intake (Lee et al 2009; Mozaffarian et al 2015). Currently, in both American 
and European populations, hypertension, diabetes mellitus and obesity are the 
leading cause of cardiovascular related deaths (Nichols et al 2004; Mozaffarian et al 
2015). Similarly, in South Africa, the prevalence of cardiovascular disease is 
increasing (Bradshaw et al 2003; Steyn et al 2006; Rayner 2010; Mozaffarian et al 
2015) and this is also attributed to a rising prevalence of the cardiovascular risk 
factors hypertension, obesity and diabetes mellitus, a consequence of urbanisation, 
globalisation and marked changes in lifestyle (Steyn et al 2006; Rayner 2010; 
Maredza et al 2011).  
The increasing global prevalence of certain cardiovascular risk factors has led 
not only to an increase in the development of heart failure (Kenchaiah et al 2002; 
Kane et al 2011; Burke et al 20 14; Nichols et al 2004), but also modified the type of 
heart failure that may develop. For a number of years, heart failure with a reduced 
ejection fraction (HFrEF), which is associated with systolic chamber dysfunction, was 
identified as the most common form of heart failure. In this regard, it was perceived 
that the lower the ejection fraction the less likely the patient was to survive 
(Federmann & Hess 1994; McMurray et al 2012). However, over the past few 
decades there has been an increase in the prevalence of heart failure with a 
preserved ejection fraction (HFpEF). Numerous studies have shown that heart failure 
with a preserved ejection fraction is accompanied by left ventricular (LV) diastolic 
dysfunction (DD), which is an abnormality of the LV during diastolic relaxation and 
filling periods (Aurigemma & Gaasch 2004). Importantly, heart failure with a 
preserved ejection fraction is commonly associated with hypertension, diabetes 
mellitus and obesity (Borlaug & Redfield 2011; Scantlebury & Borlaug 2011). 
To date, most of the treatment strategies that have been implemented to 
improve the survival of patients with heart failure are based on targeting heart failure 
with a reduced ejection fraction (Paulus & van Ballegoij 2010; Borlaug & Redfield 
2011). Data from large multicenter clinical trials show that current therapeutic 
approaches can reduce the risk of death or hospitalisation for heart failure in patients 
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with a reduced ejection fraction (Borlaug & Redfield 2011). However, data from 
clinical trials in patients with heart failure with a preserved ejection fraction show that 
none of the current therapeutic regimens make an impact on the prevention of death 
or hospitalisation for heart failure in patients with a preserved ejection fraction 
(Borlaug & Redfield 2011). In order to improve on the management of patients with 
heart failure with a preserved ejection fraction, a better understanding of the factors 
associated with LV diastolic dysfunction and its progression is therefore warranted. 
Moreover, as healthcare sectors worldwide are burdened by the high prevalence of 
cardiovascular disease (Bhatia et al 2006; Yancy et al 2006; Fonarow et al 2007; 
Lam et al 2007; Borlaug & Redfield 2011; Chirinos et al 2012; Nichols et al 2014), it 
would be preferable to try and prevent heart failure with preserved ejection fraction 
by identifying individuals at risk of developing LV diastolic dysfunction and targeting 
the risk factors involved. 
Major modifiable risk factors suggested to be associated with LV diastolic 
dysfunction include obesity and hypertension and the associated left ventricular 
hypertrophy (LVH) and remodelling that often occurs with these conditions. However, 
at present the relative independent contribution of obesity as a determinant of LV 
diastolic dysfunction is uncertain. In addition, although abnormalities of pulsatile 
haemodynamics and aortic function have frequently been described in hypertensive 
heart failure with a normal ejection fraction, the primary aortic functional change 
responsible for preclinical LV diastolic dysfunction is unclear. Moreover, ethnicity is 
reported to impact on the prevalence of LV diastolic dysfunction and ultimately heart 
failure with preserved ejection fraction. In this regard, the effectiveness of treatment 
strategies in heart failure with preserved ejection fraction may therefore also depend 
on the overall genetic variance of a population and a better understanding as to the 
mechanisms through which genetic factors linked either directly to LV diastolic 
dysfunction or to LV diastolic function through their impact on LVH and remodelling 
mediate their effects. Hence, in my thesis I further explored the possible independent 
role and relative importance of each of these risk factors (obesity, aortic 
haemodynamics, and inheritance) in determining LV diastolic dysfunction. To provide 
the contextual background to these questions addressed in my thesis, in the 
introduction to my thesis I will therefore briefly discuss the current classification of 
heart failure and the role of LV diastolic dysfunction as a determinant of heart failure 
with preserved ejection fraction. I will then review the literature to-date on the role of 
hypertension and obesity in the development of LV diastolic dysfunction. When 
discussing the role of obesity I will provide context as to the importance of insulin 
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resistance and when discussing the role of hypertension context as to the importance 
of the impact of aortic haemodynamic changes on LV diastolic function. Last, I will 
summarise the current literature on the role of genetic factors (inheritance) in 
determining LV remodelling and diastolic function. 
 
1.2 Heart failure  
 
Clinically, heart failure is described as a collection of signs and symptoms that 
arise from an increase in filling pressures in the heart (Borlaug & Redfield 2011; 
Yancy et al 2013). There are various classifications of the types of heart failure. One 
of the traditional categorisations of heart failure has been linked to cardiac systolic 
function as measured by LV ejection fraction (Hundely et al 2001; Lee et al 2009). 
According to this classification, there are two major types of heart failure, namely 
heart failure with reduced ejection fraction in which heart failure is accompanied by a 
decreased ejection fraction (EF<40%), and heart failure with preserved ejection 
fraction in which ejection fraction is normal. Heart failure with a reduced ejection 
fraction, which is also termed systolic heart failure as it is caused by chamber systolic 
dysfunction, is associated with coronary artery disease and cardiac dilatation 
(extensive eccentric LV remodelling), and is commonly seen in elderly males 
(Federmann & Hess 1994; Masoudi et al 2003; Bhatia et al 2006; Borlaug & Redfield 
2011). Alternatively, heart failure with a preserved ejection fraction, which is also 
termed diastolic heart failure and is preceded by LV diastolic dysfunction, is 
associated with hypertension, obesity and LVH and more commonly occurs in elderly 
women (Borlaug & Redfield 2011).  
The pathophysiology of heart failure with a reduced ejection fraction is 
essentially reasonably well understood and forms the basis of the current therapeutic 
approaches for heart failure. These approaches include the administration of agents 
that block the sympathetic nervous system (beta blockers, BB), or the renin-
angiotensin-aldosterone system (angiotensin-converting enzyme inhibitors [ACEI], 
angiotensin receptor blockers [ARBs], and aldosterone receptor blockers). 
Importantly, data from large multicentre clinical trials such as CHARM-
ALTERNATIVE, SOLVD, MDC, CIBIS, PRECISE, OPTIMIZE-BB, OPTIMIZE-ACE, 
RALES have shown that these current therapeutic approaches can reduce the risk of 
death or hospitalisation for heart failure in patients with heart failure with a reduced 
ejection fraction (Borlaug & Redfield 2011). Hence, survival in patients with systolic 
heart failure has improved over the years (Roger et al 2004). 
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The proportion of patients with heart failure with a preserved as opposed to 
reduced ejection fraction is increasing steadily. Indeed, each year the prevalence of 
diastolic heart failure increases by approximately 1% compared to systolic heart 
failure (Federmann & Hess 1994; Owan et al 2006; Fonarow et al 2007; Borlaug & 
Redfield 2011; Borlaug & Paulus 2011; Scantlebury & Borlaug 2011). The increased 
prevalence of heart failure with a preserved ejection fraction is possibly because of 
ageing populations and an increasing prevalence of obesity, and/or an increased 
physician recognition of the syndrome (Owan et al 2006). Generally there is a poor 
understanding of the pathophysiology of heart failure with a preserved ejection 
fraction, and hence there is a reliance on therapeutic approaches largely based upon 
the pathophysiology of heart failure with a reduced ejection fraction, which have 
failed to improve survival in patients with diastolic heart failure (Borlaug & Redfield 
2011; Owan et al 2006). Bearing in mind the increased incidence of heart failure with 
a preserved ejection fraction and the poor survival rates in these patients, the topic of 
my thesis as previously mentioned, is to further elucidate the impact of risk factors 
associated with the development of LV diastolic dysfunction, which is thought to be 
the precursor to diastolic heart failure. Hence, in this chapter I will not further discuss 
systolic heart failure, but rather focus my discussion on diastolic heart failure. In this 
regard, what is currently known regarding the pathophysiology of diastolic 
dysfunction and heart failure with a preserved ejection fraction?  
 
1.2.1 Current understanding of the pathophysiology of heart failure with a 
preserved ejection fraction 
 
As previously indicated, data from large community-based studies have 
shown that patients diagnosed with heart failure with a preserved ejection fraction are 
more likely to be women and of an advanced age, are less likely to have coronary 
artery disease and more often present with underlying diseases such as obesity and 
hypertension (Masoudi et al 2003; Redfield et al 2003; Bhatia et al 2006; Bursi et al 
2006; Owan et al 2006; Lee et al 2009). In addition, in contrast to heart failure with a 
reduced ejection fraction which is associated with cardiac dilatation, concentric 
cardiac remodelling is commonly present in patients with heart failure with a 
preserved ejection fraction (Drazner et al 2004). It is therefore thought that age-, 
hypertension-, and/or obesity-related ventricular remodelling precedes the 
development of heart failure with a preserved ejection fraction (Borlaug & Redfield 
2011; Scantlebury & Borlaug 2011). 
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Although the progression of a number of abnormalities such as loss of 
contractile reserve, chronotropic reserve, vasodilatory reserve and endothelial 
dysfunction (Borlaug et al 2006; Brubaker et al 2006; Borlauga et al 2010; Borlaugb et 
al 2010) promote the transition from diastolic dysfunction to heart failure with a 
preserved ejection fraction, as mentioned in the aforementioned discussion, the 
essential abnormality of cardiac function in heart failure with a preserved ejection 
fraction is an abnormality of the diastolic period of the cardiac cycle. In this regard, 
the basic pathophysiology of diastolic heart failure is that cardiomyocyte resting 
tension (the tension during the diastolic period of the cardiac cycle) is increased 
(Borebely et al 2005; van Heerebeek et al 2006; van Heerebeek et al 2008). The 
higher cardiomyocyte resting tension may be produced by incomplete relaxation such 
as may occur when a decreased calcium reuptake by the sarcoplasmic reticulum 
occurs (van Heerebeek et al 2006); an increase in the stiffer isoform of the 
macromolecule titin (van Heerebeek et al 2006), or to alterations in the interstitium 
producing a stiffer myocardium. In this regard, increases in myocardial collagen 
(fibrosis) associated with an increased activity of the renin-angiotensin system and/or 
increases in the cross-linking of collagen (often associated with accumulation of 
advanced glycation end-products in diabetes mellitus) result in increased myocardial 
stiffness which impairs cardiac filling (Borlaug & Paulus 2011; Norton et al 1996; 
Kasner et al 2011; Lopez et al 2012; van Heerebeek et al 2006). Increases in the 
expression of the protein lysyl oxidase, which mediates collagen cross-linking, has 
been observed in association with increased collagen deposition and cross-linking in 
patients with heart failure with a preserved ejection fraction, even in the absence of 
diabetes mellitus (Kasner et al 2011; Lopez et al 2012). Based upon these 
pathophysiological changes, pharmacological agents that improve myocardial 
sarcoplasmic reticulum calcium re-uptake, decrease collagen deposition, or decrease 
collagen cross-linking, have been developed. However, only few of these agents 
have progressed from pre-clinical studies to clinical trials. The outcomes of these 
studies will be discussed in the section below which summarises the current 
therapeutic approaches to preventing and treating heart failure with a preserved 
ejection fraction. 
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1.2.2 What are the current therapeutic approaches to preventing and treating heart 
failure with a preserved ejection fraction? 
 
Clinically, the treatment approaches to patients with heart failure with a 
preserved ejection fraction are largely based on an understanding the 
pathophysiology of systolic dysfunction and heart failure with a reduced ejection 
fraction (Federmann & Hess 1994; Yusuf et al 2003; Cleland et al 2006; Massie et al 
2008; Hernandez et al 2009; Borlaug & Redfield 2011). However, data from large 
multicentre clinical trials (I-PRESERVE, CHARM-Preserved, PEP-CHF, DIG-
Preserved, OPTIMIZE-BB, OPTIMIZE-ACE) have shown that none of the current 
therapeutic regimens (digitalis, ARBs, ACEIs and beta-blockers), reduce the rate of 
death or hospitalisation for heart failure in patients with heart failure with a preserved 
ejection fraction (Owan et al 2006; Paulus & van Ballegoij 2010; Borlaug & Paulus 
2011; Borlaug & Redfield 2011; Li et al 2013; Pitt et al 2014). Moreover, to-date the 
outcomes of more novel agents (based upon the current understanding of the 
pathophysiological basis of heart failure with a preserved ejection fraction, as 
discussed in section 1.2.1 above) have been equally as disappointing. In this regard, 
therapies targeting fibrosis and related changes in ventricular and arterial stiffness, 
as well as vasoconstriction, have largely proved unsuccessful (Nanayakkara & Kaye 
2015). Indeed, an advanced glycosylation end-product breaker (ALT-711) (Little et al 
2005), failed to improve measurements of diastolic function (either early-to-late 
transmitral velocity or an index of ventricular filling pressure [E/e’], see section 1.3.2 
for a description of these measurements). In addition, the aldosterone receptor 
antagonist, eplerenone (Deswal et al 2011) (which reduces the degree of myocardial 
fibrosis), showed no impact on standard measures of diastolic function (early-to-late 
transmitral velocity, see section 1.3.2) and only a modest (p=0.04) reduction in an 
index of ventricular filling pressure (E/e’, see section 1.3.2). Moreover, despite 
evidence of an improved diastolic function with the aldosterone receptor antagonist, 
spironolactone in the Aldosterone Receptor Blockade in Diastolic Heart Failure (Aldo-
DHF) study (Edelmann et al 2013), in a larger outcomes based study (TOPCAT), 
spironolactone treatment was not associated with an improved survival (Pitt et al 
2014). Alternative antifibrotic approaches such as the use of the phosphodiesterase 
5 inhibitor, sildenafil, have similarly reported no beneficial effects on clinical or 
cardiac structural measurements (Redfield et al 2013). The possible impact of 
soluble guanylate cyclase agonists, which potentially produce vasodilatation and 
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inhibit smooth muscle proliferation, is currently being assessed (Pieske et al 2014). 
Furthermore, the possible effects of other pharmacological approaches largely aimed 
at reducing vasoconstriction or promoting vasodilation such as endothelin receptor 
antagonism, iron supplementation, and the combination of hydralazine and 
isosorbide mononitrate are currently being investigated (Nanayakkara & Kaye 2015).      
As current therapeutic approaches to the management of patients with heart 
failure with a preserved ejection fraction have proved inadequate (Borlaug & Redfield 
2011), and the burden of disease is high (Bhatia et al 2006; Yancy et al 2006; 
Fonarow et al 2007; Lam et al 2007; Borlaug & Redfield 2011; Chirinos et al 2012; 
Nichols et al 2014), the most likely approach that will effectively reduce morbidity and 
mortality related to this form of heart failure is to prevent the development of diastolic 
heart failure. In this regard, there may be better approaches to identifying those 
patients most at risk of developing heart failure with a preserved ejection fraction and 
targeting the fundamental problem. As various biomarkers of collagen turnover 
(matrix metalloproteinase [MMP]-2, MMP-8, tissue inhibitor of matrix 
metalloproteinase [TIMP]-4, collagen III N-terminal propetide [PIIINP]) are increased 
in patients with cardiac hypertrophy and heart failure with a preserved ejection 
fraction (Zile et al 2011), it has been suggested that combinations of these 
biomarkers could be used to identify patients with LV diastolic dysfunction who are 
likely to develop heart failure with a preserved ejection fraction. Although these 
biomarkers are unlikely to distinguish patients with diastolic heart failure from patients 
with systolic heart failure, as they are increased similarly in patients with either type 
of heart failure (de Denus et al 2012), there are presently no studies which have 
assessed whether these biomarkers of collagen turnover predict the development of 
heart failure with a preserved ejection fraction. Until such time as these studies 
provide evidence for the use of biomarkers of collagen turnover to predict the 
development of heart failure with a preserved ejection fraction, other approaches 
should be sought to identify those patients most at risk.  
In summary the current understanding of the pathophysiology of heart failure 
with a preserved ejection fraction has not proved helpful in developing agents to 
target diastolic heart failure. Indeed, there is presently no treatment with proven 
benefit for heart failure with a normal ejection fraction (Borlaug & Paulus 2011; 
Borlaug & Redfield 2011; Pitt et al 2014). Hence, a better approach may be to 
improve on our understanding of the risk factors for LV diastolic dysfunction which is 
the precursor of heart failure with a preserved ejection fraction. Once we have better 
insight into how these risk factors mediate their adverse effects, targeting specific 
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aspects of these risk factors may assist in the prevention of LV diastolic dysfunction 
and hence the development of diastolic heart failure. As the current thesis is focused 
on aspects of LV diastolic function, for the remainder of this chapter I will discuss LV 
diastolic rather than systolic function.  
 
1.3 Cardiac diastolic function and outcomes  
 
What is the evidence in support of LV diastolic dysfunction being a precursor 
of cardiovascular events and heart failure with a preserved ejection fraction? In a 
large (approximately 36 000 patients) outcomes-based study LV diastolic dysfunction 
was shown to be an independent predictor of all-cause mortality (Halley et al 2011). 
These data confirmed earlier reports in a small follow-up study where LV diastolic 
dysfunction was shown to be associated with all-cause mortality independent of 
coronary artery disease or cancer (Achong et al 2009). Moreover, worsening of LV 
diastolic function is associated with a worse prognosis (AlJaroudi et al 2012), and LV 
diastolic dysfunction is a predictor of primary cardiovascular events (Desai et al 2012; 
Sharp et al 2010). There is therefore substantial evidence to support an association 
between LV diastolic dysfunction and cardiovascular or all-cause mortality. However, 
what is the evidence to support LV diastolic dysfunction as being the precursor to 
heart failure with a preserved ejection fraction? 
There is now considerable evidence indicating that LV diastolic dysfunction 
can occur without the presence of heart failure (Masoudi et al 2003; Redfield et al 
2003; Bhatia et al 2006; Bursi et al 2006; Owan et al 2006; Lee et al 2009). In 
support of these studies, findings from our group performed in a South African 
population of African ancestry have also highlighted the relatively high prevalence of 
LV diastolic dysfunction in the absence of heart failure (Libhaber et al 2014; Millen et 
al 2014). Importantly, however, in support of earlier studies which demonstrated that 
in patients with a preserved ejection fraction, symptoms of congestive heart failure 
are associated with LV diastolic dysfunction (Senni et al 1998; Angeja & Grossman 
2003), subclinical changes in diastolic function have been noted to precede the 
development of clinical heart failure (Bella et al 2002; Hogg et al 2003; Wan et al 
2014; Wang et al 2003; Zile et al 2002), as well as to increase the risk of developing 
heart failure with a preserved ejection fraction (Bella et al 2002; Hogg et al 2003; 
Wang et al 2003; Zile et al 2002). Noteworthy is that a number of studies have now 
shown that LV diastolic dysfunction predicts the progression to heart failure with a 
preserved ejection fraction (Aurigemma et al 2001; Bella et al 2002; Kane et al 2011; 
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Lam et al 2011; Redfield et al 2003; Schillaci et al 2002). Also of importance is that 
the pathophysiological changes thought to determine heart failure with a preserved 
ejection fraction, such as increases in ventricular stiffness and reductions in 
relaxation, are associated with diastolic heart failure (Burke et al 2014; Mohammed et 
al 2012; Shah et al 2014; Westerman et al 2008; Zile et al 2004). Hence, there is 
substantial evidence to indicate that LV diastolic dysfunction is central to the 
pathophysiology and outcomes of heart failure with a normal ejection fraction. Before 
describing the evidence on the role of risk factors for LV diastolic dysfunction, it is 
nevertheless important to expand on the current approaches to assessing LV 
diastolic function and the classification of LV diastolic dysfunction.  
 
1.4. Measurement of and approaches to the classification of cardiac 
diastolic dysfunction 
 
The classification of cardiac diastolic dysfunction is based on measurements 
of function of the ventricular chamber during the diastolic period of the cardiac cycle 
including increases in filling pressures. As the studies in my thesis were conducted in 
a community-based sample only non-invasive assessments of diastolic function and 
filling pressures were performed. The physiological basis, merits and limitations of 
the non-invasive assessments performed in my studies will be discussed in the 
subsequent sections, following which the approaches to the classification of cardiac 
diastolic dysfunction will be addressed (see section 1.4.2).        
 
1.4.1 Non-invasive measurements of diastolic dysfunction 
 
The diastolic component of the cardiac cycle commences at the closure of the 
aortic and pulmonary valves and ends at the closure of the atrio-ventricular (mitral 
and tricuspid) valves. Diastole consists of 4 phases, namely isovolumic relaxation, 
rapid filling, diastasis and atrial contraction (Brutsaert et al 1993; Nagueh et al 2009). 
Left ventricular diastolic dysfunction is the result of impaired relaxation, reduced early 
diastolic suction and increased LV chamber stiffness, which result in an increase in 
cardiac filling pressures. Hence, in echocardiographic studies to determine the 
presence versus absence of LV diastolic dysfunction, LV diastolic function must be 
determined and LV filling pressures estimated. The most useful, feasible and 
reproducible echocardiographic measurements of LV diastolic function and estimates 
of LV filling pressures include traditional assessments of mitral inflow (trans-mitral 
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peak early [E] wave velocity, late diastolic or atrial filling [A] wave velocity, trans-
mitral E/A ratio; and trans-mitral E wave velocity deceleration time) and more 
contemporary measurements of tissue Doppler imaging (pulsed-wave tissue Doppler 
imaging derived mitral annular early diastolic velocity [e’] and mitral E/e’ ratio), as 
well as two-dimensional assessments of left atrial (LA) volume index (Nagueh et al 
2016). Alternative variables, such as changes in mitral inflow with the Valsalva 
maneuver, are not feasible in all patients and need to be carefully standardised in 
order for accurate interpretations to be made (Nagueh et al 2016). In addition, the E-
e’ time interval is difficult to acquire and requires matching electrocardiographic R-R 
intervals (Nagueh et al 2016). Although isovolumic relaxation time (IVRT) is reported 
to be feasible and reproducible, it is in part affected by heart rate and arterial 
pressures which would impact on its interpretation (Nagueh et al 2016). Hence, in my 
thesis, I focused on the measurements of diastolic function and filling pressures 
which are both reported to be reliable and reproducible (Nagueh et al 2016), as well 
as to have a low degree of variability (Norton et al 2008) in our hands. These will be 
discussed below. 
 
1.4.1.1 Mitral inflow 
 
Mitral inflow measurements are obtained by pulsed-wave (PW) Doppler 
performed in the apical 4-chamber view of the heart. The primary measurements of 
mitral inflow include peak early (E wave) velocity, late diastolic or atrial filling (A 
wave) velocity, the ratio of E wave to A wave velocity (E/A), and deceleration time of 
early filling velocity (Figure 1.1). Measurements of mitral inflow velocity are used to 
non-invasively assess LV filling pressures (Appleton et al 1997). As mitral peak E 
wave velocity reflects the pressure gradient between the LA and LV during early 
diastole, it best relates to earlier LV diastolic pressures, such as mean pulmonary 
capillary wedge pressure and mean LV diastolic pressure. In comparison, mitral A 
wave velocity reflects the pressure gradient between the LA and LV during late 
diastole, and hence correlates best with LV end diastolic pressure (Nagueh et al 
2016). The mitral A wave velocity is an index of LV compliance as well as contractile 
function of the LA; whereas mitral peak E wave velocity and E wave velocity 
deceleration time are indices of the rate of LV relaxation and LA pressures. In 
addition, the mitral E wave velocity is directly influenced by alterations in LV volumes 
and therefore LV volume preloads. Although a number of variables other than LV 
diastolic function and filling pressures (such as heart rate and rhythm, PR interval, 
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cardiac output, mitral annular size, and LA function) affect mitral inflow velocities, 
measurements of mitral inflow remain an integral component of the classification of 
diastolic dysfunction (see section 1.4.2 below).   
 
1.4.1.2 Tissue Doppler imaging 
 
Pulsed wave Tissue Doppler imaging (TDI) is a reproducible 
echocardiographic tool which is performed in the apical 4 chamber view to obtain 
quantitative assessments of peak myocardial early (e’ or Ea) and late (a’ or Aa) 
diastolic velocity at the mitral annulus (Waggoner & Bierig 2001) (Figure 1.1). These 
velocities can be measured from either the septal or the lateral mitral annulus; 
however septal measurement values are reported to be lower than lateral 
measurements (Isaaz et al 1993, Nagueh et al 2009). The current recommendation is 
that e’ is expressed as the average of septal and lateral measurements (Nagueh et al 
2009). Aa or a’ represents active atrial contraction in late diastole (Thomas et al 
2003). Similar to E wave velocity, e’ reflects the rate of early diastolic myocardial 
relaxation (Nagueh et al 2001; Oki et al 1997). In normal individuals, e’ is augmented 
by increases in the trans-mitral pressure gradient, as occurs with elevations in 
preload. However, in patients with an impaired relaxation, e’ is decreased at rest and 
the response to increases in preload is reduced in comparison to normal individuals 
(Yu et al 2005). Therefore, in patients with impaired relaxation, because e’ remains 
reduced (remains constant), whereas mitral E wave velocity increases in response to 
higher filling pressures, the ratio E/e’ is increased (Ommen et al 2000). In 
comparison, as both e’ and E wave velocity increase with increasing trans-mitral 
pressure gradients in normal individuals, E/e’ is similar at rest and with exercise 
(usually <8).  E/e’ correlates well with mean LV filling pressure and pulmonary 
capillary wedge pressure (Sohn et al 1997, Nagueh et al 1997; Ommen et al 2000). If 
E/e’ is ≥15 then the pulmonary capillary wedge pressure is reported to be ≥20 mm 
Hg, and if E/e’ is <8 then the pulmonary capillary wedge pressure is reported to be 
normal. Moreover, the prognostic importance of E/e’ has been highlighted by a 
number of studies which have reported increases in cardiac mortality in patients with 
heart failure who had E/e’≥15 (Dokainish et al 2005; Yamamoto et al 2003). Hence, 
the use of TDI to assess e’ and a’ and the subsequent calculation of E/e’ has become 
an essential component of the echocardiographic evaluation of diastolic function 
(Sohn et al 1997, Nagueh et al 1997; Ommen et al 2000). 
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Figure 1.1 Example of echocardiographic images of pulsed wave Doppler transmitral 
E wave (E) and A wave (A) velocities (upper panel), and TDI peak myocardial early 
(e’) and late (a’) diastolic velocity at the mitral annulus(lower panel) used to assess 
diastolic function.  
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1.4.1.3 LA volume  
 
Echocardiographic assessment of left atrial (LA) volume is most accurately 
performed from the apical 4-chamber and 2-chamber views (Lang et al 2015). 
Importantly, in order to correct for differences in body size so that comparisons to 
normal values can be made, LA volume is indexed to body surface area (Vasan et al 
2000; Prichett et al 2003). Although increases in LA size can be caused by increases 
in filling volumes, they are most commonly related to increases in wall tension due to 
augmented filling pressures (Simek et al 1995; Appleton et al 1993). Importantly, the 
adverse cardiovascular outcomes associated with increased LA dimensions (Tsang 
et al 2002 & 2003; Kizer et al 2006) are more strongly related to increases in filling 
pressures than filling volumes. Left atrial enlargement is reported to be a marker of 
both the severity of diastolic dysfunction and the magnitude of LA pressure elevation 
(Kizer et al 2006; Simek et al 1995; Appleton et al 1993). An additional benefit of the 
assessment of LA volume is that unlike Doppler velocities which reflect filling 
pressures only at the time of measurement, LA volume reflects the cumulative effects 
of increases in filling pressures over time (Nagueh et al 2009; Kizer et al 2006; Simek 
et al 1995; Appleton et al 1993).  
In large observational studies, an LA volume index ≥ 34 ml/m2 is an 
independent predictor of death, heart failure, atrial fibrillation and ischaemic stroke 
(Abhayaratnab et al 2006). However, measurements of LA volume should not be 
interpreted in isolation, as alone they are not specific to diastolic dysfunction. A 
dilated LA is a feature of a number of other clinical entities including bradycardia and 
4-chamber enlargement, anaemia and other high-output state, atrial flutter and 
fibrillation, and significant mitral valve disease in the absence of diastolic dysfunction 
(Nagueh et al 2009). In addition, an increased LA volume index is commonly 
reported in elite athletes in the absence of cardiovascular disease (Nagueh et al 
2009). Hence, in the classification of diastolic function, measurements of LA volume 
index need to be assessed in conjunction with Doppler 
 parameters (see section 1.4.2 below).  
 
1.4.2 Classification of diastolic dysfunction 
 
One of the concerns about differentiating between normal and abnormal 
diastolic function is that normal aging is associated with slowing of LV relaxation. 
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Indeed, LV filling patterns in the elderly resemble those of younger patients (40 to 60 
years) with mild diastolic dysfunction (Caballero et al 2015). However, in comparison 
to the mitral E/A ratio and e’ velocity, the E/e’ ratio appears to be less age dependent 
(Caballero et al 2015).  
Another consideration in the classification of diastolic dysfunction is the 
development of a pseudonormal E wave to A wave velocity pattern. In normal 
individuals, the E wave is higher than the A wave, and this pattern reverses in early 
diastolic dysfunction. In advanced diastolic dysfunction, the E wave velocity again 
becomes higher than the A wave velocity resulting in a so-called pseudonormal 
pattern and hence the use of the mitral inflow patterns to diagnose diastolic 
dysfunction becomes problematic (Oh et al 2011). However, reductions in e’ velocity 
precede reductions in E velocity by 10-15 years (Sohn et al 1997), and are reduced 
in subjects with early diastolic dysfunction. Hence, in the diagnosis of diastolic 
dysfunction, it is useful to combine measurements of mitral inflow and TDI annular 
velocities. Indeed, the utility of TDI assessments is evident from their inclusion in the 
EAE/ASE guidelines for the assessment of diastolic dysfunction (Nagueh et al 2009, 
Nagueh et al 2016).  
According to the EAE/ASE guidelines diastolic dysfunction is defined primarily 
according to mitral inflow E/A, TDI septal e’, TDI lateral e’, and LA volume values 
(Nagueh et al 2009, Nagueh et al 2016). In accordance with these guidelines, in 
individuals with normal ejection fraction, the presence of LV diastolic dysfunction is 
identified by lateral e′ < 10 cm/s, septal e′ < 8 cm/s or left atrial volume ≥ 34 ml/m2. 
Mild diastolic dysfunction is defined as E/A ≤ 0.80 (impaired relaxation) or E/e′ ≤ 8. 
Moderate diastolic dysfunction is defined as E/A from 0.80 to 1.5 or E/e′ from 9 to 12, 
and severe diastolic dysfunction is defined as E/A ≥ 2 or E/e′ ≥ 13. In addition, the 
change in E/A during the Valsalva maneuvre is used to grade mild (I) (Valsalva 
change in E/A<0.5) compared to moderate (II) and severe (IIII) (Valsalva change in 
E/A≥0.5) diastolic dysfunction. Although, the time difference between the duration of 
pulmonary venous flow and mitral inflow during atrial contraction (A wave) (Ar-A 
duration) and E wave velocity deceleration time were incorporated in the 2009 
algorithm (Nagueh et al 2009), they were not included in the recently published 
updated algorithm (Nagueh et al 2016). According to the simplified 2016 algorithm, in 
persons with normal ejection fraction, diastolic function is normal if <50% of the 
following criteria are present: average E/e’ > 14; septal e’ < 7 cm/s or lateral e’ <10 
cm/s; LA volume index > 34 ml/m2; tricuspid regurgitation velocity > 2.8 m/s. In 
persons with normal ejection fraction, diastolic dysfunction is present if >50% of the 
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following criteria are present: average E/e’ > 14; septal e’ < 7 cm/s or lateral e’ <10 
cm/s; LA volume index > 34 ml/m2; tricuspid regurgitation velocity > 2.8 m/s. 
 
1.5 Factors associated with the development of LV diastolic dysfunction 
  
A number of factors are associated with the development of LV diastolic 
dysfunction. In this regard, the two major contributing factors are age and female 
gender (Borlaug & Redfield 2011). However, little is understood as to how age and 
female gender contribute toward LV diastolic dysfunction. Hence, these two factors 
are not currently potential modifiable targets in order to decrease the overall risk of 
developing heart failure with a preserved ejection fraction. I will therefore only 
discuss aspects of these risk factors and when doing so, this will only be done in a 
cursory manner. Among the number of modifiable risk factors which have been 
associated with LV diastolic dysfunction, obesity and associated metabolic 
abnormalities (diabetes mellitus, insulin resistance) as well as blood pressure or 
hypertension have been identified as the major determinants (Bhatia et al 2006; Bursi 
et al 2006; Desai et al 2012; Lee et al 2009; Masoudi et al 2003; Owan et al 2006; 
Redfield et al 2003). Importantly, increases in LV mass as well as a concentric LV 
geometry, which are often associated with these risk factors, have been shown to 
play a significant role (Chahal et al 2010; Lorell et al 1990). Nevertheless, obesity, 
blood pressure and associated changes in LV mass and geometry fail to account for 
all of the inter-individual variation in diastolic function. Hence, genetic factors may be 
responsible for some of the unexplained inter-individual variation in LV diastolic 
function. In the subsequent sections of the present chapter I will therefore discuss the 
current knowledge on the role of obesity, blood pressure (and the associated 
changes in LV mass and geometry) and the possible role of genetic factors in 
determining LV diastolic function. In so doing I will highlight the several areas of 
missing evidence that I subsequently pursued as part of my thesis to attempt to add 
to our understanding of these topics. 
 
1.5.1 Obesity as a cause of LV diastolic dysfunction 
 
 In the following section I will discuss obesity as a possible cause of LV 
diastolic dysfunction. However, it is important in the context of the present thesis to 
provide a more overall approach to the relevance of this topic in the setting of obesity 
as a cause of heart failure. It is also important to underscore the mechanisms that 
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may explain the relationship between obesity and either heart failure or LV diastolic 
dysfunction. Hence, in the following sections I will deal with each of these topics in 
turn. 
 
1.5.1.1 Obesity as a risk factor for heart failure 
 
Over the past two decades, a nested case-control study and a number of 
prospective studies have demonstrated an independent relationship between the 
degree of adiposity and the development of heart failure (Chen et al 1999, He et al 
2001, Johansson et al 2001, Wilhelmsen et al 2001, Kenchaiah et al 2002, 2009, 
Ingelssona et al 2005, Ingelssonb et al 2005, Nicklas et al 2006, Bahrami et al 2008, 
Spies et al 2009). This relationship has been demonstrated in the general population 
(He et al 2001, Kenchaiah et al 2002 Ingelssonb et al 2005, Bahrami et al 2008), in 
the middle-aged (Ingelssona et al 2005), in the elderly (Chen et al 1999, Nicklas et al 
2006), in men (Wilhelmsen et al 2001, Ingelssonb 2005), in women (He et al 2001), in 
general practice (Johansson et al 2001), in physicians (Kenchaiah et al 2009) and in 
persons with established coronary artery disease (Spies et al 2009). 
As compared to a referent body mass index (BMI) between 20 and 25 kg/m2 
(normal) a BMI of between 25 and 30 kg/m2 (overweight) may increase the risk of 
heart failure by 39-49% (Bahrami et al 2008, Kenchaiah et al 2009) and a BMI 
greater than or equal to 30 kg/m2 (obese) increases the risk of heart failure by 83-
180% independent of conventional cardiovascular risk factors (Johansson et al 2001, 
Kenchaiah et al 2002, Bahrami et al 2008, Kenchaiah et al 2009). In one study, 
however, no increased risk for heart failure was noted in persons with a BMI of 
between 25 and 30 kg/m2 (overweight) in a general practice setting (Johansson et al 
2001). Moreover, in one study (Spies et al 2009), but not in other studies (Ingelssonb 
et al 2005, Nicklas et al 2006) the adipose tissue-heart failure relationship was better 
predicted by the use of indices of adiposity that reflect an accumulation of fat in 
central (abdominal) stores, such as waist circumference or waist-to-hip ratio, than 
indices of general adiposity, such as BMI. Depending on the study population and the 
study design, the independent risk for heart failure in people who are overweight or 
obese is quantitatively comparable with the impact of, for example, the presence of 
hypertension, or diabetes mellitus in these same studies. 
Although the relationship between excess adiposity and the development of 
heart failure is modified by adjustments for conventional cardiovascular risk factors, 
including hypertension, diabetes mellitus and cholesterol concentrations as well as 
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with adjustments for coronary events, the impact of these adjustments is surprisingly 
modest. Indeed, considering overweight and obese persons overall, the percentage 
risk for heart failure is diminished by only 1-13% with these adjustments (He et al 
2001, Ingelssona et al 2005, Ingelssonb et al 2005, Nicklas et al 2006, Spies et al 
2009) and by only 55% in obese individuals in a study in which obesity increased the 
risk for heart failure by 180% (Kenchaiah et al 2009). Thus, although there is no 
question that to prevent overweight/obesity-induced heart failure, targeting modifiable 
cardiovascular risk factors with lifestyle interventions and medication is an essential 
approach, the large residual risk for heart failure after adjustments for conventional 
cardiovascular risk factors indicates that this may not be the most appropriate 
solution. Better understanding of the mechanisms by which excess adiposity 
contributes toward heart failure may shed light on more effective therapeutic 
approaches other than weight loss per se. 
   
1.5.1.2 Obesity as a risk factor for the development of LV diastolic dysfunction 
  
The impact of obesity on the risk of heart failure may in part be explained by 
the association of obesity with LV diastolic dysfunction. Indeed, previous studies, first 
reported on by our group in a general community-based sample with a high 
prevalence of obesity (Libhaber et al 2009), have demonstrated that LV diastolic 
abnormalities are correlated with obesity and these studies were performed in study 
samples where generally most participants had a preserved ejection fraction (Tsioufis 
et al 2008; Libhaber et al 2009; Russo et al 2011, AlJaroudi et al 2012; Cil et al 
2012). However, bearing in mind that obesity often occurs together with diabetes 
mellitus and hypertension, what is the evidence for an effect of obesity on diastolic 
function independent of these co-morbidities? In addition, obesity is a well-
recognised cause of LVH and several studies have reported associations between 
obesity and an increased LV relative wall thickness (Millen et al 2014; Woodiwiss & 
Norton 2015). Moreover, as will be further discussed in section 1.5.1.4, increases in 
LV relative wall thickness are strongly correlated with changes in diastolic function 
(Hsuan et al 2010), and decreases in LV relative wall thickness subsequent to 
bariatric surgery are accompanied by increases in LV diastolic function (Hsuan et al 
2010; Ippisch et al 2008; Luaces et al 2012). As obesity, diabetes mellitus and 
hypertension induce cardiac hypertrophy, and LVH as well as an increased relative 
wall thickness are determinants of diastolic function (as discussed in section 1.5.1.4 
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below), the evidence for an impact of obesity on LV diastolic function independent of 
increases in LV mass or relative wall thickness needs to be considered.  
In 966 hypertensives, Tsioufis et al (2008) reported that waist circumference 
was independently associated with LV E/A, thus providing the first data from a large 
study sample that indices of obesity are independently and substantively associated 
with LV diastolic function. However, in that study (Tsioufis et al 2008) hypertensives 
were evaluated and it is uncertain whether the obesity effects could be dissociated 
from the blood pressure effects. Moreover, whether the relations between obesity 
and LV diastolic function in that study (Tsioufis et al 2008) were independent of LV 
mass and LV remodelling was unclear. However, Libhaber et al (2009) subsequently 
demonstrated in a randomly selected community sample with a low prevalence of 
antihypertensive therapy, that a significant proportion of LV E/A could be accounted 
for by increases in waist circumference and that this effect was independent of 
ambulatory and central aortic blood pressure and LV mass or LV relative wall 
thickness. However, in that study (Libhaber et al 2009), only E/A was assessed as a 
measure of LV diastolic function. In a subsequent larger community-based study 
conducted in 950 randomly recruited participants, an increased body mass index 
(BMI) was associated with LV diastolic dysfunction assessed from both trans-mitral 
and tissue Doppler indices of diastolic function, independent of LV mass, diabetes 
mellitus and hypertension (Russo et al 2011). However relative wall thickness was 
not assessed and blood pressure was not assessed as a continuous trait with 
diastolic and systolic blood pressure contributing differentially to different 
components of LV diastolic function (Libhaber et al 2014).  In a subsequent large (21 
666 patients) study, BMI was also associated with LV diastolic dysfunction assessed 
from both trans-mitral and tissue Doppler indices of diastolic function (AlJaroudi et al 
2012). This relationship was independent of diabetes mellitus, blood pressure and LV 
mass; however, relative wall thickness was not assessed and again blood pressure 
was not assessed as a continuous trait with diastolic and systolic blood pressure 
contributing differentially to different components of LV diastolic function (Libhaber et 
al 2014). Moreover, in a large study of 2228 participants, BMI, hypertension and 
diabetes mellitus were all identified as independent predictors of LV diastolic 
dysfunction (Çil et al 2012). However, once again the possible impact of LV mass 
and relative wall thickness were not assessed and again blood pressure was not 
assessed as a continuous trait with diastolic and systolic blood pressure contributing 
differentially to different components of LV diastolic function (Libhaber et al 2014). 
Therefore, although several lines of evidence suggest that obesity is independently 
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associated with LV diastolic function, only one study (Libhaber et al 2009) showed 
that this was independent of both LV mass and LV remodeling, and many of these 
studies, again with the exception of Libhaber et al (2009), failed to appropriately 
adjust for blood pressure effects. Hence, it is possible that the relationship between 
adiposity indices and LV diastolic function in many of these studies were due to 
residual confounding of LV remodelling and blood pressure. In this regard, 
independent of blood pressure control during 4 years of anti-hypertensive therapy, an 
increase in BMI is associated with less of a decrease in LV mass (de Simone et al 
2013). Moreover, more recent evidence from our group suggests that blood pressure 
effects on LV diastolic function at a community level are far more important than 
obesity effects on LV diastolic function (Millen et al 2014). Nevertheless, in order to 
identify cause versus effect relationships it is best to assess data from intervention 
studies. What is the evidence that weight loss influences LV diastolic function and is 
this independent of LV mass, LV remodelling and blood pressure effects?  
The most effective method of losing weight (extent and sustainability) is 
bariatric surgery, an intervention that is usually only conducted in morbidly obese 
patients. In this regard, a number of intervention studies have assessed the impact of 
weight loss subsequent to bariatric surgery on LV diastolic function. Indeed, a 
systematic review and meta-analysis of 23 studies assessing the effects of bariatric 
surgery on cardiac structure and function in obese patients with preserved systolic 
function has fairly recently been published (Cuspidi et al 2014). This meta-analysis 
showed that improvements in LV diastolic function as well as reductions in LV mass 
and relative wall thickness were indeed a consequence of weight loss. Hence, it is 
possible that obesity is causally related to decreases in LV diastolic function as well 
as LVH and LV concentric remodelling. However, whether the improvements in LV 
diastolic function subsequent to weight loss were a consequence of the reductions in 
LV mass and LV relative wall thickness or independent of changes in LV mass and 
LV remodelling could not be determined from these studies. In this regard, a previous 
study has suggested an interactive effect between LV structure and diastolic function 
where improvements in LV E/A with a decrease in body weight were only observed in 
those patients with LVH (Syed et al 2009). Moreover, whether the improvements in 
LV diastolic function were independent of blood pressure or diabetes mellitus could 
not be assessed from the studies included in this meta-analysis (Cuspidi et al 2014). 
Is there a possible mechanism that could explain obesity effects on LV diastolic 
function independent of LVH, LV remodelling and blood pressure? 
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1.5.1.3 Insulin resistance as a possible mechanism explaining the independent 
relationship between obesity and LV diastolic dysfunction 
  
Insulin resistance may occur as a consequence of excess adiposity and this 
effect is more closely associated with the extent of abdominal as opposed to general 
obesity (Kahn and Flier 2000). At a cellular level, insulin binds to its receptor on the 
surface of target cells, thereby causing tyrosine autophosphorylation and consequent 
intracellular signaling. These events culminate in cellular responses, such as the 
translocation of glucose transporters to the cell surface to allow glucose uptake for 
use or glycogen storage. In obesity, however, insulin signaling may be defective. 
Insulin-stimulated protein kinase activity of the insulin receptor, which mediates 
tyrosine autophosphorylation, is reduced in obese as compared to non-obese people, 
and it is further reduced in patients with obesity-induced type 2 diabetes mellitus 
(Caro et al 1989). However, euglycaemia is maintained in the initial stages of insulin-
resistance through compensatory hyperinsulinaemia. Indeed, there is considerable 
evidence to suggest that a large proportion of obese individuals are insulin-resistant, 
but that compensatory hyperinsulinaemia maintains fasting blood glucose 
concentrations (Reaven 2003). Thus, insulin resistance goes undetected in these 
individuals. 
Insulin resistance will undoubtedly promote adverse cardiac effects once type 
2 diabetes mellitus develops and the effects of hyperglycaemia are noted. However, 
insulin resistance may also induce adverse cardiac changes prior to the development 
of diabetes mellitus and poor blood glucose control through a number of 
mechanisms. In this regard, insulin resistance is not specific to skeletal muscle, but 
also involves myocardial muscle tissue as well (Nikolaidis et al 2004, Ouwens et al 
2005, Coort et al 2007) where it downregulates glucose uptake and hence precludes 
the energetic advantage provided by glucose versus free fatty acid oxidation 
(Nikolaidis et al 2004, Ouwens et al 2005). Moreover, insulin resistance is associated 
with an accumulation of intracellular triacylglycerol which promotes lipotoxicity (Coort 
et al 2007). Hence, through either a reduced efficiency of energy utilisation or 
through cell death (lipotoxicity), obesity could promote LV diastolic dysfunction 
through a reduced ability of the myocardium to relax. 
Insulin resistance is often associated with leptin resistance and a reduced 
cardiac efficiency and an altered myocardial substrate metabolism may accompany 
obesity associated with leptin deficiency or leptin resistance (Buchanan et al 2005). 
These changes in myocardial substrate metabolism may contribute toward an 
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increased cardiomyocyte apoptosis in obesity models of leptin deficiency or leptin 
resistance (Barouch et al 2006). The cardiomyocyte apoptosis in leptin resistant or 
leptin deficient animals is thought to occur through a reduced cardioprotection 
mediated by leptin, possibly induced via a resultant increase in ectopic lipid overload 
in cardiac myocytes (lipoapoptosis) (Zhou et al 2000). Irrespective of the potential 
adverse myocardial changes that may be mediated by insulin resistance, an 
important question is to what extent does the current evidence suggest that obesity in 
humans may promote LV diastolic dysfunction through the presence of insulin 
resistance? 
Evidence for a role for insulin resistance as a possible factor involved in 
promoting obesity-associated LV diastolic dysfunction has been conflicting. In this 
regard, in 33 hypertensives, although those with an impaired glucose tolerance had a 
reduced E/A, E/A was unrelated to the area under the insulin curve after an oral 
glucose load (Nagano et al 1994). In 50 hypertensives, insulin resistance, as 
assessed using the euglycaemic insulin clamp technique, was associated with E/A; 
however, whether this association survived adjustments for adiposity indices is 
uncertain (Lind et al 1995). In 27 otherwise healthy overweight and obese 
participants, 12 of whom had insulin resistance, insulin resistance was not associated 
with LV isovolumic relaxation time (an index of LV diastolic relaxation) after adjusting 
for body weight (Mureddu et al 1998). In 29 hypertensives men, insulin resistance, as 
assessed using the euglycaemic insulin clamp technique, was associated with LV 
isovolumic relaxation time independent of BMI (Galderisi et al 1997). In 26 
hypertensives with an impaired glucose tolerance, 39 hypertensives with a normal 
glucose tolerance and 18 normotensives, insulin resistance, as determined from the 
insulin suppression test, was related to E/A independent of BMI (Watanabe et al 
1999). In 89 hypertensives, insulin resistance, as assessed with the euglycaemic 
insulin clamp technique, was not independently associated with E/A and LV 
isovolumic relaxation time (Olsen et al 2003). In 109 obese and 33 normal weight 
participants, fasting insulin concentrations were inversely correlated with tissue 
Doppler indices of both systolic and diastolic myocardial but not chamber function 
(Wong et al 2004). In 29 participants with a normal glucose tolerance, 20 with 
impaired glucose tolerance and 70 with type 2 diabetes mellitus, insulin resistance, 
as identified from the Quantitative Insulin Sensitivity Check Index, was associated 
with LV diastolic dysfunction independent of BMI and waist-to-hip ratio (Bajraktari et 
al 2006). In 208 patients with normal ejection fraction, of whom 57 had type 2 
diabetes mellitus, insulin resistance was independently associated with left 
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ventricular diastolic dysfunction in subjects without overt type 2 diabetes mellitus 
(Dinh et al, 2010). Although in 29 insulin resistant and 36 insulin sensitive women, 
diagnosed on the basis of the homeostasis model of insulin resistance (HOMA-IR), 
LV peak filling rate, an index of an abnormal diastolic function was reduced, it is 
uncertain whether these differences were independent of adiposity indices (Utz et al 
2011). Similarly, in 42 prediabetic adults with a HOMA-IR above 2.7, as compared to 
79 prediabetics with a HOMA-IR below 2.7, although E/A was reduced (Sliem et al 
2011), whether these differences were independent of adiposity indices is uncertain. 
Furthermore, in 92 participants either with or without an impaired glucose tolerance 
or diabetes mellitus, HOMA-IR was not correlated with E/A (Wada et al 2010) and in 
102 otherwise healthy individuals although visceral fat was associated with diastolic 
dysfunction, HOMA-IR was not (Wu et al 2012). In 18 lean and 25 overweight/obese 
people, although tissue Doppler indices of diastolic function were noted to be 
abnormal in overweight or obese individuals, HOMA-IR did not account for these 
differences (Lambert et al 2010). The results of the aforementioned studies 
conducted in small sample sizes of select clinical populations, may nevertheless 
reflect inadequate sample sizes and a selection bias. What is the evidence with 
respect to studies conducted with a large sample size in unselected populations? 
In 2399 participants of the Jackson Heart Study, in women with a normal 
fasting blood glucose, HOMA-IR was related to a higher proportion with a lower EF 
after adjustments for BMI, but this only achieved marginal significance (p=0.02) (Fox 
et al 2011). In that study (Fox et al 2011), although diastolic function was assessed 
using trans-mitral velocity and tissue Doppler assessments, the results were not 
reported on. I therefore assume that no relationship was noted beyond indices of 
obesity. Moreover, in 1599 participants being evaluated for health checks, although 
increasing quartiles of HOMA-IR were associated with decreases in E/A and 
increases in E/e’, whether these relationships survived adjustments for indices of 
excess adiposity was not reported on (Hwang et al 2012).  
In a longitudinal study (CARDIA, Coronary Artery Risk Development in Young 
Adults) in which 1211 participants had measurements before and after 25 years, the 
relationship between the diagnosis of diabetes mellitus and diastolic function was 
assessed (Kishi et al 2016). In this study (Kishi et al 2016), both early (diagnosis 
before year 15) and late (diagnosis at or after year 15) onset of diabetes mellitus with 
poor blood glucose control (HbA1c>7%) was associated with an increase in E/e’. In 
addition, the groups with early and late onset of diabetes mellitus and poor blood 
glucose control had an increased risk of developing LV diastolic dysfunction (defined 
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as E/e’≥13) (OR [95% CI]: 3.27 [1.07 to 10.04] for early and 2.21 [1.03 to 4.75] for 
late). Although the relationship between onset of diabetes mellitus with poor blood 
glucose control and E/e’ survived adjustments for waist-to-hip ratio, the risk of 
developing diastolic dysfunction was no longer significant (OR [95% CI]: 2.99 [0.96 to 
9.37] for early and 2.01 [0.90 to 4.47] for late) (Kishi et al 2016). Moreover, in this 
study, moderate and high HOMA-IR in the absence of diabetes mellitus were 
associated with increased relative wall thickness independent of BMI category. 
However, the impact of HOMA-IR in the non-diabetes mellitus cohort on E/e’ and 
diastolic dysfunction was not reported on in this study (Kishi et al 2016). Hence, I 
assume that no relationships between HOMA-IR and E/e’ or diastolic dysfunction 
were observed independent of obesity.  
Thus, in summary, the aforementioned studies were either characterised by 
small sample sizes in select clinical populations, thus raising the question of a 
selection bias confounding the results or type I or II statistical errors occurring, or 
positive relationships between HOMA-IR and diastolic function were not adjusted for 
indices of excess adiposity. Moreover, although in some large studies relationship 
between indices of insulin resistance and LV diastolic function were noted, it is 
unclear whether the relationship was independent of adiposity indices. Hence, not 
only is there uncertainty as to the role of obesity as an independent determinant of 
LV diastolic function, but also the role of insulin resistance. Hence, there is a need to 
better identify those factors which determine whether obesity or insulin resistance 
translate into LV diastolic dysfunction. In this regard, in the present thesis I propose 
that LV remodelling may influence the relationship between either obesity or insulin 
resistance and LV diastolic function. What is the evidence that LV remodelling may 
determine LV diastolic dysfunction and is there an indication that LV remodelling may 
influence whether obesity or insulin resistance influence LV diastolic function? 
 
1.5.1.4 Could LV remodelling influence the impact of obesity or insulin resistance on 
LV diastolic function?  
  
It is well known that LVH is a major risk factor for cardiovascular events 
(including heart failure), independent of conventional risk factors and coronary artery 
disease (Levy et al 1990; Taylor et al 2007; McMurray et al 2012; Yancy et al 2013). 
In addition, concentric LV remodelling (an increased relative wall thickness without 
an increase in LV mass) is associated with a worse prognosis in comparison to a 
normal LV geometry (Bluemke et al 2008; Koren et al 1991; Milani et al 2006; 
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Verdecchia et al 1991). Although LVH rather than concentric LV remodelling is 
known to predict incident heart failure (Bluemke et al 2008), concentric LV 
remodelling is associated with the development of LV diastolic dysfunction (Chahal et 
al 2010). In addition, concentric LVH (an increased relative wall thickness together 
with an increase in LV mass), rather than eccentric LVH (an decreased or normal 
relative wall thickness together with an increase in LV mass, is associated with 
greater increases in indices of LV filling pressures (Chahal et al 2010). Hence, the 
extent of concentric LV remodelling may determine whether progression from LVH to 
heart failure with a preserved rather than a reduced systolic chamber function 
(ejection fraction) occurs. In summary, there is considerable evidence to suggest that 
a more concentrically remodelled LV is independently associated with LV diastolic 
dysfunction and that this may determine whether LVH progresses to LV diastolic 
heart failure. As several studies have reported associations between obesity and an 
increased LV relative wall thickness (Millen et al 2014; Woodiwiss & Norton 2015), 
due consideration should be given to the possibility that the LV remodelling process 
in obesity modifies the impact of obesity or insulin resistance on LV diastolic function. 
In this regard, overweight individuals with insulin resistance are reported to have an 
increased relative wall thickness and a decreased diastolic function in comparison to 
overweight individuals without insulin resistance (Dahiya et al 2015). Importantly, 
although possible interactive effects between body weight and LVH on LV diastolic 
function have been reported (Syed et al 2009), to my knowledge no study has 
investigated the possible interactive effect of LV geometric remodelling on the 
association between metabolic disease and LV diastolic function. Hence, as part of 
the present thesis, I aimed to evaluate whether the extent of LV concentric 
remodelling determines the impact of either obesity or insulin resistance on LV 
diastolic function. These data have been published in the International Journal of 
Cardiology (Petersonb et al 2016) and are described in chapter 2 of the present 
thesis.   
 
1.5.2 Hypertension as a cause of LV diastolic dysfunction 
 
In the following section I will discuss hypertension as a possible cause of LV 
diastolic dysfunction. However, as with the topic of obesity and LV diastolic 
dysfunction it is important in the context of the present thesis to provide a more 
overall approach to the relevance of this topic from a perspective of hypertension as 
a cause of heart failure. In this regard, it is important to focus this discussion on 
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hypertension as a cause of heart failure with a preserved ejection fraction and a 
reduced LV diastolic function and the possible haemodynamic determinants through 
which hypertension may mediate these effects. Hence, in the following sections I will 
deal with each of these topics in turn. 
 
1.5.2.1 Hypertension as a cause of heart failure and a reduced LV diastolic function 
 
There is substantial evidence to support a role for hypertension as a major 
cause of heart failure. Indeed, hypertension is one of the most common comorbidities 
in heart failure (Levy et al 1996) and in primary care settings, approximately 48% of 
patients diagnosed with heart failure have hypertension (Cleland et al 2002). 
Moreover, in clinical trials of heart failure, hypertension is one of the four most 
frequently cited comorbidities (Krum and Gilbert 2003). The role of blood pressure in 
heart failure is highlighted by the ability of antihypertensive therapy to prevent the 
development of heart failure (Dahlof et al 1991, Kostis et al 1997, MRC Working 
Party Medical Research Council 1992). Hypertension may contribute to heart failure 
with either a reduced or preserved ejection fraction. Indeed, as previously 
highlighted, heart failure with a preserved ejection fraction is frequently associated 
with hypertension (Masoudi et al 2003, Redfield et al 2003, Owan et al 2006, Desai 
et al 2009, Kane et al 2011) and hypertension is a major co-morbidity associated with 
LV diastolic dysfunction (AlJaroudi et al 2012; Redfield et al 2003; Russo et al 2011; 
Sharp et al 2010). What is the evidence to support a role for hypertension as a major 
cause of LV diastolic dysfunction? 
Several studies have shown relationships between systolic blood pressure 
(SBP) (Abhayaratna et al 2008; Chung et al 2010; Hsu et al 2010; Masugata et al 
2005; Pavlopoulos et al 2008) or diastolic blood pressure (DBP) (AlJaroudi et al 
2012; Hwang et al 2012; Tsioufis et al 2008; Libhaber et al 2014) and LV E/A. 
Importantly, in multivariate regression analysis the blood pressure most strongly 
related to E/A or LV diastolic dysfunction in some large studies is DBP rather than 
SBP (AlJaroudi et al 2012, Hwang et al 2012, Tsioufis et al 2008, Libhaber et al 
2009) and more recently DBP has been demonstrated to be associated with E/A 
independent of SBP whilst SBP is not associated with E/A independent of DBP 
(Libhaber et al 2014). In contrast to what is noted with E/A, SBP, but not DBP, is 
more frequently associated with an index of LV filling pressures (E/e’)  (Abhayaratna 
et al 2008; Chung et al 2010; Hsu et al 2010; Libhaber et al 2014; Mottram et al 
2005; Pavlopoulos et al 2008; Russo et al 2010). However, in one study both SBP 
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and DBP (Hwang et al 2012) were noted to be independently related to E/e’. 
Irrespective of the brachial blood pressure value that best associates with decreases 
in LV diastolic function in cross-sectional studies, importantly, antihypertensive 
therapy produces improvements in tissue Doppler measures of diastolic dysfunction 
and the blood pressure value which best associates with these improvements in 
diastolic function is SBP (Almuntaser et al 2009). Moreover, in cross-sectional 
analysis of a community-based study with a high prevalence of obesity, blood 
pressure contributed substantially more to LV diastolic dysfunction than did any other 
factor other than age (Millen et al 2014). Although the debate on the brachial blood 
pressure best associated with LV diastolic function is an important clinical debate, of 
more fundamental importance is the possibility that neither brachial SBP nor DBP are 
the best assessments to determine the impact of vascular load on LV diastolic 
function. What is the evidence to support a role of vascular haemodynamic factors 
that may not be best indexed by brachial blood pressure measurements as 
determinants of LV diastolic function? 
 
1.5.2.2 Loading conditions responsible for LV diastolic dysfunction: The importance 
of aortic stiffness  
 
Increased LV loading conditions in hypertension may be determined to a 
large extent by an interaction between pressures generated by ventricular stiffening 
in systole, (which may be enhanced in a concentrically remodelled LV), and the 
impedance to aortic flow generated by several factors, of which a stiffer than normal 
aorta is the most commonly cited. This interaction is frequently referred to as a 
“vascular–ventricular interaction” and may have a major role to play in determining 
LV diastolic dysfunction. This haemodynamic effect has been proposed to be a 
critical mechanism involved in the transition from compensated LVH to heart failure 
with a preserved ejection fraction (Borlaug et al 2007, Borlaug & Kass 2008). The 
increased LV systolic stiffness is thought to be mediated by the same mechanisms 
as the increased LV diastolic stiffness accompanying a heart with diastolic 
dysfunction (see section 1.2.1). The increased aortic stiffness is mediated by several 
factors of which the most important is age (Weber et al 2008; Desai et al 2009; Kang 
et al 2010; Scantlebury et al 2011), hence accounting for heart failure with a 
preserved ejection fraction presenting more frequently in the elderly. These age-
induced changes in aortic stiffness then manifest as isolated systolic hypertension 
and hence hypertension, especially isolated systolic hypertension, is a common co-
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morbidity in heart failure with a preserved ejection fraction (Masoudi et al 2003; 
Borlaug & Redfield 2011; Scantlebury & Borlaug 2011). However, the age-induced 
changes in aortic stiffness may be exacerbated by several additional factors, of which 
hypertension (increases in either DBP or SBP) is the most important cause.  There is 
substantial evidence to support a role for aortic stiffness as an important determinant 
of LV diastolic dysfunction. In this regard, increases in large artery stiffness have 
frequently been associated with heart failure with a preserved ejection fraction 
(Mohammed et al 2012, Hundley et al 2001, Kawaguchi et al 2003, Kang et al 2010, 
Desai et al 2009, Kitzman et al 2013). Moreover, large artery stiffness has also often 
been shown to be associated with LV diastolic dysfunction even in patients without 
heart failure (Palmieri et al 2003; Yambe et al 2004; Tsioufis et al 2005; Mottram et al 
2005; Masugata et al 2005; Borlaug et al 2007; Abhayaratna et al 2008; Weber et al 
2008; Chung et al 2010; Borlaug 2011; Shim et al 2011; Xu et al 2011; Russo et al 
2012; Coutinho et al 2013). 
Although an increase in aortic stiffness is undisputedly an important cause of 
LV diastolic dysfunction and the progression from compensated LVH to heart failure 
with a preserved ejection fraction, aortic stiffness only begins to increase to a 
significant degree from an age of 50-60 years (Mitchell et al 2010, McEniery et al 
2005, Hodson et al 2016), whereas community-based studies indicate that LV 
diastolic dysfunction can occur well before this age (Libhaber et al 2009, Libhaber et 
al 2014, Millen et al 2014). As LV diastolic dysfunction is determined by the adverse 
effects of LV load, another factor which should be considered as a possible important 
determinant of LV diastolic dysfunction is the load on the LV induced by increases in 
aortic backward (reflected) waves. In this regard, aortic backward waves begin to 
increase from early adulthood (McEniery et al 2005, Booysen et al 2015, Hodson et 
al 2016). What are aortic backward waves, what is the importance of aortic backward 
waves in contributing to LV load and do aortic backward waves contribute to LV 
diastolic dysfunction? 
 
1.5.2.3 Loading conditions responsible for LV diastolic dysfunction: The importance 
of aortic backward waves  
 
Pressure waves determined by ventricular ejection into the aorta (aortic forward 
waves) travel down arteries and encounter reflection points which may occur at 
innumerable sites in the arterial bed (Nichols et al 2011). These reflection points are 
generated by discontinuities in the arterial tree produced by branch points, changes in 
 29 
 
wall structure and tapering of vessels. Increases in tapering of vessels may occur 
with vasoconstriction of either arterioles or of more proximal vessels. At these sites 
pressure waves are reflected back and return to the ascending aorta. Summation of 
reflected waves derived from multiple reflection points, results in a single backward 
wave returning to the aorta. The backward wave may return sufficiently early that the 
pressure generated by this wave (Pb) adds to the pressure generated by the forward 
wave (Pf) and hence Pb augments aortic SBP (Figure 1.2). With aging, because 
backward wave pressures (Pb) begin to increase from as early as 20-30 years of age, 
brachial SBP increases less than aortic SBP from early adult life to old age. This is 
because brachial SBP only detects the peak of the percussion wave which is driven 
by the forward wave pressure (Pf) (Figure 1.3). In contrast, aortic SBP increases 
more than brachial SBP as aortic SBP is determined by both Pf and Pb (Figure 1.3). 
With advanced age, Pb may be sufficiently large that peak brachial SBP reflects 
either Pf or Pb (Figure 1.3)(Nichols et al 2011). Hence, it is important to note that to 
adequately assess aortic backward wave pressure effects, aortic pressure 
measurements are required. Despite aortic backward wave pressures being lower 
than forward wave pressures (Figures 1.2 and 1.3), there is now significant evidence 
that aortic backward waves contribute more than forward waves to increases in aortic 
pulse pressure and LV mass across the adult lifespan (Booysen et al 2015). The 
relatively greater contribution of the aortic backward as compared to the forward 
wave pressures to variations in aortic pulse pressure and left ventricular mass applies 
to several other end-organ changes as well (Sibiya et al 2015) and translates into a 
greater contribution of aortic backward wave pressures as compared to forward wave 
pressures to cardiovascular outcomes (Zamani et al 2015). Hence, the question 
arises as to the role of aortic backward (reflected) wave pressures as possible 
determinants of LV diastolic function beyond aortic forward wave pressures. What is 
the evidence to support a role of aortic reflected wave function as a determinant of LV 
diastolic function and the development of heart failure with a preserved ejection 
fraction and is there clarity on the role of aortic backward waves in this regard? 
Few studies have provided the evidence to suggest that increases in aortic backward 
(reflected) waves are associated with LV diastolic dysfunction (Weber et al 2006, 
Weber et al 2008, Ikonomidis et al 2008, Hashimoto et al 2006). Moreover, in one 
small study (n=188) a dominant role of aortic stiffness over aortic augmented 
pressures, an index of aortic backward wave function, in the identification of LV 
diastolic dysfunction was noted (Abhayaratnaa et al 2006) and in another small study 
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(n=53) (Desai et al 2009) a relationship between aortic stiffness, but not aortic 
augmentation index and heart failure with a preserved ejection fraction was reported. 
 
This raises the possibility that aortic backward waves may not play as 
significant a role in contributing toward LV diastolic dysfunction and ultimately heart 
failure with a preserved ejection fraction as do increases in aortic stiffness. From a 
preventative perspective however, whilst there is little evidence to support a 
therapeutic approach to modify age-related increases in aortic stiffness, there is 
significant evidence to suggest that aortic backward wave pressures may be targeted 
by conventional antihypertensive therapy (Agabiti-Rosei et al 2007). Importantly, as 
indicated in previous sections, marked age-related increases in backward wave 
pressures precede significant age-related increases in aortic stiffness by several 
decades (Booysen et al 2015). Moreover, increases in aortic backward wave 
pressures are a fundamental mechanism responsible for increases in aortic stiffness 
(Sibiya et al 2015) and hence may be the initial (primary) target in preventing the 
progression to LV diastolic dysfunction and consequently heart failure with a 
preserved ejection fraction. 
However, it is uncertain whether the impact of backward wave pressures on 
LV diastolic dysfunction antedate the effects of aortic stiffness. In this regard, prior 
studies assessing relations between aortic and LV diastolic function have assessed 
patients with average ages of 60-77 years, (Mohammed et al 2012; Hundley et al 
2001; Kawaguchi et al 2003; Weber et al 2006; Weber et al 2008; Fernandes et al 
2008; Kang et al 2010; Desai et al 2009; Kitzman et al 2013), age ranges when large 
vessel stiffness is markedly increased (Mitchell et al 2010, Hodson et al 2016). 
Hence, none of these studies could address the question of whether the impact of 
backward wave pressures on LV diastolic dysfunction antedate the effects of aortic 
stiffness. Hence, as part of the present thesis, I aimed to evaluate the relationship 
between several aortic functional parameters and LV diastolic function in a 
predominantly young-to-middle aged community-based sample with an average age 
where increases in aortic backward wave pressures are well established, but prior to 
an age when striking increases in aortic stiffness are noted. These data have been 
published in the American Journal of Hypertension (Petersonc et al 2016) and are 
described in chapter 3 of the present thesis.  
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Figure 1.2. The contribution of aortic forward and aortic backward waves to aortic 
and radial (approximate of brachial) pulse waves. The dashed lines show temporal 
alignment of 1st and 2nd systolic shoulders. The figure shows actual data obtained 
from SphygmoCor recordings. 
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Figure 1.3 Age effects on aortic and radial artery pressure waves (which 
approximate brachial pressure waves). The figure shows changes in the combined 
effect of the aortic forward and aortic backward waves on pressure waveforms with 
age. The dashed lines show how the forward and backward pressure waves 
contribute to radial and aortic pressure waves in a young and an old participant. The 
figures show actual data obtained from SphygmoCor recordings. 
 
 
 
 
 
 
 
 
Young participant Old participant 
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1.5.3 Genetic factors may play a significant role in determining LV diastolic 
dysfunction 
 
The well recognised demographic and clinical risk factors for heart failure with 
a preserved ejection fraction, which include age, female gender, obesity, 
hypertension and diabetes mellitus fail to account for all of the inter-individual 
variation in LV diastolic function (Bielin et al 1991; Fox et al 2010; Jin et al 2011; 
Kloch-Badelek et al 2014; Noh et al 2015; Swan et al 2003; Tang et al 2002). 
Moreover, ethnicity is reported to impact on the prevalence of LV diastolic 
dysfunction and ultimately heart failure with preserved ejection fraction (Bhatia et al 
2006; Yancy et al 2006; Fonarow et al 2007; Lam et al 2007; Scantlebury & Borlaug 
2011; Chirinos et al 2012; Nichols et al 2004; Mozaffarian et al 2015). Hence, 
independent of well recognised demographic and clinical risk factors for heart failure 
with a preserved ejection fraction, genetic factors may be responsible for some of the 
unexplained inter-individual variation in LV diastolic function. In this regard because 
of the impact of LV remodelling on LV diastolic function (see section 1.5.1.4), these 
genetic factors may contribute toward LV diastolic dysfunction through the effects of 
LV remodelling. Alternatively independent of LV structural changes, genetic factors 
may influence LV diastolic function through direct effects on cardiomyocyte function 
or through interstitial changes. In this regard, as will be discussed, both LVH and LV 
relative wall thickness as well as LV diastolic function have been shown to aggregate 
in families and to be inherited. However, at the time of conducting the present thesis 
there were several aspects of these findings which required further clarity. Before 
embarking on attempting to identify the genetic factors that could explain LV 
remodelling and LV diastolic function, a better understanding of these issues is 
required. In the following section I will therefore review the current understanding of 
the evidence for genetic factors contributing to LV remodelling and diastolic function, 
including the evidence on the intra-familial aggregation and heritability of LV 
remodelling and diastolic function. In doing so I will also highlight the outstanding 
issue on these topics and hence argue in favor of several of the studies conducted as 
part of the present thesis. 
 
1.5.3.1 Possible role of genetic factors as determinants of LV remodelling. 
 
The impact of age (Dannenberg et al 1989), sex (Aurigemma & Gaasch 
1989), blood pressure (Devereux et al 1983), and obesity (Cuspidi et al 2014; Lauer 
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et al 1991; Woodiwiss & Norton 2015) on LV geometric remodelling has been well 
described. However, these factors only partly explain the inter-individual variation in 
LV mass and geometry in any population (Bella & Goring 2012). Furthermore, the 
prevalence of LVH and geometric remodelling is reported to differ amongst various 
population groups. In this regard, populations of African ancestry are reported to 
have a higher LV mass (Arnett et al 1994; Fox et al 2010) as well as a greater LV 
relative wall thickness (Arnett et al 1994; Devereux et al 1998; Tang et al 2002; Fox 
et al 2010) in comparison to other populations. Although various factors, including 
blood pressure levels and blood pressure control, could explain these ethnic 
differences, a greater LV wall thickness for the same level of clinic blood pressure 
has been reported in African as compared to white Americans (Devereux et al 1998; 
Tang et al 2002). Hence, it has been suggested that these differences in LV mass 
and relative wall thickness between population groups have a genetic basis. Indeed, 
LV mass (Arnett et al 2001; Assimes et al 2007; Bella et al 2004; Bella et al 2012; 
Bielen et al 1991; Fox et al 2010; Harshfield et al 1990; Kuznetsova et al 2003; 
Schunkert et al 1999; Tang et al 2002; Verhaaren et al 1991) and LV relative wall 
thickness have been shown to be inherited in various populations (Arnett et al 2001; 
Bella et al 2004; Fox et al 2010; Kuznetsova et al 2003). There is however 
uncertainty as to the role of genetic factors in determining LV relative wall thickness 
independent of LV mass. In this regard LV mass is a major determinant of LV wall 
thickness (Harshfield et al 1990; Verhaaren et al 1991; Bielen et al 1991; Schunkert 
et al 1999; Arnette et al 2001; Kuznetsova et al 2003; Bella et al 2004; Assimes et al 
2007; Bella & Goring 2012). It is important to distinguish between these two factors 
for several reasons. First, an increased LV relative wall thickness, although not a 
predictor of heart failure per se, will determine whether LVH progresses to LV 
diastolic or LV systolic heart failure. Indeed, concentric LV remodeling is associated 
with the development of LV diastolic dysfunction (Chahal et al 2010). Second, an 
increased LV relative wall thickness may be determined not just by the extent of LVH, 
but by several other cellular factors (Badenhorst et al 2003). Hence, if LV relative wall 
thickness is inherited, and LV remodelling is a major determinant of LV diastolic 
function, then the genetic determinants of LV diastolic dysfunction are not only going 
to be regulated by those factors which influence the extent of hypertrophy of the 
heart, but rather those that determine the remodelling process itself. Is there 
evidence to either support or refute a role for LV relative wall thickness being 
inherited independent of LV mass? 
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 Siblings of those with LVH have a greater risk of concentric LVH as 
compared to age- and sex-matched controls (Schunkert et al 1999). In that study 
(Schunkert et al 1999), the siblings of those with LVH had no greater risk of eccentric 
LVH than the age- and sex-matched controls. Hence, the possibility arises that the 
intrafamilial clustering of concentric LVH in that study (Schunkert et al 1999) was in-
part driven by the LV remodelling process. However, whether these siblings had a 
greater risk of concentric LV remodelling was not reported. Hence, it is also possible 
that the increased risk of concentric LVH in that study (Schunkert et al 1999) may 
have been largely a consequence of LV mass effects. Furthermore, in the 
Framingham Heart Study although the risk of concentric LVH was markedly greater 
in related as compared to unrelated individuals, the risk of concentric LV remodelling 
was reported to be only modestly greater in related compared to unrelated individuals 
(Lam et al 2010). These data (Lam et al 2010) again point toward the possibility that 
the inheritance of LV mass explains the inheritance of LV concentric remodelling. 
Although, a number of previous studies report that LV relative wall thickness is 
inherited (Arnett et al 2001; Bella et al 2004; Fox et al 2010; Kuznetsova et al 2003), 
none of these previous studies have reported on the inheritance of LV relative wall 
thickness independent of LV mass. Hence, as part of the present thesis, I aimed to 
evaluate the intrafamilal aggregation and heritability of LV relative wall thickness 
independent of LV mass in a group of African ancestry. These data have been 
published in the American Journal of Hypertension (Peterson et al 2015) and are 
described in chapter 4 of the present thesis. 
 
1.5.3.2 Possible role of genetic factors as determinants of LV diastolic function 
beyond confounders.  
 
What is the evidence for a possible contribution of genetic factors to LV 
diastolic function and is there a need for further clarity on this issue? Several studies 
have demonstrated heritability or intra-familial aggregation of LV diastolic function 
identified from trans-mitral blood flow velocity measurements. In this regard, studies 
in twins have reported heritability estimates of 43% and 49% for the E and 26% and 
36% for the A wave respectively (Bielen et al 1991; Swan et al 2003). Similarly, in 
black and white hypertensive sibships, it was estimated that 54% to 77% of the 
genetic variation in E and A waves, respectively, were due to shared genes (Tang et 
al 2002). Furthermore, in an African-American cohort of hypertensive siblings, 
heritability estimates of 37% and 45% for E and A waves respectively were reported 
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(Fox et al 2010). In family-based studies, heritability estimates ranging from 11% to 
29% for the E wave, from 25% to 27% for the A wave (Jin et al 2011; Kloch-Badelek 
et al 2014), and of 25% for E/A (Noh et al 2015) have been reported.      
Despite consistent evidence for the heritability of E and A waves across 
various populations, the genetic influence on contemporary measures employed to 
evaluate LV diastolic dysfunction, such as e’ or E/e’ (as discussed in section 1.3.2), is 
nevertheless unclear. In this regard, few studies have reported on the heritability of 
E/e’. Although a Korean twin and family study showed significant heritability (33%) for 
E/e’ (Noh et al 2015), a study conducted in 52 European families failed to show 
significant heritability (Jin et al 2011). However, subsequent analysis in an expanded 
data set (316 European families) showed significant heritability (31%) (Kloch-Badelek 
et al 2014). Although the heritability of E/e’ has been assessed in Caucasian and 
Asian groups, whether E/e’ is inherited in groups of African ancestry has not been 
assessed. Hence, the inheritance of E/e’ is controversial, and whether E/e’ is 
inherited in groups of African ancestry is unknown. 
Importantly, LV mass and LV remodelling which, as previously discussed in 
section 1.5.1.4, are well recognised determinants of LV diastolic dysfunction (Chahal 
et al 2010) are also inherited (see section 1.3.4.3 above and Peterson et al 2015). In 
addition, other factors which influence LV diastolic function such as blood pressure, 
aortic function, obesity and diabetes mellitus or insulin resistance (see sections 1.5.1 
and 1.5.2 above) are also inherited (see section 1.5.3.). Hence, it is possible that the 
heritability of E/e’ is by virtue of genetic influences on factors such as LV mass, LV 
relative wall thickness, brachial and aortic blood pressure, body mass, diabetes 
mellitus and insulin resistance. Is there sufficient evidence to indicate that the 
heritability of LV E/e’ is independent of these potential confounders? In this regard, 
the heritability of E/e’ has been shown to be independent of body mass index and 
brachial blood pressure (Kloch-Badelek et al 2014). In addition, Noh et al (2015) 
reported heritability of E/e’ after adjusting for confounding factors including body 
mass index, brachial blood pressure and diabetes mellitus (fasting blood glucose and 
receiving medication for diabetes mellitus). However, these previous studies (Jin et al 
2011; Kloch-Badelek et al 2014; Noh et al 2015) failed to determine whether E/e’ is 
inherited independent of LV mass and relative wall thickness. Hence, whether 
significant heritability of E/e’ occurs independent of LV remodelling is currently 
unknown. Moreover, although previous studies have reported on the inheritance of 
E/e’ independent of brachial blood pressure (Kloch-Badelek et al 2014; Noh et al 
2015), whether heritability of E/e’’ is independent of aortic BP is unknown. In this 
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regard, central aortic blood pressure has been reported to show stronger heritability 
estimates than brachial blood pressure (Redelinghuys et al 2012). Hence, to address 
the aforementioned questions, as part of the present thesis, I aimed to evaluate 
whether the intrafamilal aggregation and heritability of LV diastolic function is 
independent of LV mass, LV relative wall thickness and aortic blood pressure in a 
group of African ancestry. These data have been published in the Journal of the 
American Society of Hypertension (Petersona et al 2016) and are described in 
chapter 5 of the present thesis. 
 
1.6 Aims 
 
In summary, the aims of the present thesis are as follows:  
 
1) To determine whether relations between adiposity indices or associated-
insulin resistance and LV diastolic function are modified by LV mass or relative wall 
thickness and if so whether these interactive effects with LVH or remodelling are also 
noted for alternative causes of LV diastolic abnormalities such as increases in blood 
pressure or age. These data are described in chapter 2 of the present thesis and 
have been published in the International Journal of Cardiology (Petersonb et al 2016). 
2) To determine whether the impact of aortic backward wave pressure on LV 
diastolic dysfunction antedates the effects of aortic stiffness in a predominantly 
young-to-middle–aged community-based sample with an average age where 
increases in aortic backward wave pressures are well established, but prior to an age 
when striking increases in aortic stiffness are noted. These data are described in 
chapter 3 of the present thesis and have been published in the American Journal of 
Hypertension (Petersonc et al 2016). 
3) To determine whether LV relative wall thickness shows intra-familial 
aggregation and heritability independent of LV mass and additional confounders in a 
family-based study. These data are described in chapter 4 of the present thesis 
thesis and have been published in American Journal of Hypertension (Peterson et al 
2015). 
4) To determine whether the intra-familial aggregation and heritability of LV 
filling pressures (E/e’) occur independent of LV remodelling and aortic function in a 
community of African ancestry. These data are described in chapter 5 of the present 
thesis and have been published in Journal of the American Society of Hypertension 
(Petersona et al 2016). 
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CHAPTER 2 
 
 
 
 
 
Insulin Resistance-Associated Decreases in Left Ventricular Diastolic Function 
are Strongly Modified by the Extent of Concentric Remodelling in a Community 
Sample. 
 
 
 
 
The data in this chapter have been published in the International Journal of 
Cardiology: 
Peterson V.R., Norton G.R., Raymond A., Libhaber C.D., Millen A.M.E., Majane 
O.H.I., Maseko M.J. and Woodiwiss, A.J. (2016). Insulin Resistance-Associated 
Decreases in Left Ventricular Diastolic Function are Strongly Modified by the Extent 
of Concentric Remodelling in a Community Sample, International Journal of 
Cardiology, 220, 349-355.  
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2.1 Abstract 
 
Background. Whether excess adiposity, associated metabolic abnormalities or 
alternative risk factors for left ventricular (LV) diastolic function are modified rather 
than mediated by geometric LV remodelling, is uncertain. 
Methods. Echocardiographic LV mass index (LVMI), relative wall thickness (RWT) 
and diastolic function (lateral and septal wall myocardial tissue lengthening at the 
level of the mitral annulus [e’] [n=430], ratio of early-to-late transmitral blood flow 
velocity (E/A), and E/e’ [n=430]) were determined in 737 randomly recruited 
participants of a community-based study (43% obese). 
Results. Independent of LVMI and confounders, indices of adiposity and the 
homeostasis model of insulin resistance (HOMA-IR) were independently associated 
with LV diastolic function (p<0.05). In addition, RWT was independently associated 
with LV diastolic function (p<0.002). Importantly, an independent interaction between 
HOMA-IR and RWT, but not between blood pressure or age and RWT, was related 
to LV diastolic function (p<0.05). This translated into an independent relationship 
between HOMA-IR and lateral e’ (partial r=-0.17, p<0.02), septal e’ (partial r=-0.14, 
p=0.05), E/A (partial r=-0.17, p<0.005) and E/e’ (partial r=0.19, p<0.01) in those with 
RWT above, but a lack of relationship between HOMA-IR and LV diastolic function 
(p>0.59) in those with RWT below the median for the sample. Similarly, HOMA-IR 
was independently associated with LV diastolic dysfunction in those with RWT above 
(p<0.05) but not below (p>0.19) the median for the sample.  
Conclusions. The relationship between insulin resistance, but not alternative risk 
factors and LV diastolic function is markedly modified by the presence of a more 
concentrically remodelled LV. 
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2.2 Introduction 
 
Independent of conventional cardiovascular risk factors and myocardial 
infarction, obesity and associated insulin resistance predicts the development of 
heart failure (Kenchaiah et al 2002; Ingelsson et al 2005; Bahrami et al 2008). The 
impact of obesity or insulin resistance on the risk for heart failure may in-part be 
explained by abnormalities in left ventricular (LV) diastolic function. Indeed, LV 
diastolic abnormalities are correlated with obesity (Tsioufis et al 2008; Russo et al 
2011; Çil et al 2012; AlJaroudi et al 2012) independent of haemodynamic 
confounders (Libhaber et al 2009); improved by bariatric surgery-induced weight loss 
(Cuspidi et al 2014); and predict the development of heart failure (Aurigemma et al 
2001; Kane et al 2011; Lam et al 2011). However, the relative importance of obesity, 
as opposed to alternative co-morbidities as a determinant of LV diastolic dysfunction 
has recently been questioned (Millen et al 2014). Hence identifying clinical features 
that characterise those in whom weight loss may be of benefit in preventing the 
progression to heart failure is of importance. 
Well-recognised determinants of a reduced LV diastolic function are LV 
hypertrophy (LVH) and concentric LV remodelling (as indexed by relative wall 
thickness [RWT]) (Chahal et al 2010). As obesity causes LVH and several studies 
have shown associations between obesity and an increased RWT (concentric LV 
remodelling) (Cuspidi et al 2014; Woodiwiss & Norton 2015), the question arises as 
to whether LVH and/or RWT modify the impact of obesity or associated metabolic 
alterations on diastolic LV function. In this regard, although numerous studies have 
reported an association between metabolic disease and diastolic dysfunction 
independent of LVH (Masaguta et al 2006; de las Feuntes et al 2007; Ayalon et al 
2014); to our knowledge no study has investigated the possible interactive 
(synergistic) effect of LV remodelling on the association between metabolic disease 
or alternative risk factors and diastolic dysfunction. Importantly, LV remodelling may 
not mediate the effect of a risk factor, but may have a pronounced modifying 
influence on the impact of a risk factor on LV diastolic function. Indeed, as strong 
correlations between change in RWT and diastolic function (Hsuan et al 2010) and 
consistent decreases in RWT and increases in diastolic function (Hsuan et al 2010; 
Ippisch et al 2008; Luaces et al 2012) occur with bariatric surgery, it is possible that 
RWT if not mediating the impact of metabolic disease on diastolic function, may 
modify the impact of metabolic disease on diastolic function. This would suggest that 
targeting metabolic disease may only influence LV diastolic function in a more 
 41 
 
concentrically remodelled LV. However, whether obesity- or insulin resistance-
associated LV diastolic abnormalities are influenced by LV geometric remodelling is 
unknown. Hence, in the present study conducted in a relatively large community-
based sample with a high prevalence of obesity-associated LVH (Woodiwiss et al 
2008; Libhaber et al 2014) and increases in RWT (Woodiwiss et al 2008), I evaluated 
whether relations between adiposity indexes or associated-insulin resistance and LV 
diastolic function are modified by LV mass or RWT and if so whether these 
interactive effects with LVH or remodelling are also noted for alternative causes of LV 
diastolic abnormalities such as increases in blood pressure or age. 
 
2.3 Methods 
 
2.3.1  Study group 
 
The present study was approved by the University of the Witwatersrand 
Committee for Research in Human Subjects (approval number M02-04-72 renewed 
as M07-04-69 and M12-04-108). Participants gave informed, written consent. The 
study design has previously been described (Woodiwiss et al 2008; Libhaber et al 
2014; Woodiwiss et al 2009). 737 Participants of nuclear families of black African 
descent with siblings older than 16 years were randomly recruited from the South 
West Township of Johannesburg, South Africa. Tissue Doppler measures of 
myocardial function were obtained in a sub-study conducted in 430 participants. 
 
2.3.2  Clinical, demographic, blood and anthropometric measurements 
 
A standardised questionnaire was administered to obtain demographic and 
clinical data (Woodiwiss et al 2008; Libhaber et al 2014; Woodiwiss et al 2009). 
Height, weight, and waist circumference (WC) were measured using standard 
approaches and participants were identified as being overweight if their body mass 
index (BMI) was ≥25 kg/m2, obese if their BMI was ≥30 kg/m2 and morbidly obese of 
their BMI was ≥35 kg/m2. Central obesity was defined as an enlarged WC (≥88 cm in 
women and ≥102 cm in men). Laboratory blood tests including percentage glycated 
haemoglobin (HbA1c) were performed. Fasting plasma insulin concentrations were 
determined from an insulin immulite, solid phase, two-site chemiluminescent 
immunometric assay (Diagnostic Products Corporation, Los Angeles, CA, USA). 
Diabetes mellitus or an abnormal blood glucose control was defined as the use of 
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insulin or oral hypoglycaemic agents or a glycated haemoglobin (Roche Diagnostics, 
Mannheim, Germany) value greater than 6.1%. Insulin resistance was estimated by 
the homeostasis model assessment of insulin resistance (HOMA-IR) using the 
formula (insulin [uU/ml] x glucose [mmol/l])/22.5. 
Nurse-derived conventional blood pressure (BP) was measured according to 
guidelines using a mercury sphygmomanometer after five minutes of rest in the 
seated position as previously described (Woodiwiss et al 2009; Redelinghuys et al 
2010). Five consecutive BP readings were obtained using an appropriately sized 
cuff, 30 to 60 seconds apart. The average of the five readings was taken as the BP. 
None of the visits had fewer than the planned BP recordings. Hypertension was 
defined as the use of antihypertensive medication or if the mean of the five 
conventional BP measurements was >140/90 mm Hg in those not receiving 
medication. 
 
2.3.3  Echocardiography 
 
Echocardiographic measurements were performed as previously described 
(Millen et al 2014; Libhaber et al 2014) by two experienced observers (AJW and 
CDL) using a Sonosite M-Turbo ultrasound (SonoSite® Inc., Bothell, WA, USA) 
device with the participants in the partial left decubitus position. All potential 
participants were assessed for mitral valve abnormalities as determined using 2-
dimensional and colour Doppler imaging and excluded if significant valve 
abnormalities were present. Left ventricular (LV) dimensions were determined using 
two-dimensional directed M-mode echocardiography in the short axis view (Figure 
2.1) and these recordings were analysed according to the American Society of 
Echocardiography convention (Sahn et al 1978). The LV dimensions were measured 
only when appropriate visualisation of both the right and the left septal surfaces 
occurred and where the endocardial surfaces of both the septal and posterior wall 
were clearly visible. Left ventricular ejection fraction was calculated using the biplane 
Simpson method. Left ventricular mass (LVM) was determined using a standard 
formula (Devereux et al 1986) (LVM = 0.8 x [1.04 (LV end diastolic diameter + LV 
end diastolic septal wall thickness + LV end diastolic posterior wall thickness)3 – (LV 
end diastolic diameter)3] + 0.6g) and indexed (LVMI) to height1.7(at the request of 
reviewers, I used height1.7 and not height2.7 as was used in subsequent chapters). 
Left ventricular diastolic function was assessed from a pulsed wave Doppler 
examination of the mitral inflow at rest and using tissue Doppler indices (TDI) as well  
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Figure 2.1 Echocardiographic M-mode image showing the measurement of left 
ventricular dimensions. LVEDD, left ventricular end diastolic diameter; LVESD, left 
ventricular end systolic diameter; PWED, left ventricular posterior wall thickness at 
end diastole; PWES, left ventricular posterior wall thickness at end systole; SEPED, 
left ventricular septal wall thickness at end diastole; SEPES, left ventricular septal 
wall thickness at end systole. 
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as left atrial volumes (Nagueh et al 2009). Pulse wave Doppler recordings of trans-
mitral velocity were obtained with the sample volume at the tip of the mitral valve in 
the apical 4-chamber view. Trans-mitral velocity measurements were obtained during 
the early (E) and late (atrial-A) period of left ventricular diastolic inflow. To perform 
TDI, the velocity of myocardial tissue lengthening at the level of the mitral annulus 
was recorded in the apical four-chamber view. The sample volume was positioned at 
the septal and lateral corners of the mitral annulus. To determine diastolic function 
using TDI, peak velocities during early (e’) and late (atrial) (a’) diastole were 
measured and the mean of septal and lateral wall values calculated. Data were 
expressed as the E/e’ ratio (an index of LV filling pressures). Because mitral annular 
velocity (e’) remains constant and trans-mitral flow (E) increases with an increased 
filling pressure, E/e’ ratio correlates well with left ventricular filling pressures. Left 
atrial volume indexed to body surface area, was calculated using the area-length 
method, where length was defined as the shortest of the two long axes measured in 
the apical four-chamber and two-chamber views. Left atrial area was measured by 
planimetry in the apical four-chamber and two-chamber views at left ventricular end 
systole (maximum left atrial dimensions) (Figure 2.2). The presence of left ventricular 
diastolic dysfunction (DD) was identified by lateral e’<10 cm/s, septal e’<8 cm/s or 
left atrial volume ≥34ml/m2. Mild DD was defined as E/A≤0.80 (impaired relaxation) 
or E/e’≤8. Moderate-to-severe DD was defined as E/A≥0.80 or E/e’≥9. 
 
2.3.4  Data analysis 
 
Database management and statistical analyses were performed with SAS 
software, version 9.3 (SAS Institute Inc., Cary, North Carolina, USA). Data from 
individuals were averaged and expressed as mean±SD. To improve on distribution of 
data, HOMA-IR, lateral e’, septal e’, E/A, E/e’ and left atrial volume were 
logarithmically transformed. To determine independent relations, multivariate 
adjusted linear (continuous data) or logistic (discrete data) regression analysis was 
performed. Indexes of diastolic LV function were adjusted for several confounders 
associated with diastolic function noted in bivariate analysis. As we have recently 
demonstrated that systolic BP (SBP) is more closely related to E/e’ and diastolic BP 
(DBP) to E/A (Libhaber et al 2014), SBP was employed in models with lateral e’, 
septal e’ and E/e’ and DBP in models with E/A. Relationships (partial r values) were 
compared with z-statistics. 
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Figure 2.2 Echocardiographic images showing the measurement of left atrial area 
and long axis lenght by planimetry in the apical four-chamber (left image) and two-
chamber (right image) views at left ventricular end systole (maximum left atrial 
dimensions). These measurements were used to calculate left atrial volume indexed 
to body surface area using the area-length method. 
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2.4 Results 
 
2.4.1 Participant characteristics 
 
Table 2.1 gives the demographic and clinical characteristics of the 
participants. More women than men participated in the study and a high proportion of 
participants were overweight, obese or morbidly obese and had central obesity. In 
participants with TDI measurements, 13.5% of participants had mild DD, and 16.5% 
had moderate-to-severe DD. No participants had an ejection fraction<40% and 3.1% 
had an ejection fraction<50%. Of the sample 47% had LV hypertrophy (LVMI>80 
g/m1.7 for men and >60 g/m1.7 for women) and 26.3% had concentric LV remodelling 
(RWT>0.42). 42.5% of participants with normal diastolic function had RWT greater 
than the median and 31.0% and 33.8% of participants with mild or moderate-to-
severe DD respectively had RWT<median. 
 
2.4.2 LV mass and remodelling are associated with LV diastolic function 
 
With adjustments for age, sex, diastolic BP, regular tobacco use, regular 
alcohol consumption, treatment for hypertension, diabetes mellitus or an abnormal 
blood glucose control (HbA1c>6.1%), and pulse rate both LVMI (partial r=-0.08, 95% 
CI=-0.15 to -0.01, p<0.05) and RWT (partial r=-0.12, 95% CI=-0.19 to -0.05, p<0.005) 
were associated with log E/A. Moreover, with adjustments for the same confounders 
except pulse rate and with systolic rather than diastolic BP in the model, RWT (partial 
r=0.14, 95% CI=0.04 to 0.23, p<0.01) but not LVMI (partial r=0.07, 95% CI=-0.03 to 
0.16, p=0.17) was associated with E/e’. Similarly, RWT (lateral e’: partial r=-0.14, 
95% CI=-0.24 to -0.05, p=0.005; septal e’: partial r=-0.18, 95% CI=-0.27 to -0.09, 
p=0.0001) but not LVMI (lateral e’: partial r=-0.09, 95% CI=-0.18 to 0.01, p=0.07; 
septal e’: partial r=-0.08, 95% CI=-0.17 to 0.01, p=0.10) was associated with lateral e’ 
and septal e’. 
 
2.4.3 Metabolic factors and LV diastolic function 
 
With adjustments for confounders, BMI, waist circumference and HOMA-IR 
were all independently associated with E/A, E/e’, lateral e’ (Table 2.2) and septal e’ 
(Table 2.3). However, with further adjustments for either LVMI or RWT, only relations 
between waist circumference or HOMA-IR and E/A or E/e’ persisted (Table 2.2). With  
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Table 2.1. Characteristics of the study sample. 
_________________________________________________________________ 
Sample number (% female)    737 (64.0) 
Age (years)       44.8±18.0 
Body mass index (kg/m2)                   29.6±7.8  
% Overweight/obese/morbidly obese                  23.6/19.9/24.3 
Waist circumference (cm)    91.3±16.6  
% Abnormal waist circumference           45.8   
Regular tobacco (% subjects)                14.5   
Regular alcohol (% subjects)                  19.5  
% Diabetes mellitus or an HbA1c>6.1%           26.6  
% Hypertensive             45.9  
% Treated hypertension            25.1  
HOMA-IR       3.30±4.85 
Brachial SBP/DBP (mm Hg)           130±22/84±12  
E/A        1.27±0.48      
E/e’ (n=455)       7.81±4.38                          
Lateral e’ (cm/s) (n=455)      10.9±3.7 
Septal e’ (cm/s) (n=455)        9.6±3.4 
Left atrial volume index (ml/m2) (n=455)    19.7±6.6 
Left ventricular mass index (g/m1.7)    68.3±23.9    
LV relative wall thickness     0.39±0.08        
___________________________________________________________________        
HbA1c, glycated haemoglobin; SBP, systolic blood pressure; DBP, diastolic BP; 
HOMA-IR, homeostasis model of insulin resistance; E/A, ratio of transmitral early-to-
atrial (late) blood flow velocity; E/e’, E/velocity of the mean value of lateral and septal 
wall myocardial tissue lengthening in early diastole at the mitral annulus; LV, left 
ventricle. 
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Table 2.2. Multivariate adjusted relationships between indexes of adiposity or the 
homeostasis model of insulin resistance (HOMA-IR) and left ventricular diastolic 
function in a community sample. 
 
    Adjustments        Partial r    p value 
            (95% CI)          
_____________________________________________________________ 
Waist circumference versus  
 Log E/A (n=737) *          -0.10 (-0.17 to -0.02) <0.05 
    * + LVMI       -0.08 (-0.16 to -0.01) <0.05 
    * + RWT       -0.09 (-0.17 to -0.02) <0.05 
 Log E/e’ (n=430) *           0.13 (0.03 to 0.23) <0.01 
    * + LVMI        0.12 (0.02 to 0.22) <0.02 
    * + RWT        0.12 (0.02 to 0.22) <0.02 
Log lateral e’ (n=430) *          -0.14 (-0.23 to -0.04) <0.01 
    * + LVMI       -0.12 (-0.22 to -0.03) <0.02 
    * + RWT       -0.13 (-0.23 to -0.03) <0.02 
Body mass index versus 
 Log E/A (n=737) *          -0.07 (-0.15 to -0.001) <0.05 
    * + LVMI       -0.05 (-0.13 to  0.02) =0.15 
    * + RWT       -0.07 (-0.14 to  0.000) =0.05 
 Log E/e’ (n=430) *           0.10 (0.003 to 0.19) <0.05 
    * + LVMI        0.08 (-0.01 to 0.18) =0.09 
    * + RWT        0.09 (-0.01 to 0.18) =0.07 
 Log lateral e’ (n=430) *          -0.13 (-0.23 to -0.04) <0.01 
    * + LVMI       -0.11 (-0.21 to -0.02) <0.02 
    * + RWT       -0.12 (-0.21 to -0.03) <0.02 
Log HOMA-IR versus 
 Log E/A (n=737) *          -0.11 (-0.18 to -0.04) <0.005 
    * + LVMI       -0.10 (-0.17 to -0.03) <0.01 
    * + RWT       -0.10 (-0.17 to -0.03) <0.01 
 Log E/e’ (n=430) *           0.12 (0.02 to 0.21) <0.02 
    * + LVMI        0.11 (0.01 to 0.20) <0.05 
    * + RWT        0.11 (0.01 to 0.20) <0.05 
Log lateral e’ (n=430) *          -0.12 (-0.21 to -0.02) <0.02 
    * + LVMI       -0.11 (-0.20 to -0.01) <0.05 
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    * + RWT       -0.10 (-0.20 to -0.01) <0.05 
___________________________________________________________________ 
E/A, ratio of transmitral early-to-atrial (late) blood flow velocity; E/e’, E/velocity of the 
mean value of lateral and septal wall myocardial tissue lengthening in early diastole 
at the mitral annulus; LVMI, left ventricular mass index; RWT, relative wall thickness. 
*Adjustments are for age, sex, diastolic blood pressure (E/A) or systolic blood 
pressure (E/e’ and lateral e’), regular tobacco use, regular alcohol consumption, 
treatment for hypertension, diabetes mellitus or an abnormal blood glucose control 
(HbA1c>6.1%), pulse rate (E/A) and LVMI or RWT as indicated. 
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Table 2.3. Multivariate adjusted relationships between indexes of adiposity or the 
homeostasis model of insulin resistance (HOMA-IR) and left ventricular diastolic 
function in a community sample. 
    Adjustments        Partial r    p value 
            (95% CI) 
______________________________________________________________ 
Waist circumference versus  
 Log septal e’ (n=430) *          -0.18 (-0.27 to -0.08) <0.0005 
    * + LVMI       -0.16 (-0.26 to -0.06) =0.001 
    * + RWT       -0.17 (-0.26 to -0.07) <0.001 
 Log LA vol (n=430)    *           0.05 (-0.05 to 0.15) =0.28 
    * + LVMI        0.01 (-0.09 to 0.11) =0.81 
    * + RWT        0.05 (-0.05 to 0.15) =0.33 
Body mass index versus 
 Log septal e’ (n=430) *          -0.17 (-0.26 to -0.07) =0.0005 
    * + LVMI       -0.14 (-0.23 to -0.05) <0.005 
    * + RWT       -0.15 (-0.25 to -0.06) <0.005 
 Log LA vol (n=430) *           0.07 (-0.03 to 0.16) =0.15 
    * + LVMI        0.02 (-0.08 to 0.11) =0.73 
    * + RWT        0.06 (-0.03 to 0.16) =0.19 
Log HOMA-IR versus 
 Log septal e’ (n=430) *          -0.11 (-0.20 to -0.02) <0.05 
    * + LVMI       -0.10 (-0.20 to -0.01) <0.05 
    * + RWT       -0.10 (-0.19 to -0.01) <0.05 
 Log LA vol (n=430) *           0.05 (-0.05 to 0.15) =0.30 
    * + LVMI        0.03 (-0.06 to 0.13) =0.49 
    * + RWT        0.05 (-0.05 to 0.14) =0.36 
_______________________________________________________________ 
LVMI, left ventricular mass index; RWT, relative wall thickness; e’, velocity of the 
septal wall myocardial tissue lengthening in early diastole at the mitral annulus; LA 
vol, left atrial volume. *Adjustments are for age, sex, systolic blood pressure, regular 
tobacco use, regular alcohol consumption, treatment for hypertension, diabetes 
mellitus or an abnormal blood glucose control (HbA1c>6.1%), and L VMI or RWT as 
indicated.
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further adjustments for either LVMI or RWT, relations between waist circumference, 
BMI or HOMA-IR and lateral e’ (Table 2.2) or septal e’ (Table 2.3) persisted. In 
contrast, neither indexes of obesity nor HOMA-IR were independently associated 
with E/A<0.80, moderate-to-severe DD or LA volume (Table 2.3 and Table 2.4). 
HOMA-IR but not indexes of obesity were independently associated with E/A<0.80 
(Table 2.4). Independent of the individual terms and additional confounders, 
interactions between HOMA-IR and RWT, but not LVMI (data not shown) were 
independently associated with lateral e’, septal e’, E/A, E/e’ and mild or moderate-to-
severe DD (Tables 2.5 and 2.6). Interactions between HOMA-IR and RWT were not 
independently associated with left atrial volume (Table 2.6). No significant 
interactions between indexes of excess adiposity and RWT were independently 
associated with indexes of LV diastolic function (Table 2.5 and Table 2.6). Moreover, 
independent of the individual terms and additional confounders, interactions between 
neither age nor blood pressure and RWT, were independently associated with lateral 
e’, septal e’, E/A, E/e’ (Table 2.7), and mild or moderate-to-severe DD (data not 
shown). The interactions between HOMA-IR and RWT translated into independent 
relationships between HOMA-IR and lateral e’, septal e’, E/A and E/e’ (Figure 2.3 
and Table 2.8), and between HOMA-IR and the odds of E/A<0.80 or moderate-to-
severe DD (Figure 2.4) only in those with a RWT above the median for the sample. 
In contrast, similar independent relationships were noted between age or blood 
pressure and E/A, E/e’, lateral e’ or septal e’ (Figures 2.3 and 2.5) and between BP 
or age and the odds of E/A<0.80 or moderate-to-severe DD (Figure 2.4) in those with 
a RWT above the median for the sample compared to those with RWT below the 
median. Notably lateral e’, septal e’, E/A and E/e’ showed stepwise increases across 
tertiles of HOMA-IR only in those participants with a RWT above the median for the 
sample (Figure 2.6 and Table 2.9). Only in those with the highest tertile of HOMA-IR 
was diastolic function significantly different between those with and those without 
RWT values above versus below the median for the sample (Figure 2.6 and Table 
2.9). 
 
2.5 Discussion 
 
 The main findings of the present study are as follows: In a large, community-
based sample with a high prevalence of obesity and LV DD, an interaction between 
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Table 2.4. Multivariate adjusted associations between indexes of adiposity or the 
homeostasis model of insulin resistance (HOMA-IR) and left ventricular (LV) diastolic 
dysfunction (DD) in the study group. 
 
               Odds ratio*                    Wald Х2   p value          
                (95% CI)           
_________________________________________________________________ 
Associations with E/A<0.80 
       Waist circumference  1.014 (0.994 to 1.034)      1.920 =0.17 
       Body mass index   1.017 (0.977 to 1.058)      0.666 =0.41 
       Log HOMA-IR   1.967 (1.112 to 3.480)      1.054 =0.02 
Associations with moderate-to-severe DD (Lateral e’<10, Septal e’<8, or LA 
volume≥34, and E/e’≥13 and E/A≥0.80) 
       Waist circumference  1.014 (0.992 to 1.037)      1.54 =0.21 
       Body mass index   1.029 (0.983 to 1.077)      1.53 =0.22 
       Log HOMA-IR   1.462 (0.769 to 2.783)      1.34 =0.25 
___________________________________________________________________ 
E/A, ratio of transmitral early-to-atrial (late) blood flow velocity; E/e’, E/velocity of the 
mean value of lateral and septal wall myocardial tissue lengthening in early diastole 
at the mitral annulus. *Included in the models were age, sex, diastolic blood pressure 
(decreased E/A) or systolic blood pressure (moderate-to-severe DD), regular tobacco 
use, regular alcohol consumption, treatment for hypertension, diabetes mellitus or an 
abnormal blood glucose control (HbA1c>6.1%), pulse rate (for E/A) and left ventricular 
mass index. 
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Table 2.5. Independent associations between adiposity index (or the homeostasis model of insulin resistance [HOMA-IR])-left ventricular (LV) 
relative wall thickness (RWT) interactions and LV diastolic function in a community sample. 
 
        Adjustments             
_________________________________________________________________________________________________ 
             Partial r  (95% CI)     p value 
Log E/A vs 
     Waist circumference*RWT interaction              *    0.07 (-0.01 to 0.14)      =0.09 
     Body mass index*RWT interaction                   *    0.07 (0.00 to 0.14)      =0.05 
     Log HOMA-IR*RWT interaction                     *               -0.09 (-0.17 to -0.02)      <0.02 
Log E/e’ vs 
     Waist circumference*RWT interaction              *    0.04 (-0.06 to 0.14)      =0.39 
     Body mass index*RWT interaction                   *               -0.01 (-0.10 to 0.09)      =0.89 
     Log HOMA-IR*RWT interaction                     *    0.11 (0.02 to 0.21)      <0.02 
Log lateral e’ vs 
     Waist circumference*RWT interaction              *    0.03 (-0.07 to 0.13)      =0.56 
     Body mass index*RWT interaction                   *               0.08 (-0.02 to 0.17)      =0.12 
     Log HOMA-IR*RWT interaction                     *                        -0.11 (-0.24 to -0.05)      <0.005 
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Odds ratio* (95% CI)        Wald Х2    p value  
E/A<0.80 vs 
     Waist circumference*RWT interaction              *  1.045 (0.844 to 1.293)       0.16    =0.69 
     Body mass index*RWT interaction                  *  1.052 (0.706 to 1.567)       0.06    =0.80 
     Log HOMA-IR*RWT interaction                     *  7.305 (1.821 to 29.305)     7.87   <0.005 
 
Moderate-to-severe DD (Lateral e’<10, Septal e’<8, LA volume≥34, E/e’≥13, E/A≥0.80) vs 
     Waist circumference*RWT interaction              *  0.879 (0.696 to 1.110)       1.17    =0.28 
     Body mass index*RWT interaction                   *  0.668 (0.412 to 1.084)       2.66    =0.10 
     Log HOMA-IR*RWT interaction                     *  5.829 (1.296 to 26.223)     6.09    =0.014 
 _________________________________________________________________________________________________ 
E/A, ratio of transmitral early-to-atrial (late) blood flow velocity; E/e’, E/velocity of the mean value of lateral and septal wall myocardial tissue 
lengthening in early diastole at the mitral annulus. *Adjustments are for age, sex, diastolic blood pressure (E/A) or systolic blood pressure (E/e’ 
and lateral e’), regular tobacco use, regular alcohol consumption, treatment for hypertension, diabetes mellitus or an abnormal blood glucose 
control (HbA1c>6.1%), and pulse rate (E/A). 
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Table 2.6. Independent associations between adiposity index (or the homeostasis 
model of insulin resistance [HOMA-IR])-left ventricular (LV) relative wall thickness 
(RWT) interactions and LV diastolic function in a community sample. 
 
     Adjustments Partial r  (95% CI)     p value 
___________________________________________________________________ 
Log septal e’ vs 
     Waist circumference*RWT interaction  *  0.02 (-0.07 to 0.12)      =0.63 
     Body mass index*RWT interaction       *             0.05 (-0.05 to 0.14)      =0.32 
     Log HOMA-IR*RWT interaction         *            -0.10 (-0.20 to -0.01)      <0.05 
Log LA volume vs 
     Waist circumference*RWT interaction  *            -0.03 (-0.13 to 0.07)      =0.57 
     Body mass index*RWT interaction       *            -0.04 (-0.10 to 0.06)      =0.43 
     Log HOMA-IR*RWT interaction         *            -0.06 (-0.15 to 0.04)      =0.24 
___________________________________________________________________ 
e’, velocity of the septal wall myocardial tissue lengthening in early diastole at the 
mitral annulus; LA, left atrial. *Adjustments are for age, sex, systolic blood pressure, 
regular tobacco use, regular alcohol consumption, treatment for hypertension, 
diabetes mellitus or an abnormal blood glucose control (HbA1c>6.1%). 
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Table 2.7. Lack of independent associations between age or blood pressure-left 
ventricular (LV) relative wall thickness (RWT) interactions and LV diastolic function in 
a community sample. 
 
     Adjustments Partial r  (95% CI)     p value 
___________________________________________________________________ 
Log E/A vs 
     Age*RWT interaction    *  0.04 (-0.04 to 0.11)      =0.31 
     DBP*RWT interaction         *             0.05 (-0.02 to 0.12)      =0.18 
Log E/e’ vs 
     Age*RWT interaction    *  0.07 (-0.02 to 0.16)      =0.15 
     SBP*RWT interaction         *             0.03 (-0.06 to 0.13)      =0.49 
Log lateral e’ vs 
     Age*RWT interaction    *  -0.03 (-0.13 to 0.06)      =0.51 
     SBP*RWT interaction         *             -0.04 (-0.13 to 0.06)      =0.44 
Log septal e’ vs 
     Age*RWT interaction    *  -0.07 (-0.17 to 0.02)      =0.13 
     SBP*RWT interaction         *             -0.06 (-0.16 to 0.03)      =0.19 
___________________________________________________________________ 
e’, velocity of the septal wall myocardial tissue lengthening in early diastole at the 
mitral annulus; LA, left atrial. *Adjustments are for age, sex, diastolic blood pressure 
(E/A), systolic blood pressure (E/e’, lateral e’ and septal e’), regular tobacco use, 
regular alcohol consumption, treatment for hypertension, diabetes mellitus or an 
abnormal blood glucose control (HbA1c>6.1%) and pulse rate (E/A). 
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Figure 2.3. Synergistic effect of left ventricular (LV) relative wall thickness (RWT) and the homeostasis model of insulin resistance (HOMA-IR) 
(left panels), or blood pressure (BP) (right panels) on indexes of left ventricular (LV) diastolic function. Figures show significant relations (partial 
r) between HOMA-IR and LV diastolic function in participants with a RWT above, but not below the median for the sample, whilst relations 
between BP and LV diastolic function are similar in participants with a RWT above and below the median for the sample. See table 2.1 for 
abbreviations. Adjustments are for age, sex, diastolic blood pressure (HOMA-IR vs E/A), systolic blood pressure (HOMA-IR vs E/e’ and lateral 
e’), pulse rate (E/A), regular smoking, regular alcohol consumption, diabetes mellitus or an HbA1c>6.1%, treatment for hypertension, and left 
ventricular mass index. *p<0.05 versus the partial r value of the HOMA-IR vs E/A, E/e’, or lateral e’ relationship in those with a RWT< median 
for the sample. 
*
*
*
 58 
 
Table 2.8. Strength (partial r) of relations between the homeostasis model of insulin 
resistance (HOMA-IR) and septal e’ in participants with a LV relative wall thickness 
(RWT) above or below the median for the sample. 
 
    Adjustments        Partial r    p value 
            (95% CI) 
____________________________________________________________ 
RWT<0.361 
Log HOMA-IR versus  
 Log septal e’ (n=215)  *         -0.03 (-0.17 to 0.11) =0.66 
RWT≥0.361 
Log HOMA-IR versus 
 Log septal e’ (n=215)  *         -0.14 (-0.27 to -0.01) =0.05 
____________________________________________________________ 
e’, velocity of the septal wall myocardial tissue lengthening in early diastole at the 
mitral annulus; LA vol, left atrial volume. *Adjustments are for age, sex, systolic blood 
pressure, regular tobacco use, regular alcohol consumption, treatment for 
hypertension, diabetes mellitus or an abnormal blood glucose control (HbA1c>6.1%) 
and left ventricular mass index. 
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Figure 2.4. Synergistic effect of left ventricular (LV) relative wall thickness (RWT) and the homeostasis model of insulin resistance (HOMA-IR) 
(left panels), or blood pressure (BP) (right panels) on the odds of LV diastolic dysfunction (DD) (E/A<0.80 or lateral e’<10, septal e’<8, LA 
volume≥34, E/e’≥13, E/A≥0.80). Figures show an impact of HOMA-IR on DD in participants with a RWT above, but not below the median for 
the sample, but a similar impact of BP on DD in participants with a RWT above and below the median for the sample. See table 2.1 for 
abbreviations. Adjustments are as given in figure.2.3. 
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Figure 2.5. Relations (partial r) between blood pressure (BP) and left ventricular (LV) 
diastolic function in participants with a LV relative wall thickness (RWT) above and 
below the median for the sample. See table 2.1 for abbreviations. Adjustments are 
for age, sex, pulse rate (E/A), regular smoking, regular alcohol consumption, 
diabetes mellitus or an HbA1c>6.1%, treatment for hypertension, and left ventricular 
mass index. 
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Figure 2.6 Impact of synergistic effect of left ventricular (LV) relative wall thickness 
(RWT) and the homeostasis model of insulin resistance (HOMA-IR) on LV diastolic 
function. Figures show differences in LV diastolic function across tertiles of HOMA-IR 
in participants with a RWT above, but not below the median for the sample. See 
table 2.1 for abbreviations. Adjustments are as given in figure.2.3. *p<0.05, 
**p<0.005 versus tertile 1, †p<0.05 versus tertile 2. 
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Table 2.9. Adjusted septal e’ across tertiles of the homeostasis model of insulin 
resistance (HOMA-IR) in participants with a LV relative wall thickness (RWT) above 
or below the median for the sample.  
      Tertiles of HOMA-IR 
    1    2   3 
RWT<0.361 
HOMA-IR  <1.09   1.09 – 2.37   ≥2.37  
n=    71   74    70 
Adjusted septal e’      10.27±0.32  10.71±0.31   10.18±0.32 
RWT≥0.361 
HOMA-IR  <1.11   1.11 – 2.76   ≥2.76  
n=    70   74    71 
Adjusted septal e’       9.54±0.32  9.19±0.30   8.58±0.31* 
e’, velocity of the septal wall myocardial tissue lengthening in early diastole at the 
mitral annulus. Adjustments are for age, sex, systolic blood pressure, regular tobacco 
use, regular alcohol consumption, treatment for hypertension, diabetes mellitus or an 
abnormal blood glucose control (HbA1c>6.1%) and left ventricular mass index. 
*p<0.05 versus tertile 1. 
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HOMA-IR and RWT, but not other risk factors (namely age, blood pressure, waist 
circumference and BMI), was independently associated with lateral e’, septal e’, E/A, 
E/e’ and mild or moderate-to-severe DD. This interaction translated into an 
association between HOMA-IR and diastolic function or dysfunction and stepwise 
decreases in E/A, lateral e’ and septal e’ and increases in E/e’, only in those with a 
RWT above the median for the sample. In those with a RWT below the median for 
the sample, HOMA-IR was not independently associated with indices of LV diastolic 
function or with the prevalence of LV DD. In contrast, blood pressure and age, the 
major risk factors for diastolic dysfunction were equally as well associated with 
diastolic function or dysfunction in those with a RWT greater than as compared to 
less than the median for the sample. 
 Although several large cross-sectional and intervention (bariatric surgery) 
studies have demonstrated independent associations between adiposity indices and 
abnormalities of LV diastolic function (Tsioufis et al 2008; Russo et al 2011; Çil et al 
2011; AlJaroudi et al 2012; Libhaber et al 2009; Cuspidi et al 2014), the relative 
importance of obesity as compared to alternative risk factors has recently been 
highlighted as being modest at best in some populations (Millen et al 2014). Indeed, 
in the present study neither indices of excess adiposity, nor of insulin resistance were 
independently associated with the presence of moderate to severe LV DD. As weight 
loss programs seldom achieve target body weight or result in sustained decreases in 
body weight (Latner et al 2002; Anderson et al 2001), there is a need to identify those 
in whom weight loss is most likely to prevent the progression to heart failure. In this 
regard, the present study suggests that the presence of a more concentric LV 
(RWT>0.361 or the median of the sample) characterises those in whom insulin 
resistance is likely to translate into either mild or moderate-to-severe DD. 
Importantly, in contrast to the lack of impact of HOMA-IR on moderate-to-severe DD 
in the whole group, in those with a RWT >median for the sample, HOMA-IR was 
independently associated with both mild and moderate-to-severe DD. Moreover, the 
strength of the relations between HOMA-IR and indices of LV diastolic function in 
those with a RWT above the median of the sample was similar to that of the strength 
of the relation between BP and LV diastolic function. Hence, the present study 
suggests that those at risk of progressing to obesity-associated DD, and hence 
possibly heart failure with a preserved ejection fraction, are most likely to be insulin 
resistant individuals with a more concentric LV. 
 Although several studies have demonstrated independent relations between 
adiposity indices and abnormalities of LV diastolic function (Russo et al 2011; Çil et 
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al 2011; AlJaroudi et al 2012; Libhaber et al 2009; Millen et al 2014), few of these 
studies (Libhaber et al 2009; Millen et al 2014) adjusted for BP as a continuous trait 
or employed diastolic BP when adjusting relations with E/A and systolic BP when 
adjusting relations with E/e’, as recently recommended (Libhaber et al 2014). Indeed, 
a number of these studies identified independent relations between obesity and DD 
using only the presence of hypertension as an adjustor (Russo et al 2011; Çil et al 
2011; AlJaroudi et al 2012), and hence did not fully account for the confounding 
effect of BP as a co-morbidity. Thus, although these studies (Russo et al 2011; Çil et 
al 2011; AlJaroudi et al 2012) demonstrated strong independent relations between 
BMI and LV DD, the strength of these relations is likely to be attributed to BP effects. 
Indeed, as noted in the present study, with appropriate BP adjustments, the impact of 
an excess adiposity or the associated insulin resistance on LV DD in unselected 
individuals may be modest at best (Millen et al 2014). Nevertheless, in the present 
study we provide evidence to suggest that in those with a more concentrically 
remodelled LV, insulin resistance, a well-recognised metabolic abnormality in 
obesity, is indeed independently associated with both mild and moderate-to-severe 
DD. In those without concentric remodelling, neither obesity nor the associated 
insulin resistance impact on LV diastolic function. Thus, it is possible that attempts to 
modify insulin resistance are most likely to have benefits to the development of DD in 
those individuals with a more concentrically remodelled LV. 
 An important caveat of the present study is that the present results do not 
suggest that obesity or insulin resistance mediate LV DD through concentric LV 
remodelling. Indeed, independent relations between adiposity indices or HOMA-IR 
and LV diastolic functional parameters were unaffected by adjustments for RWT. 
Rather, the interactive effect of LV remodelling with HOMA-IR should be viewed as 
RWT providing a modifying influence on the impact of insulin resistance. In this 
regard RWT is likely to influence diastolic function (Chahal et al 2010) and hence 
generate the conditions where insulin resistance-induced metabolic effects on 
diastolic function translate into relaxation abnormalities and raised LV filling 
pressures. Whether therapeutic approaches that increase insulin resistance translate 
into an improved diastolic function and hence a reduced risk for heart failure mainly 
in those with a more concentrically remodelled LV requires further study. 
 The limitations of the present study are as follows: First, this is a cross-
sectional study and hence we cannot draw conclusions regarding cause and effect. 
Whether the development of insulin resistance influences the development of DD in 
those with concentric rather than eccentric LV remodelling requires further study. 
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Second, we failed to measure several alternative indices of diastolic function 
previously recommended (Nagueh et al 2009) and which have now been 
incorporated into guidelines. However, many of these measurements showed a low 
degree of reproducibility and a high degree of inter-observer variability in our hands 
and absolute world-wide consensus on which measures are required to best identify 
DD has not been reached. Third, we were not statistically powered to perform sex-
specific analysis and hence it is possible that as more women than men volunteered 
for the study, that the results may relate mainly to women.   
 In conclusion, in a relatively large community-based sample with a high 
prevalence of obesity, we show that independent of confounders, although a higher 
RWT does not mediate the impact of insulin resistance on LV diastolic function, a 
more concentrically remodelled LV modifies the impact of insulin resistance on LV 
diastolic function. These data suggest that from a clinical perspective, those with a 
more concentrically remodelled LV may be particularly prone to insulin resistance-
associated LV DD and thus possibly the progression to heart failure with a preserved 
ejection fraction. Future studies will determine whether targeting the degree of insulin 
resistance in obese individuals is more likely to be beneficial in those with a more 
concentrically remodelled LV. 
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CHAPTER 3 
 
 
 
 
 
 
Cardiac Diastolic dysfunction is Associated with Aortic Wave Reflection, but 
not Stiffness in a Predominantly Young-to-Middle-Aged Community Sample 
 
 
 
 
 
The data in this chapter have been published in the American Journal of 
Hypertension: 
 
Peterson, V.R., Woodiwiss, A.J., Libhaber, C.D., Raymond, A., Sareli, P. and Norton, 
G.R. (2016). Cardiac Diastolic Dysfunction is Associated with Aortic Wave Reflection, 
but not Stiffness in a Predominantly Young-to-Middle-Aged Community Sample. 
American Journal of Hypertension, 29, 1148-1157. 
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3.1 Abstract  
 
Background. Whether the impact of backward wave pressures on left ventricular 
(LV) diastolic dysfunction (DD) antedates the effects of aortic stiffness is uncertain. 
We compared the relative contribution of various aortic haemodynamic parameters to 
preclinical DD in a predominantly young-to-middle aged community-based sample. 
Methods. In 524 randomly selected participants of African ancestry (mean 
age=46.8±18.4 years) we assessed central aortic pulse pressure (PPc), forward 
wave pressure (Pf), backward wave pressure (Pb), augmented pressure (Pa), the 
time to wave reflection (Rt) and aortic pulse wave velocity (PWV) using applanation 
tonometry (SphygmoCor software). LV mass index (LVMI), early to late trans-mitral 
velocity (E/A) and E/velocity of myocardial tissue lengthening (E/e’) were determined 
using echocardiography. 
Results. Independent of age, sex, mean arterial pressure, body mass index, 
diabetes mellitus or and HbA1c>6.1%, regular smoking, regular alcohol intake, 
treatment for hypertension, pulse rate and LVMI; PPc (p<0.002), Pb (p<0.0005), Pa 
(p<0.002), and Pf (p<0.02), but not Rt or PWV were independently associated with 
E/e’ (but not with E/A). With adjustments for confounders, PPc (p<0.005), Pb 
(p<0.002) and Pa (p<0.001), but not Pf, Rt or PWV were independently associated 
with E/e’ ≥12 (moderate-to-severe DD, n=69). The independent relations between 
PPc and E/e’ or moderate-to-severe DD were not affected by adjustments for PWV, 
Pf or Rt, but were abolished with adjustments for Pb. 
Conclusions. In a predominantly young-to-middle aged community sample, the 
impact of backward wave pressures on LV DD antedates the effects of aortic 
stiffness, the time to wave reflection or forward wave pressures. 
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3.2 Introduction 
 
 Heart failure with a preserved (normal) ejection fraction may contribute to 
close to half of all admissions for heart failure, and the outcomes may be equally as 
poor as heart failure with a reduced ejection fraction (Borlaug & Redfield 2011; Lee 
et al 2009; Owan et al 2006; Bhatia et al 2006). There is presently no treatment with 
proven benefit for heart failure with a normal ejection fraction (Borlaug & Redfield 
2011; Borlaug & Paulus 2011; Pitt et al., 2014) and hence understanding the 
pathophysiological mechanisms responsible may shed light on potential therapeutic 
targets. In this regard, diastolic dysfunction (DD) is central to the pathophysiology 
and outcomes of heart failure with a normal ejection fraction (Zile et al 2004; 
Westermann et al 2008; Burke et al 2014; Mohammed et al 2012; Shah et al 2014) 
and pre-clinical DD predicts the progression to heart failure with a normal ejection 
fraction (Wan et al 2014). Although abnormalities of pulsatile haemodynamics and 
aortic function have frequently been described in hypertensive heart failure with a 
normal ejection fraction (Mohammed et al 2012; Hundley et al 2001; Kawaguchi et al 
2003; Weber et al 2006; Weber et al 2008; Borlaug et al 2007; Fernandes et al 2008; 
Kang et al 2010; Desai et al 2009; Kitzman et al 2013) the primary aortic functional 
change responsible for pre-clinical left ventricular (LV) DD is unclear. 
 Several studies have identified associations between aortic stiffness or 
reflected waves and aspects of LV diastolic function in those without heart failure 
(Kawaguchi et al 2003, Weber et al 2006; Weber et al 2008; Borlaug et al 2007). 
However, whilst there is little evidence to support a therapeutic approach to modify 
age-related increases in aortic stiffness, there is significant evidence to suggest that 
aortic backward wave pressures may be targeted by conventional therapy (Agabiti-
Rosei et al 2007). Importantly, marked age-related increases in backward wave 
pressures precede significant age-related increases in aortic stiffness by several 
decades (Booysen et al 2015). Moreover, increases in aortic backward wave 
pressures are a fundamental mechanism responsible for increases in aortic stiffness 
(Sibiya et al 2015), and hence may be the initial (primary) target in preventing the 
progression to LV DD and consequently heart failure with a preserved ejection 
fraction. However, it is uncertain whether the impact of backward wave pressures on 
LV DD antedates the effects of aortic stiffness. In this regard, prior studies assessing 
relations between aortic and LV diastolic function have assessed patients with 
average ages of 60-77 years (Mohammed et al 2012; Hundley et al 2001; Kawaguchi 
et al 2003; Weber et al 2006; Weber et al 2008; Fernandes et al 2008; Kang et al 
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2010; Desai et al 2009; Kitzman et al 2013), age ranges when large vessel stiffness 
is markedly increased (Booysen et al 2015). Hence, none of these studies could 
address the question of whether the impact of backward wave pressures on LV DD 
antedate the effects of aortic stiffness. In the present study we therefore evaluated 
the relationship between several aortic functional parameters and LV diastolic 
function in a predominantly young-to-middle aged community-based sample with an 
average age where increases in aortic backward wave pressures are well 
established, but prior to an age when striking increases in aortic stiffness are noted 
(Booysen et al 2015). 
 
3.3 Methods 
 
3.3.1 Study participants.  
 
The present study was conducted according to the principles outlined in the 
Helsinki declaration. The Committee for Research on Human Subjects of the 
University of the Witwatersrand approved the protocol (approval number: M02-04-72 
and renewed as M07-04-69 and M12-04-108). Participants gave informed, written 
consent. The present study design has previously been described (Booysen et al 
2015). Briefly, families of black African descent (Nguni and Sotho chiefdoms) with 
siblings older than 16 years of age were randomly recruited from the South West 
Township (SOWETO) of Johannesburg, South Africa. Of 832 participants with 
echocardiography, in a sub-study 524 participants had trans-mitral velocity 
measurements, myocardial tissue Doppler imaging (TDI) and all aortic function 
measurements. None of these participants had evidence of significant valve 
abnormalities assessed using 2-dimensional and colour Doppler imaging. None of 
the participants had previously had a myocardial infarction (only three had a history 
of ischaemic heart disease), and there were no cases of atrial fibrillation. 
 
3.3.2 Clinical, demographic, anthropometric and laboratory assessments.  
 
A standardised questionnaire was administered to obtain demographic and 
clinical data (Booysen et al 2015). Height and weight were measured using standard 
approaches and participants were identified as being overweight if their body mass 
index (BMI) was ≥25 kg/m2 and obese if their BMI was ≥30 kg/m2. Standard 
laboratory blood tests of renal function, liver function, blood glucose, haematological 
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parameters, and percentage glycated haemoglobin (HbA1c) were performed. 
Diabetes mellitus (DM) or abnormal blood glucose control was defined as the use of 
insulin or oral hypoglycemic agents or an HbA1c value greater than 6.1%. 
 
3.3.3 Office blood pressure. 
  
High quality office BP measurements were obtained by a trained nurse-
technician using a standard mercury sphygmomanometer (Booysen et al 2015) 
according to guidelines. The nurse was of the same ethnic origins (black African) as 
the participants and had previously lived in SOWETO. Korotkov phases I and V were 
employed to identify systolic and diastolic BP respectively and care was taken to 
avoid auscultatory gaps. Office BP was measured 5 times consecutively using 
appropriately sized cuffs after the subjects had rested for 5-10 minutes in the sitting 
position. The mean of all 5 office BP measurements was used in the analysis. 
 
3.3.4 Aortic haemodynamics. 
 
Aortic haemodynamic parameters were assessed from pulse wave and wave 
separation analysis conducted using techniques previously described (Booysen et al 
2015) (Figures 3.1 and 3.2). After participants had rested for 15 minutes in the 
supine position, arterial waveforms at the radial (dominant arm) pulse were recorded 
by applanation tonometry during an 8-second period using a high-fidelity SPC-301 
micromanometer (Millar Instrument, Inc., Houston, Texas) interfaced with a computer 
employing SphygmoCor, version 9.0 software (AtCor Medical Pty. Ltd., West Ryder, 
New South Wales, Australia). Recordings where the systolic or diastolic variability of 
consecutive waveforms exceeded 5% or the amplitude of the pulse wave signal was 
less than 80 mV were discarded. All measurements were made by a single 
experienced trained technician unaware of the clinical history of the participants. To 
obtain central aortic PP (PPc), the pulse wave was calibrated by manual 
measurement (auscultation) of brachial BP taken immediately before the recordings. 
From an inbuilt validated generalised transfer function an aortic waveform was 
generated from which PPc was derived. Aortic backward (Pb) and forward (Pf) wave 
pressures were determined using SphygmoCor software which separates the aortic 
waveform using a triangular flow wave (Figure 3.2). Reflected wave magnitude (RM) 
was determined as Pb/Pf x 100. Aortic augmented pressure (Pa) was determined 
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Figure 3.1 A SphygmoCor device coupled with an applanation tonometer (panel A) 
which was used to determine aortic haemodynamics. Panel B illustrates the 
applanation tonometer used to detect the pressure waveforms. 
A 
B 
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Figure 3.2 Derivation of aortic functional parameters from the aortic pressure 
waveform using SphygmoCor software. The aortic pressure wave was separated into 
the forward and backward waves assuming the aortic flow wave to have a triangular 
shape.  Pa, augmented pressure; PPc, central aortic pulse pressure; AIx, 
augmentation index; Pf, forward wave pressure; Pb, backward (reflected) wave 
pressure; RM, reflection magnitude; Ft, time to peak forward wave; Rt, reflected 
wave time; P1, first systolic peak; P2, second systolic peak. 
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using SphygmoCor software and identified as the difference between aortic systolic 
BP and the first systolic peak of the aortic pulse wave (Figure 3.2). To avoid 
obtaining negative aortic augmentation index (AIx) values in young participants, AIx 
was determined as the pressure at the second systolic peak of the aortic pulse 
wave/the pressure at the first systolic peak of the aortic pulse wave expressed as a 
percentage. The time to the peak of the forward wave (Ft) and the time to wave 
reflection (Rt) were also determined from SphygmoCor software (Figure 3.2).  
Aortic PWV was determined from sequential waveform measurements at 
carotid and femoral sites using applanation tonometry and SphygmoCor software 
(Figure 3.3). The time delay in the pulse waves between the carotid and femoral sites 
was determined using an electrocardiograph-derived R wave as a fiducial point. 
Pulse transit time was taken as the average of 10 consecutive beats. The distance 
which the pulse wave travels was determined as the difference between the distance 
from the femoral sampling site to the suprasternal notch, and the distance from the 
carotid sampling site to the suprasternal notch. Aortic PWV was calculated as the 
ratio of the distance to the transit time (m/sec). 
 
3.3.5 Echocardiography. 
 
Echocardiographic measurements were performed using a Sonosite M-Turbo 
ultrasound (SonoSite® Inc., Bothell, WA, USA) device with the patient in the partial 
left decubitus position as previously described (Libhaber et al 2014; Millen et al 2014; 
Norton et al 2008; Woodiwiss et al 2009) (see chapter 2, section 2.3.3). Left 
ventricular mass (LVM) was indexed (LVMI) to height2.7. An LVMI>51 g/m2.7 was 
considered as LV hypertrophy (LVH). Left ventricular end diastolic and systolic 
volumes were determined from M-mode images using the Teichholz method. Left 
ventricular ejection fraction (EF) was calculated as [(LV end diastolic volume-LV end 
systolic volume)/ LV end diastolic volume] x 100. 
Left ventricular diastolic function was assessed from a pulsed wave Doppler 
examination of the mitral inflow at rest and using TDI (Quiñones et al 2002). Pulse 
wave Doppler recordings of trans-mitral velocity were obtained with the sample 
volume at the tip of the mitral valve in the apical 4-chamber view. Trans-mitral blood 
flow velocity measurements were obtained during the early (E) and late (atrial-A) 
period of left ventricular diastolic inflow and expressed as the E/A ratio. To perform 
TDI, the velocity of myocardial tissue lengthening at the level of the mitral annulus  
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Figure 3.3 Aortic pulse wave velocity was determined from sequential pressure waveform measurements at carotid and femoral sites. The R-
wave in a simultaneously recorded electrocardiogram (ECG) was used as a fiducial point to determine the time delay in the waves between the 
carotid and femoral sites (green dots on both ECG and pressure waveform). 
ECG 
ECG 
Pressure waveform 
Pressure waveform 
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was recorded in the apical four-chamber view. The sample volume was positioned at 
the septal and lateral corners of the mitral annulus.To determine diastolic function 
using TDI, peak velocities during early (e’) and late (atrial) (a’) diastole were 
measured. Data were expressed as the E/lateral wall e’ ratio (an index of LV filling 
pressures). Left ventricular diastolic dysfunction (DD) was evaluated as mild 
(impaired relaxation when E/A≤0.75), moderate (pseudonormal, where 
E/A>0.75<1.5, and E/e’≥12) and severe (where E/A≥1.5 and E/e’≥12). A threshold of 
12 for E/e’ was identified from the upper 97.5 percentile (11.7) of E/e’ identified in 
140 normotensive, non-obese, non-diabetic participants who did not smoke or 
consume alcohol and who had an estimated glomerular filtration rate>60 ml/min per 
1.73m2, an LVMI<51 g/m2.7, and no cardiovascular disease.  
 
3.3.6 Data analysis.  
 
Database management and statistical analyses were performed with SAS 
software, version 9.4 (The SAS Institute Inc., Cary, North Carolina, USA). Data are 
expressed as meanSD or proportions. Indexes of diastolic function (E/A and E/e’) 
were logarithmically transformed to improve on the distribution. Relationships were 
evaluated from univariate or multivariate linear (continuous analysis) or logistic 
(discrete analysis) regression analysis. To determine probability values, further 
adjustments for non-independence of family members was performed using non-
linear regression analysis (mixed procedure as defined in the SAS package). 
 
3.4 Results 
 
3.4.1 Participant characteristics  
 
When assessing the characteristics of the total sample with and without TDI 
measures, 48.3% of the participants with TDI had uncontrolled hypertension and 
45.2% of these participants were obese (Table 3.1). Other than a modestly higher 
age, and proportion who smoked, and a modestly lower PPc, Pb, PWV and LVMI, no 
differences were noted between participants with and without TDI. In the group with 
TDI, 12.6% of participants had mild DD, 9.4% moderate DD, and 1.5% severe DD. 
No participants had an EF<40% and 5.7% had an EF<50%. LVH was more prevalent 
in those with a decreased E/A (≤7.5) (28.8%) or increased E/e’ (≥12)(27.5%) as 
compared to those with either a normal E/A or E/e’ (15.1% or 15.2%, p<0.02 for 
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both). 81.2% of participants were receiving low-dose hydrochlorothiazide, 22.4% 
calcium channel blockers, 24.8% angiotensin-converting enzyme inhibitors, 0.6% 
beta-adrenergic receptor blockers, and 9.1% other anti-hypertensive agents (Table 
3.1). 57.5% of participants were receiving monotherapy (88.3% diuretics), and 33.3% 
were receiving combined therapy (50.9% diuretic plus angiotensin-converting 
enzyme inhibitor; 30.2% diuretic plus calcium channel blocker; 18.9% diuretic plus 
others). 9.2% of participants were receiving triple or more therapy. 
 
3.4.2 Factors correlated with LV diastolic function  
 
 On univariate analysis, age, female sex, treatment for hypertension, 
hypertension, diabetes mellitus, body mass index, PP (brachial and aortic), diastolic 
BP (DBP), mean arterial pressure (MAP), Pf, Pb, RM, aortic PWV, Rt, Ft and LVMI 
were associated with E/A, E/e’ and either mild or moderate-to-severe DD (p<0.005). 
 
3.4.3 Independent associations between aortic haemodynamics and E/A.  
 
 Independent of MAP, and various confounders, only Rt showed modest 
independent associations with E/A (Table 3.2). Similar findings were noted 
irrespective of whether LVMI was or was not included as an adjustor in multivariate 
models (Table 3.2). 
 
3.4.4 Independent associations between aortic haemodynamics and E/e’.  
 
 Independent of MAP, and various confounders, and either before or after 
adjustments for LVMI, PPc, Pb, Pa and Pf, but not PWV, RM, AIx, Ft or Rt were 
independently associated with E/e’ (Table 3.3). In support of a role for aortic 
backward wave pressures, but not aortic stiffness, forward wave pressures or the 
timing of forward and backward wave pressures accounting for the PPc-E/e’ 
relations, whilst adjustments for Pb and Pa abolished relations between PPc and 
E/e’, adjustments for Pf, aortic PWV, Ft or Rt failed to significantly modify relations 
between PPc and E/e’ (Figure 3.4, upper panel). 
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Table 3.1. Demographic, clinical, anthropometric and haemodynamic characteristics of 
the study sample with and without measures of tissue Doppler indices (TDI) of left 
ventricular diastolic function. 
 
            With TDI                 Without TDI 
______________________________________________________________________ 
Sample number (% female)   524 (65.6)       402 (65.2) 
Age (years)      46.8±18.4(16.2 to 87.6)*   44.3±18.0 (16.2 to 84.1) 
Body mass index (kg/m2)   29.6±7.5       29.9±8.0 
% overweight/obese    23.7/45.2       22.9/45.0 
Regular tobacco (% subjects)     16.6           11.9 
Regular alcohol (% subjects)      18.5           21.1 
% diabetes mellitus or HbA1c>6.1%     22.1           25.6 
% hypertensive       48.3           46.0 
% treated for hypertension      31.9           24.4 
% diuretics/CCBs/ACEs/others   81.2/22.4/24.8/9.7             82.6/17.2/24.5/11.3 
Brachial SBP/DBP (mm Hg)       128±22/83±12   130±23/84±13 
Mean arterial pressure (mm Hg)    99±15        101±17 
Central aortic PP (mm Hg)     35±15         37±14 
Backward wave pressure (Pb) (mm Hg)   17±8          18±8 
Forward wave pressure (Pf) (mm Hg)   24±10         25±8 
Reflected wave magnitude (RM) (%)    71±21        73±22 
Augmented pressure (Pa) (mm Hg)    10±7          11±8 
Augmentation index (Alx)   142±25       142±26 
Time to peak forward wave (Ft) (msecs) 126±36       129±38 
Reflected wave time (Rt) (msecs)  118±14       117±14 
Aortic pulse wave velocity (PWV) (m/sec) 5.68±2.41*     6.80±2.98 
LVM index (g/m2.7)    39.1±15.1*     44.7±13.8 
LV ejection fraction (%)   67.2±9.6     67.1±8.4 
E/A      1.31±0.56    1.25±0.49 
E/e’      7.64±4.08    7.99±4.38 
_____________________________________________________________________ 
Data are shown as mean±SD (range) or proportions. CCB, calcium channel blockers; 
ACEIs, angiotensin-converting enzyme inhibitors; SBP, systolic blood pressure; DBP, 
diastolic BP; PP, pulse pressure; LVM, left ventricular mass; E/A, ratio of transmitral 
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early-to-atrial (late) blood flow velocity; E/e’, E/velocity of lateral wall myocardial tissue 
lengthening in early diastole at the mitral annulus. *p<0.05 versus without TDI.
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Table 3.2 Multivariate adjusted relationships between aortic haemodynamic parameters and 
left ventricular (LV) early-to-late (atrial) trans-mitral blood flow velocity (E/A)(n=524). 
                           
Log E/A vs    Partial r  (95% CI)     p value Partial r  (95% CI)       p value 
 Adjustments→    *     * + LVMI 
___________________________________________________________________ 
PPc     0.06 (-0.02 to 0.15)    =0.16 0.07 (-0.02 to 0.16)      =0.12 
Pb     0.04 (-0.04 to 0.13)    =0.32 0.05 (-0.04 to 0.14)      =0.25 
Pf     0.05 (-0.04 to 0.14)    =0.24 0.06 (-0.03 to 0.14)      =0.21 
Pa     0.02 (-0.07 to 0.10)    =0.70 0.02 (-0.07 to 0.11)      =0.65 
RM            -0.06 (-0.14 to 0.03)    =0.19 -0.06 (-0.14 to 0.03)      =0.21 
AIx    -0.05 (-0.13 to 0.04)    =0.28 -0.05 (-0.14 to 0.04)      =0.25 
PWV    -0.07 (-0.16 to 0.01)    =0.10 -0.07 (-0.16 to 0.02)      =0.11 
Ft    -0.08 (-0.17 to 0.01)    =0.07 -0.08 (-0.17 to 0.01)      =0.06 
Rt     0.10 (0.02 to 0.19)     <0.05   0.10 (0.01 to 0.19)      <0.05 
____________________________________________________________________    
For abbreviations see Figure 3.2 and Table 3.1. *Adjustments are for age, sex, mean arterial 
pressure, body mass index, diabetes mellitus or and HbA1c>6.1%, regular smoking, regular 
alcohol intake, treatment for hypertension, pulse rate and LV mass index as indicated.
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Table 3.3. Multivariate adjusted relationships between aortic haemodynamic parameters and left ventricular (LV) early trans-mitral blood flow 
velocity / velocity of lateral wall myocardial tissue lengthening in early diastole at the mitral annulus (E/e’)(n=524). 
 
Partial r†                Standardised   p value Partial r†              Standardised        p value 
Log E/e’ vs (95% CI)           β-coefficient±SEM‡    (95% CI)           β-coefficient±SEM‡ 
Adjustments→    *   *    * + LVMI                 * + LVMI 
__________________________________________________________________________________________ 
PPc           0.15 (0.06 to 0.23)     0.20±0.06 <0.001  0.14 (0.05 to 0.22)     0.16±0.05 <0.002 
Pb           0.17 (0.08 to 0.25)     0.22±0.06 <0.0005 0.16 (0.07 to 0.24)     0.21±0.06 <0.0005 
Pf           0.11 (0.02 to 0.19)     0.11±0.04 <0.02    0.10 (0.02 to 0.19)     0.10±0.05 <0.02 
Pa           0.14 (0.06 to 0.23)     0.21±0.06 <0.002  0.14 (0.05 to 0.22)     0.20±0.06 <0.002 
RM           0.05 (-0.04 to 0.13)    0.06±0.05  =0.26  0.05 (-0.04 to 0.13) 0.06±0.05   =0.28 
AIx           0.02 (-0.07 to 0.10)    0.02±0.05  =0.68  0.02 (-0.07 to 0.11) 0.03±0.05   =0.62 
PWV           0.05 (-0.04 to 0.14)    0.06±0.05  =0.24  0.05 (-0.04 to 0.14) 0.06±0.05   =0.27 
Ft           0.05 (-0.04 to 0.13)    0.04±0.04  =0.30  0.05 (-0.04 to 0.13) 0.04±0.04   =0.31 
Rt          -0.03 (-0.11 to 0.06)   -0.03±0.04  =0.51   -0.03 (-0.11 to 0.06) -0.03±0.04   =0.54 
__________________________________________________________________________________________ 
For abbreviations see Figure 3.2 and Table 3.1. *Adjustments are for age, sex, mean arterial pressure, body mass index, diabetes mellitus or 
and HbA1c>6.1%, regular smoking, regular alcohol intake, treatment for hypertension, pulse rate and LV mass index as indicated.†represents 
the strength of the relationship. ‡represents the slope of the relationship. 
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Figure 3.4. Impact of adjustments for aortic haemodynamic parameters on relations 
between central aortic pulse pressure (PPc) and left ventricular (LV) early trans-mitral blood 
flow velocity/ velocity of early diastolic myocardial tissue lengthening at the level of the mitral 
annulus (lateral wall) (E/e’)(upper panel) or moderate-to-severe LV diastolic dysfunction (LV 
DD)(lower panel). See table 3.1 for further abbreviations. *p<0.05 versus partial r of PPc-E/e’ 
relations without adjustments for aortic haemodynamic variables. 
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3.4.5 Independent associations between aortic haemodynamics and moderate-to-severe 
diastolic dysfunction (E/e’≥12).  
 
Independent of MAP, and various confounders, and either before or after 
adjustments for LVMI, PPc, Pb, Pa and RM, but not Pf, PWV, AIx, Ft or Rt were 
independently associated with moderate-to-severe DD (Table 3.4). Again in support of a role 
for aortic backward wave pressures, but not aortic stiffness, forward wave pressures or the 
timing or forward or backward wave pressures accounting for relations between PPc and LV 
DD, whilst adjustments for Pb and Pa abolished relations between PPc and LV DD, 
adjustments for Pf, aortic PWV, Ft or Rt failed to significantly modify relations between PPc 
and LV DD (Figure 3.4, lower panel). 
 
3.4.6 Associations between aortic haemodynamics and E/e’ or moderate-to-severe 
diastolic dysfunction (E/e’≥12) independent of brachial pressures.  
 
 Independent of brachial PP and additional confounders, the aortic haemodynamic 
variables independently associated with E/e’ and/or a moderate-to severe DD included PPc, 
Pb, Pa and RM (Table 3.5). In contrast, neither Pf, aortic PWV nor Ft and Rt were 
associated with E/e’ or moderate-to-severe LV DD independent of brachial PP (Table 3.5). 
 
3.5 Discussion 
 
 The main findings of the present study are as follows: In a predominantly young-to-
middle-aged community sample with a high prevalence of moderate-to-severe pre-clinical LV 
DD (10.9%), aortic backward wave pressures (Pb derived from wave separation analysis 
and Pa) consistently showed independent relations with E/e’, an index of filling pressures, 
and the presence of LV DD (moderate-to-severe), whilst neither forward wave pressures, 
aortic stiffness (aortic PWV), nor the timing of the forward or backward waves were 
consistently associated with E/e’ and moderate to severe LV DD. Moreover, aortic backward 
wave pressures, but not aortic forward wave pressures, aortic stiffness or the timing of 
forward and backward wave pressures accounted for independent relations between aortic 
PP and increases in E/e’ or moderate-to-severe LV DD. Several aortic haemodynamic 
changes which account for aortic pulsatility, including increases in aortic stiffness and 
backward wave pressures have been described in heart failure with a preserved ejection 
fraction (Mohammed et al 2012; Hundley et al 2001; Kawaguchi et al 2003; Weber et al 
2006; Weber et al 2008; Borlaug et al 2007; Fernandes et al 2008; Kang et al 2010; Desai et  
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Table 3.4. Multivariate adjusted associations between aortic functional parameters and moderate-to-severe left ventricular (LV) diastolic 
dysfunction (69 of 524 participants with an E/e’≥12) in the study group. 
 
E/e’≥12 vs  Odds ratio (95% CI)        Wald Х2    p value  Odds ratio (95% CI)      Wald Х2      p value  
      Adjustments→     *   *        * + LVMI                 * + LVMI           
________________________________________________________________________________________    
PPc      1.039 (1.013 to 1.067)      8.49       <0.005  1.039 (1.013 to 1.067)      8.46      <0.005 
Pb        1.084 (1.032 to 1.139)     10.26     <0.002  1.085 (1.032 to 1.140)     10.2       <0.002 
Pf        1.020 (0.993 to 1.048)      2.1 =0.14  1.020 (0.993 to 1.048)      2.1           =0.14 
Pa               1.104 (1.041 to 1.171)     10.97     <0.001  1.104 (1.041 to 1.171)     10.96     <0.001 
RM       1.020 (1.002 to 1.037)      5.01 <0.05  1.020 (1.002 to 1.037)      4.98      <0.05 
AIx       1.008 (0.994 to 1.022)      1.31 =0.25  1.008 (0.994 to 1.022)      1.33       =0.25 
PWV     1.115 (0.985 to 1.263)      2.97      =0.09  1.115 (0.985 to 1.263)       2.95      =0.09 
Ft     1.005 (0.998 to 1.012)      2.04      =0.15  1.005 (0.998 to 1.012)       2.01      =0.16 
Rt     0.987 (0.969 to 1.007)      1.64      =0.20  0.988 (0.969 to 1.007)       1.62      =0.20 
_______________________________________________________________________________________ 
For abbreviations see Figure 3.2 and Table 3.1. *Adjustments are for age, sex, mean arterial pressure, body mass index, diabetes mellitus or 
and HbA1c>6.1%, regular smoking, regular alcohol intake, treatment for hypertension (in all participants), pulse rate and LV mass index as 
indicated. 
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Table 3.5. Brachial pulse pressure-adjusted associations between aortic functional 
parameters and left ventricular (LV) early trans-mitral blood flow velocity / velocity of 
the mean value of lateral and septal wall myocardial tissue lengthening in early 
diastole at the mitral annulus (E/e’) or moderate-to-severe LV diastolic dysfunction 
(E/e’≥12) in the study group (n=524). 
 
  Partial r (95% CI)*†     Standardised    p value   
            β-coefficient±SEM*‡       
Log E/e’ vs     
________________________________________________ 
PPc     0.09 (0.00 to 0.17)  0.30±0.15     =0.05 
Pb  0.10 (0.01 to 0.18)  0.24±0.11     <0.05    
Pf           -0.004 (-0.09 to 0.08) -0.01±0.07     =0.93 
Pa  0.09 (0.001 to 0.17)  0.15±0.08     <0.05 
RM  0.07 (-0.02 to 0.16)  0.08±0.05     =0.11 
AIx  0.04 (-0.04 to 0.13)  0.05±0.05     =0.34 
PWV  0.02 (-0.07 to 0.11)  0.02±0.05     =0.66 
Ft  0.06 (-0.03 to 0.14)  0.05±0.04     =0.19 
Rt           -0.04 (-0.13 to 0.05) -0.04±0.04     =0.38 
  
  Odds ratio*                  Wald Х2     p value 
E/e’≥12 vs (95% CI)           
________________________________________________ 
PPc       1.091 (1.007 to 1.182)     4.54  <0.05    
Pb       1.128 (1.024 to 1.242)     5.95  <0.05    
Pf       0.965 (0.900 to 1.034)     1.03  =0.31    
Pa             1.095 (1.017 to 1.179)     5.77  <0.05    
RM            1.023 (1.006 to 1.041)     6.84  <0.01    
AIx       1.011 (0.997 to 1.025)     2.24  =0.13    
PWV       1.079 (0.948 to 1.227)     1.33  =0.25    
Ft       1.006 (0.999 to 1.013)     2.71  =0.10    
Rt       0.986 (0.968 to 1.005)     2.04  =0.15    
_________________________________________________ 
For abbreviations see Figure 3.2 and Table 3.1. *Adjustments are for age, sex, 
brachial pulse pressure, mean arterial pressure, body mass index, diabetes mellitus 
or and HbA1c>6.1%, regular smoking, regular alcohol intake, treatment for 
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hypertension, pulse rate and LV mass index. †represents the strength of the 
relationship. ‡represents the slope of the relationship. 
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al 2009; Kitzman et al 2013), and in pre-clinical DD (Kawaguchi et al 2003; Weber et 
al 2006; Weber et al 2008; Borlaug et al 2007). 
However, all of these studies (Mohammed et al 2012; Hundley et al 2001; 
Kawaguchi et al 2003; Weber et al 2006; Weber et al 2008; Fernandes et al 2008; 
Kang et al 2010; Desai et al 2009; Kitzman et al 2013) were conducted in 
participants of an average age of 60-77 years where striking increases in aortic 
stiffness occur (Booysen et al 2015). In contrast, the present study was conducted in 
a community sample with an average age (46.8 years) where marked increases in 
aortic stiffness have not as yet occurred, but where increases in aortic backward 
waves are well established (Booysen et al 2015). Importantly, only three prior studies 
employed study sample sizes larger than the present study (Mohammed et al 2012; 
Fernandes et al 2008; Kang et al 2010) and these studies assessed large vessel 
stiffness, but not backward wave function, thus precluding a comparison of the 
contribution of these two aortic functional changes to LV diastolic function. As I show 
that aortic backward wave pressures, but not aortic stiffness are associated with LV 
DD, the present study adds to prior studies (Mohammed et al 2012; Hundley et al 
2001; Kawaguchi et al 2003; Weber et al 2006; Weber et al 2008; Fernandes et al 
2008; Kang et al 2010; Desai et al 2009; Kitzman et al 2013) by suggesting that the 
impact of backward wave pressures on LV DD antedates the effects of aortic 
stiffness or increases in forward wave pressures. The present results therefore 
suggest an important approach to prevent the development of heart failure 
associated with a normal ejection fraction. In this regard, prospective studies 
evaluating the impact of targeting aortic backward wave pressures rather than simply 
brachial BP on the development of heart failure with a normal ejection fraction are 
required. 
In the present study I was unable to show relations between aortic backward 
wave changes and E/A, an index of myocardial relaxation, independent of age or 
steady-state pressures (MAP). This is in apparent contrast to two smaller (n=143 to 
336) studies conducted in clinical samples (Weber et al 2008; Ikonomidis et al 2008), 
but is consistent with an alternative small (n=106) study (Tsioufis et al 2005). There 
are several possible explanations for these discrepancies including the use of a 
select group of hypertensive patients (Ikonomidis et al 2008), or high risk patients 
referred for catheterisation (Weber et al 2008), whom are more likely to have LV 
relaxation abnormalities than that noted in a largely healthy community-based 
sample (present study), or in newly diagnosed hypertensives (Tsioufis et al 2005). 
However, the most likely reason for discrepant data is that diastolic is more important 
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than systolic BP in associations with E/A, whilst systolic BP (or PP) is more important 
than diastolic BP in associations with E/e’ (Libhaber et al 2014). Hence, the impact of 
aortic function (which influences systolic BP) on E/A will depend on the confounding 
effects of diastolic BP in the sample studied. Importantly, increases in E/e’, although 
not a ‘gold-standard’ measure of diastolic function, is the LV diastolic functional 
change most likely to progress to heart failure with a preserved ejection fraction 
(Kane et al 2011). 
 The results of the present study should be interpreted with caution. The 
present results do not suggest that aortic stiffness does not contribute to pre-clinical 
DD. Indeed, prior studies have repeatedly demonstrated relations between large 
vessel stiffness and indexes of DD (Mohammed et al 2012; Hundley et al 2001; 
Kawaguchi et al 2003; Weber et al 2006; Weber et al 2008; Fernandes et al 2008; 
Kang et al 2010; Desai et al 2009; Kitzman et al 2013; Tsioufis et al 2005; 
Abhayaratnaa et al 2006). In this regard, one of the three prior studies that were 
larger than the present study assessed carotid distensibility (Fernandes et al 2008) 
rather than aortic function and there is dispute as to whether carotid stiffness predicts 
outcomes or adequately reflects changes in aortic stiffness. In addition, one of the 
three prior studies that were larger than the present study assessed brachial-ankle 
stiffness (Kang et al 2010), which incorporates a stiffness assessment of medium-
sized vessels (which contain little elastic tissue) as well as the aorta. Nevertheless, in 
one small study (n=188) a dominant role of aortic stiffness over aortic augmented 
pressures in the identification of DD was noted (Abhayaratnaa et al 2006), and in 
another small study (n=53) (Desai et al 2009) a relationship between aortic stiffness, 
but not aortic augmentation index and heart failure with a preserved ejection fraction 
was reported. Thus large vessel stiffness should be seen as a critical pre-requisite to 
the development of DD. The present study nevertheless suggests that prior to an age 
when large vessel stiffness contributes toward DD, increases in aortic backward 
waves are a major contributing factor to DD. As age-related increases in backward 
wave pressures largely account for pulsatile haemodynamic effects on aortic PWV 
(Sibiya et al 2015), targeting backward wave pressures early in life may prevent 
increases in aortic stiffness and consequently further attenuate the transition to heart 
failure with a preserved ejection fraction. 
 Several studies have demonstrated relations between reflected waves as 
identified from augmentation index (AIx) and cardiac diastolic function (Weber et al 
2006; Weber et al 2008; Ikonomidis et al 2008; Hashimoto et al 2006). However, 
there is some question as to whether the impact of reflected waves should be 
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assessed using AIx or Pa or whether reflected wave function should be derived from 
wave separation analysis and consequently Pb or RM. In this regard, whilst AIx may 
not predict heart failure, RM may show a marked ability to predict heart failure 
(Chirinos et al 2012). Consistent with this notion, in the present study, although aortic 
reflected wave pressures derived with (Pb) or without (Pa) wave separation analysis 
showed independent relations with LV DD, RM but not AIx was independently related 
to LV DD. 
 The limitations of the present study include the cross-sectional nature of the 
study design and hence conclusions regarding cause and effect cannot be drawn. 
Second, more women volunteered for the present study than men, and sex 
differences may exist in the pathophysiology of LV DD (Scantlebury et al 2011). In 
this regard, I was not statistically powered to evaluate the impact of aortic functional 
parameters in sex-specific groups. Hence, the present results may reflect a dominant 
effect in women. Third, the assumptions intrinsic to the use of the ‘triangulation 
method’ of aortic wave separation may not be ideal (Kips et al 2009). However, in 
392 participants of the present sample with aortic velocity measurements, we were 
able to show a correlation (r2) between Pb derived from the ‘triangulation method’ 
versus ‘actual aortic flow’ methods of wave separation of 0.82. Hence, at least in the 
present study, the use of the ‘triangulation method’ is unlikely to have significantly 
affected our results. Fourth, in the present study, calibration of the radial waveform 
from brachial BP measurements ignores amplification of BP from brachial to radial 
arteries (Picone et al 2015). Hence, aortic pressures are likely to have been 
underestimated using the current approach. Last, several measures of LV structure 
and function, not evaluated in the present study, may be employed to identify DD, but 
world-wide consensus as to the exact measures required to best identify DD has not 
been reached. In this regard, in our hands we are unable to reproducibly assess DD 
during the Valsalva manoeuvre, or pulmonary venous velocity. Hence, we may have 
underestimated the extent of DD.  
 In conclusion, in the present study I show that in a community sample of 
predominantly young-to-middle aged participants, increases in backward (reflected) 
wave pressures, but not aortic stiffness or forward wave pressures account for aortic 
pulsatile pressure effects on LV diastolic dysfunction. Hence, the impact of backward 
wave pressures on LV diastolic dysfunction antedates the effects of aortic stiffness. 
Therefore, in the transition to pre-clinical DD and possibly therefore to heart failure 
with a preserved ejection fraction, aortic backward wave pressures rather than aortic 
stiffness could be the primary aortic haemodynamic disturbance that should be 
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targeted and this approach should be initiated in the young-to-middle aged. These 
data, in conjunction with several alternative studies showing relations of backward 
waves with end organ damage, regression of LVMI and cardiovascular outcomes 
(Booysen et al 2015; Hashimoto et al 2008; Hughes 2014) provide further support for 
the need to target aortic backward waves with antihypertensive therapy.
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CHAPTER 4 
 
 
 
 
 
Intra-Familial Aggregation and Heritability of Left Ventricular Geometric 
Remodelling is Independent of Cardiac Mass in Families of African Ancestry. 
 
 
 
The data in this chapter have been published in the Journal of American Society of 
Hypertension: 
Peterson V.R., Norton G.R., Redelinghuys M, Libhaber C.D., Maseko M.J., Majane 
O.H., Brooksbank R and Woodiwiss A.J. (2015). Intra-Familial Aggregation and 
Heritability of Left Ventricular Geometric Remodelling is Independent of Cardiac 
Mass in Families of African Ancestry. American Journal of Hypertension 28 (5): 657-
663.  
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4.1 Abstract 
 
Background. Whether left ventricular r (LV) geometric remodelling, as indexed by 
relative wall thickness (RWT), aggregates in families and is inherited independent of 
LV mass (LVM) and additional confounders is uncertain. 
Methods. I determined whether RWT as assessed from two-dimensional targeted M-
mode echocardiography shows intra-familial aggregation and heritability independent 
of LVM in 181 nuclear families (73 spouse pairs, 403 parent-child pairs and 177 
sibling-sibling pairs) with 16 families including three generations from an urban 
developing community of black Africans. Intra-familial aggregation and heritability 
estimates (SAGE software) were assessed independent of confounders, including 
central aortic systolic blood pressure (SBPc)(radial applanation tonometry and 
SphygmoCor software). 
Results. Independent of confounders including SBPc, LV RWT was correlated in 
parent-child (r=0.32, p<0.0001) and sibling-sibling (r=0.29, p<0.0001), but not in 
spouse (r=0.11, p=0.33) pairs. The relationships between parent-child (r=0.28, 
p<0.0001) and sibling-sibling (r=0.24, p<0.001) pairs persisted with further 
adjustments for LVM, or LVM indexed to height2.7 (LVMI). Similarly, independent of 
confounders, LV RWT showed significant heritability (h2±SEM=0.56±0.09, p<0.0001) 
and this persisted with further adjustments for LVM (h2±SEM=0.48±0.09, p<0.0001) 
or LVMI (h2±SEM=0.49±0.09, p<0.0001). 
Conclusions. In a group of African ancestry, independent of LVM, LV geometric 
remodelling shows significant intra-familial aggregation and heritability. Genetic 
factors may in-part determine the LV geometric remodelling process independent of 
the extent of cardiac hypertrophy. 
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4.2 Introduction 
 
 As acknowledged by all guidelines, left ventricular hypertrophy (LVH) is a 
major risk factor for cardiovascular events independent of conventional risk factors 
and coronary artery disease. In addition, as compared to a normal LV geometry, 
concentric LV remodelling (an increased relative wall thickness [RWT] without an 
increase in LV mass [LVM]) is associated with a worse prognosis (Verdecchia et al 
1995; Koren et al 1991; Bluemke et al 2008; Milani et al 2006). Although LVM rather 
than concentric LV remodeling predicts incident heart failure (Bluemke et al 2008), 
concentric LV remodelling without LVH is associated with the development of 
diastolic dysfunction, and concentric rather than eccentric LVH is associated with 
greater increases in indices of LV filling pressures (Chahal et al 2010). Thus, the 
extent of concentric LV remodelling may determine whether progression from LVH to 
heart failure with a preserved rather than reduced systolic chamber function occurs. 
The factors that determine LV remodelling are therefore of considerable interest. 
Although the impact of age, sex, blood pressure and obesity on LV geometric 
remodelling have been well described, there is nevertheless uncertainty as to the 
role of genetic factors independent of LVM, a major determinant of LV wall thickness, 
and a change which itself is well recognised as being inherited (Harshfield et al 1990; 
Verhaaren et al 1991; Bielen et al 1991; Schunkert et al 1999; Arnette et al 2001; 
Kuznetsova et al 2003; Bella et al 2004; Assimes et al 2007; Bella & Goring 2012).  
 As compared to age-, and sex-matched controls, siblings of those with LVH 
have a greater risk of concentric, but not eccentric LVH (Schunkert et al 1999).  
However, in that study (Schunkert et al 1999), whether siblings were also at risk for 
concentric LV remodelling is uncertain and hence LVM may have made a major 
contribution to the inheritance of concentric LVH. Moreover, in the Framingham Heart 
Study, the risk for concentric LV remodelling was only modestly increased in related 
as compared to unrelated individuals, whereas the risk for concentric LVH was 
markedly augmented (Lam et al 2010).  Hence, again, LVM may have been the 
major determinant of the inheritance of LV remodelling. Although alternative studies 
indicate that RWT is indeed inherited (Arnett et al 2001; Kuznetsova et al 2003; Bella 
et al 2004; Fox et al 2010), none of these studies reported on the inheritance of RWT 
independent of LVM. To address the aforementioned uncertainty as to the extent to 
which genetic factors contribute toward concentric LV remodelling beyond LVM, in 
the present study we aimed to evaluate the intra-familial aggregation and heritability 
of RWT independent of LVM and additional confounders. We hypothesised that RWT 
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would show intra-familial aggregation and heritability independent of LVM and 
additional confounders. 
 
4.3 Methods 
 
4.3.1 Study participants 
 
The present study was conducted according to the principles outlined in the 
Helsinki declaration. The Committee for Research on Human Subjects of the 
University of the Witwatersrand approved the protocol (approval number: M02-04-72 
and renewed as M07-04-69 and M12-04-108). Participants gave informed, written 
consent. Briefly families of black African descent (Nguni and Sotho chiefdoms) with 
siblings older than 16 years of age were randomly recruited from the South West 
Township (SOWETO) of Johannesburg, South Africa using the population census 
figures of 2001. Family members were invited to take part in the study if at least one 
or two offspring and one or both parents were available for examination. Eight 
hundred and twenty-nine participants (91%) consented to an echocardiographic 
procedure and had no evidence of significant valve abnormalities assessed using 2-
dimensional and colour Doppler imaging. None of the participants had previously had 
a myocardial infarction (only three had a history of ischaemic heart disease), and 
there were no cases of atrial fibrillation. High quality echocardiograms could be 
obtained in 694 participants. The high prevalence of obesity limited the quality of 
echocardiograms obtained in 135 participants of whom 91.5% were female 
(BMI=39.4±5.9 kg/m2). Six hundred and seventy-five participants from 181 nuclear 
families with 16 families including three generations with complete familial pairing 
were therefore available for the present analysis. 
 
4.3.2 Clinical, demographic, anthropometric and laboratory assessments 
 
A standardised questionnaire was administered to obtain demographic and 
clinical data (Norton et al 2008; Woodiwiss et al 2009; Redelinghuys et al 2010; 
Maseko et al 2013). Regular alcohol consumption was defined as at least five 
glasses of beer per week or 1 bottle of wine per week or ½ bottle of spirits per week. 
Height and weight were measured using standard approaches and participants were 
identified as being overweight if their body mass index (BMI) was ≥25 kg/m2 and 
obese if their BMI was ≥30 kg/m2. Standard laboratory blood tests of renal function, 
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liver function, blood glucose, haematological parameters, and percentage glycated 
haemoglobin (HbA1C) were performed. Diabetes mellitus (DM) or abnormal blood 
glucose control was defined as the use of insulin or oral hypoglycemic agents or an 
HbA1C value greater than 6.1%.
 (Bennett & Guo 2007). Participants’ blood groups 
(ABO and Rhesus) were evaluated to confirm Mendelian segregation. Mendelian 
inconsistencies were identified if blood groups of family members were incompatible 
with relationships between family members representing first, second or third 
generations. 
 
4.3.3 Office blood pressure  
 
High quality office BP measurements were obtained by a trained nurse-
technician who measured brachial artery systolic and diastolic BP to the nearest 2 
mm Hg using a standard mercury sphygmomanometer, according to the 
recommendations of the European Society of Hypertension (O’Brien et al 2003) and 
the American Heart Association (Pickering et al 2005). The nurse was of the same 
ethnic origins (black African) as the participants and had previously lived in 
SOWETO. Korotkov phases I and V were employed to identify systolic and diastolic 
BP respectively and care was taken to avoid auscultatory gaps. Office BP was 
measured 5 times consecutively using appropriately sized cuffs (a standard sized 
cuff was used, but if upper arm circumference exceeded 31cm then a larger cuff was 
used) after the subjects had rested for 5-10 minutes in the sitting position in a quiet 
room away from onlookers. The mean of all 5 office BP measurements was used in 
the analysis. 
 
4.3.4 Aortic blood pressure 
 
To determine central aortic systolic BP (SBPc), pulse wave analysis was 
conducted using techniques previously described (Redelinghuys et al 2010) (see 
chapter 3, section 3.3.4). To determine SBPc, the pulse wave was calibrated by 
manual measurement (auscultation) of brachial BP taken immediately before the 
recordings. From an inbuilt validated generalised transfer function an aortic 
waveform was generated from which SBPc was derived. 
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4.3.5 Echocardiography 
 
Two-dimensional targeted M-mode echocardiography was employed to 
determine short axis dimension measurements as previously described (Norton et al 
2008; Woodiwss et al 2009; Maseko et al 2013) and analysed according to the 
American Society of Echocardiography convention (Sahn et al 1978) (see chapter 2, 
section 2.3.3). The intra- and inter-observer variability have previously been 
described (Maseko et al 2013). Left ventricular hypertrophy was identified as an 
LVMI>51 g/m2.7 (Nunez et al 2005). Left ventricular RWT was calculated as (LV end 
diastolic septal [anterior] + posterior wall thickness)/LV end diastolic diameter. An 
RWT of >0.45 was considered as increased. 
 
4.3.6 Data analysis 
 
Database management and statistical analyses were performed with SAS 
software, version 9.1 (The SAS Institute Inc., Cary, North Carolina, USA). Data from 
individual subjects were expressed as meanSD. For intra-familial aggregation 
analysis, intra-familial correlations were determined from the PROC GENMOD 
procedure of the SAS package to determine concordance between family members.  
Using this approach, pairs of relatives are treated as clusters and the working 
correlation matrix is defined as unstructured (Kuznetsova et al 2003). Separate 
correlations were determined between father-mother pairs, parent-child pairs and 
sibling pairs. Hence, the same individual can be part of more than one pair. These 
data were confirmed using the FCOR procedure in Statistical Analysis for Genetic 
Epidemiology (S.A.G.E) software (version 6.3) (Department of Epidemiology and 
Statistics, Case Western Reserve, University of Cleveland, Ohio). Age- and sex-
adjusted and multivariate adjusted (including adjustments for SBPc or brachial office 
systolic BP) correlation coefficients were determined in 73 father-mother, 403 parent-
child and 177 sibling-sibling pairs. Based upon multivariate stepwise association with 
at least two LV structural traits (LVM, LVMI or LV RWT) the adjustors included in 
regression models were age, age2, sex, aortic systolic BP (or brachial office systolic 
BP), body weight, body height (except for LVMI), regular smoking, regular alcohol 
intake, treatment for hypertension, treatment for diabetes mellitus or a glycated 
haemoglobin >6.1% and pulse rate. Adjustments were made for aortic systolic BP in 
the primary analyses as RWT is more strongly related to central aortic than brachial 
blood pressure (Roman et al 2010).   
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Heritability (h2) of LV parameters was estimated using Statistical Analysis for 
Genetic Epidemiology (S.A.G.E) software (version 6.3) (Department of Epidemiology 
and Statistics, Case Western Reserve, University of Cleveland, Ohio) using the 
Marker-Trait Associations in Pedigree Data (ASSOC) programme. The ASSOC 
programme estimates heritability by maximum likelihood, assuming a generalization 
of multivariate normality, correlation structures (Elston et al 1992) and regression 
models (George & Elston 1987) previously described. The ASSOC programme uses 
a linear regression model, in which the total residual variance is partitioned into the 
sum of an additive polygenic component and a subject-specific random component. 
Heritability is the polygenic component divided by the total residual variance. The 
additive polygenic component of the variance of a trait is calculated from the 
pedigree data in which relationship pairs are defined. Hence, an individual can be 
part of more than one pair.   
For the heritability estimates, linear regression models were determined either 
with adjustments for age and sex only (age- and sex-adjusted) or with (adjusted) the 
inclusion of the potential confounders namely age, age2, sex, aortic systolic BP (or 
brachial office systolic BP), body weight, body height (except for LVMI), regular 
smoking, regular alcohol intake, treatment for hypertension, treatment for diabetes 
mellitus or a glycated haemoglobin >6.1% and pulse rate. Additional adjustments 
were made for LVM, and LVMI in separate models. 
 
4.4 Results  
 
4.4.1 Characteristics of participants 
 
 The number of offspring (2nd and 3rd generations) per family (n=181) 
amounted to one in 63 families, two in 84 families (7 of these families included 
grandchildren), three in 20 families, and more than three in 14 families (which 
included 4 families with 4 offspring, 1 family with 5 offspring, and 9 families with 
grandchildren and half-siblings). Pairs were defined based upon relationships within 
families. Consequently, an individual can be part of more than one pair. There were 
73 father-mother pairs, 403 parent-child pairs (46 father-son, 70 father-daughter, 104 
mother-son, and 183 mother-daughter pairs), and 177 sibling-sibling pairs (24 son-
son, 84 daughter-daughter, and 69 daughter-son pairs). No cases of Mendelian 
inconsistency were noted. More women than men participated in the study. The 
characteristics of the parents and siblings are given in Table 4.1. Importantly, 43% of 
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participants were hypertensive, 25% of participants were receiving antihypertensive 
medication and 35% of participants had uncontrolled hypertension (those that were 
not receiving anti-hypertensive medication plus those that were receiving anti-
hypertensive therapy but whose blood pressure was not controlled). 67% of 
participants had a normal LVMI and RWT, 11% had a normal LVMI, but an increased 
RWT (concentric LV remodelling), 6% had an increased LVMI and RWT (concentric 
hypertrophy), and 16% had an increased LVMI, but a normal RWT (eccentric 
hypertrophy). The prevalence of concentric or eccentric LVH in siblings was low 
(Table 4.1). The general characteristics of participants not included in the study were 
similar to the characteristics of the participants evaluated (data not shown). 
 
4.4.2 LVM and LVMI are associated with RWT 
 
Both LVM (r=0.30, p<0.0001) and LVMI (r=0.33, p<0.0001) were correlated 
with RWT.  
 
4.4.3 Heritability of LVM and LVMI  
 
With adjustments for confounders LVM and LVMI were inherited (Table 4.2). 
 
4.4.4 Intra-familial aggregation of RWT  
 
With adjustments for confounders, the correlation coefficients of parent-sibling and 
sibling-sibling pairs were significant for RWT and these relationships persisted with 
further adjustments for either LVM or LVMI (Figure 4.1). With adjustments for 
confounders, no significant correlations were noted for RWT between spouse pairs 
(Figure 4.1). 
 
4.4.5 Heritability estimates of RWT  
 
With adjustments for confounders, as well as with further adjustments for 
either LVM or LVMI, RWT showed heritability (Table 4.3). 
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Table 4.1. Characteristics of parents and offspring of the study sample. 
 
        Parents (n=320*)         Offspring (n=369*) 
___________________________________________________________________ 
Sex (% females)    68    63 
Age (years)             58±11            30±11 
Body mass index (kg/m2)            33±7             27±7 
% Regular smoking    11    17 
% Regular alcohol intake   17    23 
% with DM or HbA1C>6.1%   43    11 
% with hypertension    71    19 
% treated for hypertension   47     6 
Office SBP/DBP (mm Hg)  140±23/88±13    119±16/80±12 
Central aortic SBP (mm Hg)         132±23           110±18 
Left ventricular mass (LVM)(g)        172±57           139±40 
LVM index (g/m2.7)           48±16             38±10 
LV relative wall thickness       0.43±0.09         0.37±0.07 
LV mean wall thickness (cm)       0.96±0.21         0.83±0.17 
LV end diastolic diameter (cm)      4.80±0.59          4.70±0.52 
% concentric LVH    11     1 
% eccentric LVH    25     8 
% concentric LV remodelling   15     7 
___________________________________________________________________ 
DM, participants receiving medication for diabetes mellitus; HbA1C, glycated 
haemoglobin; SBP, systolic blood pressure; DBP, diastolic BP; LVH, left ventricular 
hypertrophy. *14 participants are included as both offspring and parents as they are 
parents of third generation offspring. 
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Table 4.2. Unadjusted and multivariate adjusted heritability estimates (h2) of left 
ventricular mass (LVM) and left ventricular mass index (LVMI). 
 
  Adjustments*      h2±SEM  p value 
___________________________________________________________________ 
LVM  Age- and sex-adjusted   0.52±0.08 <0.0001 
  Adjustors including aortic SBP  0.49±0.09 <0.0001 
  Adjustors including brachial SBP  0.48±0.09 <0.0001 
LVMI  Age- and sex-adjusted   0.47±0.09 <0.0001 
  Adjustors including aortic SBP  0.46±0.09 <0.0001 
  Adjustors including brachial SBP  0.48±0.09 <0.0001 
___________________________________________________________________ 
*Adjustments are for age, age2, sex, aortic systolic blood pressure (SBP) or brachial 
SBP, body weight, body height (except for left ventricular mass index), regular 
smoking, regular alcohol intake, treatment for hypertension, treatment for diabetes 
mellitus or a glycated haemoglobin >6.1%, and pulse rate. 
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Figure 4.1  Age- and sex-adjusted and multivariate adjusted intra-familial 
correlations (r-values) of left ventricular (LV) relative wall thickness. LVM, left 
ventricular mass; LVMI, left ventricular mass indexed to height2.7; *p<0.001, 
**p<0.0001 for significance of correlation coefficient. Adjustments are for age, age2, 
sex, aortic systolic blood pressure (SBPc) or brachial systolic blood pressure (SBP), 
body weight, body height (except when adjusting for LVMI), regular smoking, regular 
alcohol intake, treatment for hypertension, treatment for diabetes mellitus or a 
glycated haemoglobin>6.1%, and pulse rate. 
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Table 4.3. Unadjusted and multivariate adjusted heritability estimates (h2) of left 
ventricular (LV) relative wall thickness (RWT) adjusted for left ventricular mass (LVM) 
and LV mass index (LVMI). 
 
  Adjustments*             h2±SEM   p value 
______________________________________________________________ 
LV RWT     Age- and sex-adjusted                0.54±0.09       <0.0001 
         Adjustors including aortic SBP               0.56±0.09       <0.0001 
         Adjustors including brachial SBP    0.55±0.09   <0.0001 
         Adjustors including aortic SBP + LVM      0.48±0.09   <0.0001 
         Adjustors including brachial SBP + LVM  0.48±0.09   <0.0001 
         Adjustors including aortic SBP + LVMI     0.49±0.09   <0.0001 
         Adjustors including brachial SBP + LVMI 0.48±0.09   <0.0001 
______________________________________________________________ 
*Adjustments are for age, age2, sex, aortic systolic blood pressure (SBP) or brachial 
SBP, body weight, body height, regular smoking, regular alcohol intake, treatment for 
hypertension, treatment for diabetes mellitus or a glycated haemoglobin >6.1%, and 
pulse rate.  
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4.5 Discussion 
 
 In a relatively large family-based study, we show that RWT, an index of the 
extent of concentric LV geometric remodelling, demonstrated intra-familial 
aggregation and heritability (h2±SEM: 0.56±0.09). Importantly, the intra-familial 
aggregation and heritability of RWT were independent of LVM and LVMI as well as 
other confounders (h2±SEM: 0.48±0.09). 
 Although a number of prior studies have reported heritability or intra-familial 
aggregation of LVM or LVMI (Harshfield et al 1990; Verhaaren et al 1991; Bielen et al 
1991; Schunkert et al 1999; Arnett et al 2001; Kuznetsova et al 2003; Bella et al 
2004; Assimes et al 2007; Bella & Goring 2012), few studies have assessed the intra-
familial aggregation or heritability of LV RWT (Schunkert et al 1999; Arnett et al 
2001; Bella et al 2004; Bella & Goring 2012; Fox et al 2010). Only two of these five 
prior studies reported heritability values (h2±SEM: 0.17±0.08 (Bella et al 2004); 0.25 
(Fox et al 2010)) and in another prior study, heritability could be estimated from twice 
the sibling correlations (ranged from 0.08 to 0.24 (Arnett et al 2001)). In none of 
these studies (Arnett et al 2001; Bella et al 2004; Fox et al 2010)  was the heritability 
of RWT identified to be independent of LVM or LVMI. In our study without 
adjustments for LVMI we obtained heritability estimates for RWT of 0.56±0.09. The 
higher heritability values obtained in our study compared to two of these previous 
studies (Arnett et al 2001; Bella et al 2004) could be due to the characteristics of the 
populations assessed. Indeed, the mean RWT in the current study was considerably 
greater (0.48 in the parents and 0.37 in the offspring) than in two of the prior studies 
(0.35 in both) (Arnett et al 2001; Bella et al 2004). In one of these previous studies 
(Arnett et al 2001) the majority of the participants were hypertensives receiving 
antihypertensive medication, which would have influenced LV structural values.  
Although three prior studies (Arnett et al 2001; Bella et al 2004; Lam et al 
2010), have demonstrated that RWT is inherited (h2±SEM: 0.17±0.08 (Bella et al 
2004); 0.25 (Lam et al 2010); 2xsibling correlation ranged from 0.08 to 0.24 (Arnett et 
al 2001) and aggregates in families (Arnett et al 2001; Bella et al 2004), in these 
studies no adjustments for LVM or LVMI were made and hence these effects can be 
attributed to the well-known influence of hypertrophy on concentric LV geometric 
remodelling. Indeed, in the present study both LVM and LVMI were strongly 
associated with RWT. One prior study has reported on familial aggregation of 
concentric, but not eccentric LVH (Schunkert et al 1999). In contrast however, 
familial aggregation was noted for both concentric and eccentric LVH in the 
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Framingham study (Lam et al 2010). Nevertheless, in the Framingham study 
concentric LV remodelling (without LVH) also showed intra-familial aggregation (Lam 
et al 2010), an effect that suggests that concentric LV geometric remodelling may be 
inherited independent of LVM. However, in that (Lam et al 2010) no adjustments for 
LVM or alternative structural determinants of RWT were reported on. The present 
study extends the findings of this prior study (Lam et al 2010) and shows that RWT 
indeed aggregates in related individuals in families and shows heritability 
independent of LVM (h2±SEM: 0.48±0.09) and LVMI (h2±SEM: 0.49±0.09). The 
present and this prior study (Lam et al 2010) together therefore provide a degree of 
confidence that concentric LV remodelling shows heritability independent of 
hypertrophy or alternative LV structural parameters. 
In the present study, independent of confounders, heritability estimates 
(h2±SEM) for RWT were 0.56±0.09 before adjustments for confounders and LVM or 
LVMI. These RWT heritability estimates (h2±SEM) are stronger than those previously 
reported on in American Indians (0.17±0.08) (Bella et al 2004), and in largely treated 
(70%) hypertensive African Americans (0.25) (Fox et al 2010) without adjustments 
for LVM or LVMI. At present there are no data RWT heritability estimates in 
Caucasians. The greater heritability estimates reported on in the present study 
compared to previous studies, is possibly because we studied randomly recruited 
South African families of black African ancestry with a low prevalence (25%) of 
treatment for hypertension, and it is well recognised that groups of African descent 
have a greater RWT than other ethnic groups, a difference that could be attributed to 
stronger genetic effects on LV geometric remodelling. However, sibling correlations 
for RWT have been reported to be greater in European as compared to African-
Americans (Arnett et al 2001). Nevertheless, in that study (Arnett et al 2001) only 
hypertensive siblings were evaluated and hence intra-familial correlations for LV 
structure may have been confounded by the effects of BP or antihypertensive 
treatment. Importantly, in the Multi-Ethnic Study of Atherosclerosis, compared to non-
Hispanic whites, non-Hispanic blacks had an increased risk for concentric 
remodelling with an odds ratio of 1.4 (Rodriguez et al 2010).  
An important consideration of the present study is that the intra-familial 
aggregation of RWT was independent of LVM or LVMI. Thus, although LVM and 
LVMI showed heritability, the heritability of LV hypertrophy does not appear to 
determine the intra-familial aggregation and heritability of the geometric LV 
remodelling process. Hence, the genes that determine LV hypertrophy should not be 
seen as necessarily the same genes that influence the overall LV geometric 
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remodelling process. This has important implications for genetic studies as it is 
possible that the molecular mechanisms that determine cardiomyocyte cell growth 
(hypertrophy) are unable to account for a significant portion of the LV remodelling 
process. 
 The limitations of the present study require consideration. Due to the young 
age of the siblings studied, a low prevalence of LVH was noted in sibling pairs. 
Consequently, few siblings had either concentric or eccentric LVH. Therefore, we 
could not assess the intra-familial aggregation and heritability of either concentric or 
eccentric LVH, considered as discrete traits, independent of LVM or LVMI. Second, 
we assessed the intra-familial aggregation and heritability of RWT in one ethnic 
group only. Whether similar effects are noted in alternative ethnic groups requires 
further study. Third, bearing in mind the high prevalence of cardiovascular risk 
factors such as obesity, hypertension, DM or abnormal blood glucose control and 
LVH in the parents, it is possible that the heritability of RWT tracks the heritability of 
these risk factors. However, this is unlikely given that the adjusted intra-familial 
aggregation coefficients were similar between parent-child pairs and sibling pairs 
despite the higher prevalence of cardiovascular risk factors in the parents compared 
to the children. Moreover, in the present study on multivariate analyses, the 
heritability of RWT was independent of these cardiovascular risk factors.  
 In conclusion, in the present study I demonstrate that RWT, an index of 
concentric LV geometric remodelling, aggregates in families and shows heritability, 
independent of LVM and LVMI. Thus, a considerable proportion of the genetic factors 
that determine LV geometric remodelling occur independent of those genes that 
influence cardiomyocyte hypertrophy. As LV geometric remodelling predicts 
outcomes independent of LVH (Verdecchia et al 1995; Koren et al 1991; Bleumke et 
al 2008; Milani et al 2006) and may influence whether LVH progresses to heart 
failure with a preserved or reduced ejection fraction (Chahal et al 2010), discovering 
the genes associated with RWT independent of LVH may cast further light on the 
genetic mechanisms responsible for adverse cardiovascular outcomes and the 
progression to heart failure. 
 105 
 
 
 
 
 
 
CHAPTER 5 
 
 
 
 
 
Intra-Familial Aggregation and Heritability of Tissue Doppler Indexes of Left 
Ventricular Diastolic Function in a Group of African Descent. 
 
 
The data in this chapter have been published in the Journal of American Society of 
Hypertension: 
Peterson V.R., Norton G.R., Libhaber C.D., Maseko M.J., Sareli P and Woodiwiss 
A.J. (2016). Intra-Familial Aggregation and Heritability of Tissue Doppler Indexes of 
Left Ventricular Diastolic Function in a Group of African Descent. Journal of 
American Society of Hypertension 10 (6): 517-526. 
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5.1 Abstract 
 
Background. Although several indexes of left ventricular (LV) diastolic function show 
heritability, the genetic influence on the tissue Doppler index, E/e’ (early transmitral 
velocity/velocity of myocardial tissue lengthening), an index of LV filling pressures in 
those of black African descent is currently unknown. Further, whether any genetic 
influences on E/e’ are through an impact of LV remodelling or aortic function is 
unknown.  
Methods. Intra-familial aggregation and heritability (SAGE software) of E/e’ 
(echocardiography) were assessed in 129 nuclear families (29 spouse pairs, 216 
parent-child pairs and 113 sibling-sibling pairs) from an urban developing community 
of black Africans, independent of LV  mass index (LVMI), LV relative wall thickness 
(RWT), central aortic systolic pressure (SBPc) and backward wave pressures (Pb) 
(applanation tonometry, SphygmoCor software).  
Results. Independent of confounders including LVMI and RWT, E/e’ was correlated 
in parent-child (r=0.23, p<0.001) and sibling-sibling (r=0.29, p<0.005), but not in 
spouse (r=0.13, p=0.51) pairs. The relationships between parent-child (r=0.22 
p<0.001) and sibling-sibling (r=0.29, p<0.005) pairs persisted with adjustments for 
SBPc. The relationships between parent-child (r=0.22, p<0.001) and sibling-sibling 
(r=0.26, p<0.01) pairs also persisted with adjustments for Pb. Independent of 
confounders including LVMI and RWT, E/e’ showed significant heritability 
(h2±SEM=0.51±0.11, p<0.0001) which similarly persisted with adjustments for SBPc 
(h2±SEM=0.50±0.11, p<0.0001) and Pb (h2±SEM=0.49±0.11, p<0.0001).  
Conclusions. In a group of African ancestry, independent of LV remodelling and 
aortic function, E/e’, shows significant intra-familial aggregation and robust 
heritability. Hence, genetic factors may play an important role in determining 
moderate-to-severe LV diastolic dysfunction independent of cardiac remodelling or 
aortic function in groups of black African ancestry. 
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5.2 Introduction 
 
 The prevalence of heart failure with a preserved ejection fraction may soon 
exceed that of a reduced ejection fraction (Borlaug & Redfield 2011). The outcomes 
of heart failure with a preserved ejection fraction are as poor as in heart failure with a 
reduced ejection fraction (Lee et al 2009; Owan et al 2006; Bhatia et al 2006), yet 
there is presently no treatment with proven benefit for heart failure with a preserved 
ejection fraction (Borlaug & Redfield 2011; Borlaug & Paulus 2011; Pitt et al 2014). 
Understanding the pathophysiological mechanisms responsible for heart failure with 
a preserved ejection fraction may reveal potential therapeutic targets. Cardiac 
diastolic dysfunction is central to the pathophysiology and outcomes of heart failure 
with a preserved ejection fraction (Zile et al 2004; Westermann et al 2008; Burke et 
al 2014; Mohammed et al 2012; Shah et al 2014). However, the factors that 
determine cardiac diastolic function have not been completely elucidated. 
Several studies have demonstrated heritability or intra-familial aggregation of 
various aspects of left ventricular (LV) diastolic function identified from trans-mitral 
blood flow velocity measurements (Bielin et al 1991; Tang et al 2002; Swan et al 
2003; Fox et al 2010; Jin et al 2011; Noh et al 2015; Kloch-Badelek et al 2014). 
However, contemporary evaluation of LV diastolic dysfunction also includes 
E/velocity of myocardial tissue lengthening at the mitral annulus (Ea or e’) (E/e’), an 
index of filling pressures employed to identify moderate-to-severe diastolic 
dysfunction and which is independently associated with the development of heart 
failure with a preserved ejection fraction (Kane et al 2011; Lam et al 2011). The 
genetic influence on E/e’ across ethnic groups is nevertheless unclear. Whilst a 
Korean study showed significant heritability for E/e’ (Noh et al 2015), a study 
conducted in Europeans failed to do so (Jin et al 2011), but subsequent analysis in 
an expanded data set showed significant heritability (Kloch-Badelek et al 2014). 
Whether E/e’ is inherited in groups of African ancestry and the extent to which this 
occurs is unknown. Moreover, whether significant heritability of E/e’ occurs 
independent of LV remodelling, which is also inherited and a well-recognised 
determinant of diastolic dysfunction, or of aortic function, which is similarly inherited 
and a strong determinant of diastolic dysfunction (Weber et al 2006; Weber et al 
2008; Borlaug et al 2007; Ferander et al 2008), is unknown. Hence, in the present 
study I aimed to assess whether intra-familial aggregation and heritability of E/e’ 
occurs independent of LV remodelling and aortic function in a community of African 
ancestry. 
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5.3 Methods 
 
5.3.1  Study participants  
 
The present study was conducted according to the principles outlined in the 
Helsinki declaration. The Committee for Research on Human Subjects of the 
University of the Witwatersrand approved the protocol (approval number: M02-04-72 
and renewed as M07-04-69 and M12-04-108). Participants gave informed, written 
consent. The present study design has previously been described (Peterson et al 
2015; Woodiwiss et al 2009; Redelinghuys et al 2010; Libhaber et al 2014; Millen et 
al 2014). Briefly families of black African descent (Nguni and Sotho chiefdoms) with 
siblings older than 16 years of age were randomly recruited (based on population 
census figures from 2001) from the South West Township (SOWETO) of 
Johannesburg, South Africa. Eight hundred and twenty-nine participants (91% 
consent rate) consented to an echocardiographic procedure and had no evidence of 
significant valve abnormalities assessed using 2-dimensional and colour Doppler 
imaging. None of the participants had previously had a myocardial infarction (only 
three had a history of ischaemic heart disease), and there were no cases of atrial 
fibrillation. High quality echocardiograms with complete familial pairing could be 
obtained in 694 participants and in a sub-study 442 participants from 129 nuclear 
families with 12 families including three generations with complete familial pairing 
had myocardial tissue Doppler imaging (see figure 5.1 for derivation of the study 
sample). 
 
5.3.2  Clinical, demographic, anthropometric and laboratory assessments 
 
 A standardised questionnaire was administered to obtain demographic and 
clinical data (Peterson et al 2015; Woodiwiss et al 2009; Redelinghuys et al 2010; 
Libhaber et al 2014; Millen et al 2014). Regular alcohol consumption was defined as 
at least five glasses of beer per week or 1 bottle of wine per week or ½ bottle of 
spirits per week. Height and weight were measured using standard approaches and 
participants were identified as being overweight if their body mass index (BMI) was 
≥25 kg/m2 and obese if their BMI was ≥30 kg/m2. Standard laboratory blood tests of 
renal function, liver function, blood glucose, haematological parameters, and 
percentage glycated haemoglobin (HbA1C) were performed. Diabetes mellitus (DM) 
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Figure 5.1. Flow chart summarising the derivation of the study sample. Complete pairing refers to sample with at least either 2 parents and one 
sibling or one parent and 2 siblings. 341 participants were approached to participate in the study prior to the availability of tissue Doppler 
imaging (TDI) and 580 participants were approached to participate in the study after the availability of TDI. Echo, echocardiography.
Prior to  
availability of TDI 
Total Subsequent to 
availability of TDI 
921 341 580 
829 307 522 
694 252 442 
90% response rate 
High quality echo + complete pairing 
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or abnormal blood glucose control was defined as the use of insulin or oral 
hypoglycemic agents or an HbA1C value greater than 6.1%. Menopause was 
confirmed with measurements of follicle stimulating hormone concentrations. 
Participants’ blood groups (ABO and Rhesus) were evaluated to confirm Mendelian 
segregation. Mendelian inconsistencies were identified if blood groups of family 
members were incompatible with relationships between family members representing 
first, second or third generations. 
 
5.3.2  Clinical, demographic, anthropometric and laboratory assessments 
 
 A standardised questionnaire was administered to obtain demographic and 
clinical data (Peterson et al 2015; Woodiwiss et al 2009; Redelinghuys et al 2010; 
Libhaber et al 2014; Millen et al 2014). Regular alcohol consumption was defined as 
at least five glasses of beer per week or 1 bottle of wine per week or ½ bottle of 
spirits per week. Height and weight were measured using standard approaches and 
participants were identified as being overweight if their body mass index (BMI) was 
≥25 kg/m2 and obese if their BMI was ≥30 kg/m2. Standard laboratory blood tests of 
renal function, liver function, blood glucose, haematological parameters, and 
percentage glycated haemoglobin (HbA1C) were performed. Diabetes mellitus (DM) 
or abnormal blood glucose control was defined as the use of insulin or oral 
hypoglycemic agents or an HbA1C value greater than 6.1%. Menopause was 
confirmed with measurements of follicle stimulating hormone concentrations. 
Participants’ blood groups (ABO and Rhesus) were evaluated to confirm Mendelian 
segregation. Mendelian inconsistencies were identified if blood groups of family 
members were incompatible with relationships between family members representing 
first, second or third generations. 
 
5.3.3.  Office blood pressure  
 
High quality office BP measurements were obtained by a trained nurse-
technician using a standard mercury sphygmomanometer (Woodiwiss et al 2009). 
The nurse was of the same ethnic origins (black African) as the participants and had 
previously lived in SOWETO. Korotkov phases I and V were employed to identify 
systolic and diastolic BP respectively and care was taken to avoid auscultatory gaps. 
Office BP was measured 5 times consecutively using appropriately sized cuffs after 
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the subjects had rested for 5-10 minutes in the sitting position. The mean of all 5 
office BP measurements was used in the analysis. 
 
5.3.4  Aortic haemodynamics  
 
To determine central aortic systolic BP (SBPc) and backward wave pressures 
(Pb), pulse wave analysis was conducted using techniques previously described 
(Peterson et al 2015; Woodiwiss et al 2009) (see chapter 3, section 3.3.4).To 
determine SBPc, the pulse wave was calibrated by manual measurement 
(auscultation) of brachial BP taken immediately before the recordings. From an 
inbuilt validated generalised transfer function an aortic waveform was generated from 
which SBPc was derived. Aortic backward wave pressures (Pb) were determined 
using SphygmoCor software which separates the aortic waveform assuming a 
triangular flow wave. 
 
5.3.5  Echocardiography  
 
Echocardiographic measurements were performed using a Sonosite M-Turbo 
ultrasound (SonoSite® Inc., Bothell, WA, USA) device with the patient in the partial 
left decubitus position as previously described (Peterson et al 2015; Libhaber et al 
2014; Millen et al 2014) (see chapter 2, section 2.3.3). Left ventricular mass (LVM) 
was determined using a standard formula (Devereux et al 1986) (see chapter 2, 
section 2.3.3). Left ventricular RWT was calculated as (LV end diastolic septal 
[anterior] + posterior wall thickness)/LV end diastolic diameter. An LVMI>51 g/m2.7 
was considered as LV hypertrophy (LVH) and an RWT of >0.45 was considered as 
concentric remodelling (if LVMI was normal) or hypertrophy (if LVMI was increased). 
Left ventricular end diastolic and systolic volumes were determined from M-mode 
images using the Teichholz method. Left ventricular ejection fraction (EF) was 
calculated as [(LV end diastolic volume-LV end systolic volume)/ LV end diastolic 
volume] x 100. 
Left ventricular diastolic function was assessed from a pulsed wave Doppler 
examination of the mitral inflow at rest and using tissue Doppler imaging (TDI) 
(Quiñones et al 2002) (see chapter 3, section 3.3.5). Data were expressed as e’/a’ 
and the E/e’ ratio (an index of LV filling pressures). Left ventricular diastolic 
dysfunction (DD) was evaluated as mild (impaired relaxation when E/A≤0.75), 
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moderate (pseudonormal, where E/A>0.75<1.5, and E/e’≥10) and severe (where 
E/A≥1.5 and E/e’≥10) (Redfield et al 2003). 
 
5.3.6  Data analysis 
 
Database management and statistical analyses were performed with SAS 
software, version 9.3 (The SAS Institute Inc., Cary, North Carolina, USA). Data from 
individual subjects were expressed as meanSD. Indexes of diastolic function were 
logarithmically transformed to improve on the distribution (Table 5.1 and Figure 5.2). 
For intra-familial aggregation analysis, intra-familial correlations were determined 
from the PROC GENMOD procedure of the SAS package to determine concordance 
between family members. Using this approach, pairs of relatives are treated as 
clusters and the working correlation matrix is defined as unstructured (Kuznetsova et 
al 2003). Separate correlations were determined between father-mother pairs, 
parent-child pairs and sibling pairs. Hence, the same individual can be part of more 
than one pair. These data were confirmed using the FCOR procedure in Statistical 
Analysis for Genetic Epidemiology (S.A.G.E) software (version 6.3) (Department of 
Epidemiology and Statistics, Case Western Reserve, University of Cleveland, Ohio). 
Multivariate adjusted correlation coefficients were determined in 29 spouse pairs, 
216 parent-child pairs and 113 sibling-sibling pairs. The adjustors included in 
regression models were based upon multivariate stepwise associations with 
measures of diastolic function (Tables 5.2 to 5.4). Stepwise regression analysis was 
performed with age, sex, body mass index, heart rate, systolic BP (for TDI indexes), 
diastolic BP (for trans-mitral velocity measurements), regular smoking, regular 
alcohol intake, treatment for hypertension and diabetes mellitus or an HbA1c>6.1% 
included in the models. Probability values in stepwise models were considered 
significant at a 5% level (p≤0.05). If factors were independently associated with 
several indexes of diastolic function they were also included as potential confounders 
for additional indexes when assessing intra-familial correlations. Hence, for E/A, E, A 
and e’/a’, age, sex, body mass index, heart rate and diastolic blood pressure were 
included as covariates and for E/e’, e’ and a’, age, sex, body mass index, heart rate 
and systolic blood pressure were included as covariates. Additional adjustments 
were made for LVMI, RWT, SBPc, and/or Pb where appropriate.  
Heritability (h2) of LV diastolic parameters was estimated using Statistical 
Analysis for Genetic Epidemiology (S.A.G.E) software (version 6.3) (Department of 
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Table 5.1. Distribution of left ventricular diastolic function parameters before and 
after transformation of data. 
 
Parameter          Skewness          Kurtosis          Shapiro-Wilk 
Non-transformed 
Trans-mitral E/A                     0.849                          0.682   0.954 
Trans-mitral E                        1.184                          1.750   0.923 
Trans-mitral A                        0.884                          0.536   0.945 
Average e’              0.254                        -0.568   0.986  
Average a’              0.932                         1.050   0.949                      
Average e’/a’                   0.788                         0.379   0.948 
Average E/e’               1.210                          1.038   0.893 
Lateral wall e’              0.240                         -0.580   0.986             
Lateral wall a’              0.808                          0.341   0.952             
Lateral wall e’/a’             0.887                          0.535   0.939             
Lateral wall E/e’             1.317                        1.479   0.884 
Septal wall e’              0.374                         -0.188   0.984             
Septal wall a’              1.095                          1.909   0.940             
Septal wall e’/a’             0.989                          1.220   0.935             
Septal wall E/e’              1.306                        1.565   0.888 
 
Logarithm of: 
Trans-mitral E/A                    -0.154                        -0.228   0.996 
Trans-mitral E                        0.124                         -0.101   0.996 
Trans-mitral A                       -0.090                         -0.360   0.995 
Log average e’           -0.460                        -0.229              0.995 
Log average a’            0.163                         -0.278    0.996                      
Log average e’/a’                 -0.205                         -0.728    0.984 
Log average E/e’            0.290                         -0.456    0.985 
Log lateral wall e’           -0.503                         -0.232    0.976             
Log lateral wall a’            0.025                         -0.461    0.994             
Log lateral wall e’/a’           -0.202                         -0.651    0.986             
Log lateral wall E/e’             0.316                       -0.376    0.986 
Log septal wall e’           -0.701                          1.371    0.970             
Log septal wall a’            0.129                          0.129    0.997             
Log septal wall e’/a’           -0.196                         -0.542    0.987             
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Log septal wall E/e’             0.274                       -0.440    0.987 
E and A, early and late (atrial) trans-mitral blood flow velocity; e’ and a’, velocity of 
myocardial tissue lengthening in early (e’) and late (atrial-a’) diastole. 
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Figure 5.2. Distribution of indexes of left ventricular diastolic function before and 
after logarithmic transformation. E and A, early and late (atrial) trans-mitral blood flow 
velocity; e’ and a’, velocity of myocardial tissue lengthening in early (e’) and late 
(atrial-a’) diastole, table 5.1 for characteristics of the distribution curves as well as 
table 5.1 for improved characteristics with logarithmically transformed indexes.
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Table 5.2. Stepwise regression models showing factors independently associated with trans-mitral E/A, E and A and myocardial tissue Doppler 
e’/a’ (average of lateral and septal wall values). 
 
Factor                               Log trans-mitral E/A     Log trans-mitral E       Log trans-mitral A       Log e’/a’ 
                                            r2           p value          r2           p value             r2            p value   r2            p value 
__________________________________________________________________________________________       
Age                                  -0.488       <0.0001    -0.050       <0.0001        0.214         <0.0001       -0.576        <0.0001 
Female                               -                  -            0.014       <0.02             0.024        <0.0005       0.007         <0.005 
Body mass index            -0.004        <0.05             -               -             -        -          -0.026        <0.0001 
Heart rate                       -0.043        <0.0001    -0.017       =0.005              -        -             -0.014       <0.0001 
DBP                               -0.012         <0.001             -                -         0.008         <0.05           -0.015       <0.0001 
Model r2       0.550         <0.0001    0.092       <0.0001         0.254  <0.0001         0.648       <0.0001 
____________________________________________________________________________________________ 
DBP, diastolic BP; E and A, early and late (atrial) trans-mitral blood flow velocity; e’ and a’, velocity of myocardial tissue lengthening in early (e’) 
and late (atrial-a’) diastole. Factors that did not reach significance in the models include regular smoking, regular alcohol intake, treatment for 
hypertension and diabetes mellitus or an HbA1c>6.1%. 
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Table 5.3. Stepwise regression models showing factors independently associated with TDI (average of lateral and septal wall) measures of left 
ventricular diastolic function. 
                                
Factor                              Log E/e’                 Log e’                    Log a’                         
                                      r2       p value       r2         p value        r2         p value     
______________________________________________________________        
Age                             0.189   <0.0001      -0.491  <0.0001      0.253    <0.0001       
Female                       0.023   <0.0005         -           -              -0.010    <0.05                                
Body mass index       0.008    <0.05         -0.029   <0.0001      0.011    <0.01       
Heart rate                     -            -              -0.006   <0.05          0.020    <0.001          
SBP                            0.029   <0.001       -0.024   <0.0001           -          -                
Model r2             0.253   <0.0001      0.553   <0.0001      0.300    <0.0001       
_______________________________________________________________ 
DBP, diastolic BP; E and A, early and late (atrial) trans-mitral blood flow velocity; e’ and a’, velocity of myocardial tissue lengthening in early (e’) 
and late (atrial-a’) diastole. Factors that did not reach significance in the models include regular smoking, regular alcohol intake, treatment for 
hypertension and diabetes mellitus or an HbA1c>6.1%. 
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Table 5.4. Stepwise regression models showing factors independently associated with TDI (lateral and septal wall given separately) measures 
of left ventricular diastolic function. 
 
        Lateral wall         Septal wall                                
Factor                              Log E/e’                 Log e’                    Log a’                        Log E/e’                 Log e’                    Log a’                          
                                      r2       p value       r2         p value        r2         p value          r2       p value       r2         p value        r2         p value     
___________________________________________________________________________________________________________       
Age                             0.160   <0.0001      -0.460   <0.0001    0.214     <0.0001      0.183   <0.0001  -0.414   <0.0001     0.180     <0.0001       
Female                       0.030   <0.0001       0.014    <0.05        0.024     <0.0005           -           -              -          -            -0.009     <0.0001       
Body mass index       0.007   =0.05              -             -                -             -           0.020   =0.001   -0.017   <0.0005      0.013     <0.01       
Heart rate                      -            -              -0.017    =0.005          -              -                 -           -             -           -              0.029     <0.0001       
SBP                            0.036   <0.0001       0.008    =0.05        0.019     <0.001        0.018   <0.005   -0.009    <0.01            -             -       
Model r2             0.236   <0.0001       0.501   <0.0001     0.265     <0.0001      0.228  <0.0001   0.444   <0.0001      0.235     <0.0001                     
____________________________________________________________________________________________________________ 
DBP, diastolic BP; E and A, early and late (atrial) trans-mitral blood flow velocity; e’ and a’, velocity of myocardial tissue lengthening in early (e’) 
and late (atrial-a’) diastole. Factors that did not reach significance in the models include regular smoking, regular alcohol intake, treatment for 
hypertension and diabetes mellitus or an HbA1c>6.1%. 
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Epidemiology and Statistics, Case Western Reserve, University of Cleveland, Ohio) 
using the Marker-Trait Associations in Pedigree Data (ASSOC) programme. The 
ASSOC programme estimates heritability by maximum likelihood, assuming a 
generalisation of multivariate normality, correlation structures (Elston et al 1992) and 
regression models (George & Elston 1987) previously described. The ASSOC 
programme uses a linear regression model, in which the total residual variance is 
partitioned into the sum of an additive polygenic component and a subject-specific 
random component. Heritability is the polygenic component divided by the total 
residual variance. The additive polygenic component of the variance of a trait is 
calculated from the pedigree data in which relationship pairs are defined. Hence, an 
individual can be part of more than one pair. For the heritability estimates, linear 
regression models were determined with the inclusion of potential confounders 
identified as being independently associated with measures of diastolic function in 
stepwise regression analysis (Tables 5.2 to 5.4). If factors were independently 
associated with several indexes of diastolic function they were also included as 
potential confounders for additional indexes when assessing heritability estimates. 
Hence, for E/A, E, A and e’/a’, age, sex, body mass index, heart rate and diastolic 
blood pressure were included as covariates and for E/e’, e’ and a’, age, sex, body 
mass index, heart rate and systolic blood pressure were included as covariates. 
Additional adjustments were made for LVMI, RWT, SBPc, and/or Pb where 
appropriate 
 
5.4 Results  
 
5.4.1  Characteristics of participants  
 
The number of offspring (2nd and 3rd generations) per family (n=129) 
amounted to one in 44 families, two in 54 families (5 of these families included 
grandchildren), three in 19 families, and more than three in 12 families (which 
included 4 families with 4 offspring, 1 family with 5 offspring, and 7 families with   
grandchildren and half-siblings). Pairs were defined based upon relationships within 
families. Consequently, an individual can be part of more than one pair. There were 
29 father-mother pairs, 216 parent-child pairs (22 father-son, 33 father-daughter, 58 
mother-son, and 103 mother-daughter pairs), and 113 sibling-sibling pairs (18 son-
son, 50 daughter-daughter, and 45 daughter-son pairs). No cases of Mendelian 
inconsistency were noted. The characteristics of the parents and siblings are given in 
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Table 5.5. More women than men participated in the study. Importantly, 47.1% of 
participants were hypertensive, 27.4% of participants were receiving antihypertensive 
medication and 34.4% of participants had uncontrolled hypertension (those that were 
not receiving anti-hypertensive medication plus those that were receiving anti-
hypertensive therapy but whose blood pressure was not controlled). Other than a 
slightly higher E/A, and a modestly lower E and A, no differences were noted 
between participants with and without TDI (Table 5.6). In the group with TDI, 12.2% 
of participants had mild DD, 16.5% moderate DD, and 3.8% severe DD. The 
prevalence of DD in the siblings was low (Table 5.5). 
 
5.4.2 LV remodelling and aortic function are associated with diastolic function.  
 
LVM indexed to height1.7 (r=-0.28, p<0.0001) or height2.7 (r=-0.31, p<0.0001), 
RWT (r=-0.28, p<0.0001), SBPc (r=-0.38, p<0.0001), and Pb (r=-0.34, p<0.0001) 
were correlated with E/A. Indexes of LV remodelling were similarly correlated with E 
and A (data not given). LVM indexed to height1.7 (r=-0.38, p<0.0001) or height2.7 (r=-
0.40, p<0.0001), RWT (r=-0.33, p<0.0001), SBPc (r=-0.46, p<0.0001), and Pb (r=-
0.42, p<0.0001) were also correlated with e’/a’. Similarly, LVM indexed to height1.7 
(r=0.25, p<0.0001) or height2.7 (r=0.29, p<0.0001), RWT (r=0.27, p<0.0001), SBPc 
(r=0.36, p<0.0001), and Pb (r=0.40, p<0.0001) were correlated with E/e’. Indexes of 
LV remodelling were likewise correlated with e’ and a’ (data not given). 
In multivariate models LVMI and RWT retained independent relations with 
E/e’ (p<0.05), and e’ (p<0.05) but not E/A (p>0.15), E (p>0.06), A (p>0.06), or a’ 
(p>0.42) and RWT (p<0.02), but not LVMI (p=0.36) retained independent relations 
with e’/a’. Moreover, in multivariate models with mean arterial pressure included in 
the models, SBPc (p<0.005), and Pb (p<0.0005) retained independent relations with 
E/e’. However, no independent relations between SBPc or Pb and e’ (p>0.49), E/A 
(p>0.09), E (p>0.09), A (p>0.08), e’/a’ (p>0.09), or a’ (p>0.26) were noted. 
 
5.4.3 Intra-familial aggregation of indexes of diastolic function  
 
With adjustments for confounders, the correlation coefficients of parent-
sibling and/or sibling-sibling pairs were significant for E, and A (Figure 5.3), and E/e’ 
and a’ derived from the average of lateral and septal wall measurements (Figure 
5.4), lateral wall E/e’, e’ and a’ (Figure 5.5) and septal wall E/e’ and a’ (Figure 5.6). In 
contrast, no significant father-mother correlations were noted (Figures 5.3 to 5.6)
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Table 5.5 Characteristics of parents and offspring of the study sample. 
 
 Parents (n=193*) Offspring (n=262*) 
___________________________________________________________________ 
Sex (% females)          70     63 
Age (years)         61±11            34±12 
Body weight (kg)        82±18            73±20 
Body height (m)    1.59±0.08         1.62±0.09 
Body mass index (kg/m2)       32±7             28±8 
% Regular smoking                13                    17 
% Regular alcohol intake            11                     21 
% with DM or HbA1C>6.1%            43                  15 
% with hypertension             75                  27 
% treated for hypertension          53                      8 
Heart rate (bts/min)           66±11            66±11 
Office SBP/DBP (mm Hg)  139±23/86±13    121±17/81±13 
Central aortic SBP (mm Hg)        129±23             111±20 
Aortic backward wave (mm Hg)       21±8             13±5 
LVM index (g/m2.7)        46±18                  34±11 
Relative wall thickness (RWT)    0.39±0.08        0.35±0.07 
Trans-mitral E/A†                      0.94 (0.76 to 1.19)                1.46 (1.18 to 1.81) 
Trans-mitral E†                          66.0 (49.5 to 87.4)                74.7 (60.3 to 95.5) 
Trans-mitral A†                        72.9 (53.8 to 91.9)                51.7 (39.5 to 66.8) 
Average e’†               7.8 (6.5 to 9.7)                      12.0 (9.8 to 14.1)             
Average a’†          8.7 (7.5 to 10.6)                        7.0 (5.9 to 8.2)             
Average e’/a’†              0.87 (0.67 to 1.23)                   1.72 (1.31 to2.34) 
Average E/e’†                8.41 (6.19 to 11.67)             6.12 (4.75 to 7.87) 
Lateral wall e’†      8.5 (6.8 to 10.7)                   12.8 (10.4 to 15.1)   
Lateral wall a’†      9.2 (7.3 to 11.2)                     7.0 (5.7 to 8.6)             
Lateral wall e’/a’†   0.91 (0.68 to 1.30)                  1.76 (1.36 to 2.31)             
Lateral wall E/e’†       7.76 (5.71 to 10.92)             5.77 (4.30 to 7.52) 
Septal wall e’†            7.1 (5.7 to 9.0)                      11.3 (9.0 to 13.4)             
Septal wall a’†            8.3 (6.8 to 9.9)                         6.9 (5.7 to 8.2)             
Septal wall e’/a’†   0.80 (0.64 to 1.18)                  1.61 (1.22 to 2.09)             
Septal wall E/e’†      9.05 (6.82 to 13.03)             6.61 (5.00 to 8.24) 
% E/A<0.75                22                  5 
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% E/e’≥10                38                15 
% LVMI>51 g/m2.7                35                  5 
DM, participants receiving medication for diabetes mellitus; HbA1C, glycated 
haemoglobin; SBP, systolic blood pressure; DBP, diastolic BP; LVMI, left ventricular 
mass index; E and A, early and late (atrial) trans-mitral blood flow velocity; e’ and a’, 
velocity of myocardial tissue lengthening in early (e’) and late (atrial-a’) diastole. 
*Thirteen participants are included as both offspring and parents as they are parents 
of third generation offspring. †values are median and interquartile range. 
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Table 5.6 Characteristics of study sample with and without measures of tissue 
Doppler indices (TDI) of left ventricular diastolic function. 
      With TDI Without TDI 
Sample number (% females)    442 (65.2)  252 (65.2) 
Age (years)    45.3±18.1  43.6±18.0 
Body weight (kg)       77±20     76±19 
Body height (m)    1.61±0.08  1.62±0.09 
Body mass index (kg/m2)    29.7±7.9  29.2±7.4 
% Regular smoking       15.4     12.3 
% Regular alcohol intake       17.4     22.1 
% with DM or HbA1C>6.1%       26.5     25.6 
% with hypertension       47.1     45.3 
% treated for hypertension       27.4        22.8 
Heart rate (bts/min)       66±11        66±11 
Office SBP/DBP (mm Hg) 128±22/83±13 131±22/84±12 
Central aortic SBP (mm Hg)     119±23       122±23 
Aortic backward wave (mm Hg)   16±8                  17±8 
Trans-mitral E/A† 1.23 (0.89 to 1.62)* 1.17 (0.86 to 1.55) 
Trans-mitral E† 72.5 (55.5 to 91.3)* 78.1 (64.7 to 91.2) 
Trans-mitral A† 58.2 (44.5 to 80.4)* 66.8 (57.5 to 78.1) 
__________________________________________________________________ 
DM, participants receiving medication for diabetes mellitus; HbA1C, glycated 
haemoglobin; SBP, systolic blood pressure; DBP, diastolic BP. *p<0.05 versus 
without TDI. † values are median and interquartile range. 
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Figure 5.3 Multivariate adjusted intra-familial correlations (r values) of left ventricular 
diastolic function derived from trans-mitral velocity measurements. Model 1 is 
adjusted for confounders indicated in the footnote to table 5.6. Model 2 includes 
additional adjustments for left ventricular mass index and relative wall thickness. See 
table 5.5 for abbreviations. *p<0.05, **p<0.005, ***p<0.0005 for significance of 
correlation coefficient. 
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Figure 5.4 Multivariate adjusted intra-familial correlations (r values) of left ventricular 
diastolic function derived from the average of lateral and septal wall tissue Doppler 
imaging. Model 1 is adjusted for confounders indicated in the footnote to table 5.6. 
Model 2 includes additional adjustments for left ventricular mass index and relative 
wall thickness. See table 5.5 for abbreviations. *p<0.05, **p<0.005, ***p<0.0005 for 
significance of correlation coefficient. 
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Figure 5.5 Multivariate adjusted intra-familial correlations (r values) of left ventricular 
diastolic function (lateral wall tissue Doppler imaging). Model 1 is adjusted for 
confounders indicated in the footnote to table 5.6. Model 2 includes additional 
adjustments for left ventricular mass index and relative wall thickness. See table 1 for 
abbreviations. *p<0.05, **p<0.005, ***p<0.0005 for significance of correlation 
coefficient.
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Figure 5.6 Multivariate adjusted intra-familial correlations (r values) of left ventricular 
diastolic function (septal wall tissue Doppler imaging). Model 1 is adjusted for 
confounders indicated in the footnote to table 5.6. Model 2 includes additional 
adjustments for left ventricular mass index and relative wall thickness. See table 5.5 
for abbreviations. *p<0.05, **p<0.005, ***p<0.0005 for significance of correlation 
coefficient.
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except for A after adjustments for indexes of LV remodelling (Figure 5.3). The 
significant parent-sibling and sibling-sibling correlations were retained with further 
adjustments for LVMI and RWT (Figures 5.3 to 5.6) and for SBPc or Pb in place of 
brachial SBP (Figure 5.7). Similar intra-familial correlations were noted with 
adjustments for LVMI or RWT in separate models (data not shown). 
 
5.4.4 Heritability estimates of indexes of diastolic function  
 
With adjustments for confounders (Tables 5.7, 5.8, 5.9 and 5.10), as well as 
with further adjustments for LVMI and RWT (Tables 5.7 to 5.10) and additional 
adjustments for SBPc or Pb where appropriate (Table 5.11), indexes of LV diastolic 
function showed significant heritability. Importantly however, while E/A showed only 
weak heritability estimates (trend effects) (Table 5.7), the average of septal and 
lateral wall (Table 5.8), lateral wall (Table 5.9) and septal wall (Table 5.10) E/e’ 
showed strong heritability estimates. Also in contrast to strong heritability estimates 
for E/e’ and a’, the average of septal and lateral wall e’ and e’/a’ (Table 5.8), and 
lateral wall e’ and e’/a’ (Table 5.9) showed intermediate heritability estimates and 
septal wall e’ and e/a’ (Table 5.10) showed weak or insignificant heritability 
estimates. Similar heritability estimates were noted with adjustments for LVMI or 
RWT in separate models (data not shown). 
 
5.5 Discussion 
 
 The main findings of the present study are that in a relatively large family-
based study conducted in a group of African ancestry, E/e’, an index of LV filling 
pressures which when increased, is indicative of moderate-to-severe diastolic 
dysfunction, demonstrated strong intra-familial aggregation and heritability (h2±SEM 
for the average of lateral and septal wall E/e’=0.52±0.11, p<0.0001). Importantly, a 
novel finding of this study is that the intra-familial aggregation and heritability of E/e’ 
was independent of LVMI, geometric remodelling as indexed by RWT, and aortic 
function (SBPc and aortic backward wave pressures). 
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Figure 5.7 Multivariate adjusted intra-familial correlations (r values) of left ventricular 
diastolic function derived from the average of lateral and septal wall tissue Doppler 
imaging with further adjustments for central aortic systolic blood pressure (model 1) 
or aortic backward wave pressure (model 2). All models are adjusted for confounders 
indicated in the footnote to table 5.6 as well as left ventricular mass index and 
relative wall thickness. See table 5.5 for abbreviations. **p<0.005 for significance of 
correlation coefficient. 
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Table 5.7. indexes of left ventricular diastolic function derived from trans-mitral (blood flow) Doppler velocities. 
 
Adjustments     h2±SEM     p-value          Genetic            p value      Total variance    p-value  Proportion attributed  
                    variance±SEM                      ±SEM                    to covariates (r2) 
_______________________________________________________________________________________________________________ 
Log Trans-mitral E/A  *     0.29±0.12    <0.01       0.004±0.002        <0.02       0.014±0.001        <0.0001           0.53      
Log Trans-mitral E/A  * +LVMI+RWT   0.28±0.12    <0.02       0.004±0.002        <0.02       0.014±0.001        <0.0001           0.53           
Log Trans-mitral E    *     049±0.11    <0.0001      0.012±0.003       <0.0001    0.024±0.002        <0.0001           0.11           
Log Trans-mitral E    * +LVMI+RWT   0.49±0.11    <0.0001      0.012±0.003       <0.0001    0.023±0.002        <0.0001           0.13           
Log Trans-mitral A    *    0.52±0.11    <0.0001      0.014±0.003       <0.0001    0.026±0.002        <0.0001           0.19  
Log Trans-mitral A    * +LVMI+RWT   0.50±0.11    <0.0001      0.013±0.003       <0.0001    0.026±0.002        <0.0001           0.22  
_______________________________________________________________________________________________________________ 
See table 5.5 for abbreviations. *Additional adjustments include age, sex, diastolic blood pressure, body mass index and heart rate (see Table 
5.2 for justification of the inclusion of these adjustors). 
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Table 5.8. Multivariate adjusted heritability estimates of several indexes of left ventricular diastolic function derived from the average of lateral 
and septal wall tissue Doppler measurements. 
Adjustments      h2±SEM    p-value           Genetic          p value    Total variance    p-value     Proportion attributed 
                     variance ±SEM          ±SEM     to covariates (r2) 
_________________________________________________________________________________________________________________ 
Log mean E/e’  *        0.52±0.11    <0.0001       0.015±0.004      <0.0001    0.029±0.002    <0.0001  0.19 
Log mean E/e’  * +LVMI+RWT   0.51±0.11    <0.0001       0.015±0.004      <0.0001    0.029±0.002    <0.0001  0.22 
Log mean e’      *     0.30±0.14    <0.05        0.003±0.002        <0.05      0.010±0.001    <0.0001  0.54 
Log mean e’      * +LVMI+RWT   0.29±0.14    <0.05        0.003±0.002        <0.05      0.010±0.007    <0.0001  0.56 
Log mean a’      *        0.60±0.11    <0.0001       0.007±0.002       <0.0001   0.011±0.001    <0.0001  0.25 
Log mean a’      * +LVMI+RWT   0.60±0.11    <0.0001       0.007±0.002       <0.0001    0.011±0.001    <0.0001  0.26 
Log mean e’/a’  *        0.35±0.13    <0.005        0.007±0.003        <0.005     0.018±0.001    <0.0001  0.59 
Log mean e’/a’  * +LVMI+RWT   0.31±0.13    <0.01        0.005±0.002         <0.02      0.018±0.001    <0.0001  0.60 
__________________________________________________________________________________________________________________ 
See table 5.5 for abbreviations. * Additional adjustments include age, sex, brachial systolic blood pressure (except e’/a’ where diastolic blood 
pressure was employed), body mass index, and heart rate (see Tables 5.2 to 5.4 for justification of the inclusion of these adjustors). 
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Table 5.9. Multivariate adjusted heritability estimates of several indexes of left ventricular diastolic function derived from lateral wall tissue 
Doppler measurements. 
Adjustments     h2±SEM      p-value          Genetic          p value     Total variance    p-value     Proportion attributed 
                    variance ±SEM         ±SEM          to covariates (r2) 
_________________________________________________________________________________________________________________ 
Log lateral wall E/e’ *        0.48±0.11    <0.0001      0.015±0.004      <0.0001    0.032±0.002      <0.0001  0.17 
Log lateral wall E/e’  * +LVMI+RWT   0.48±0.11    <0.0001      0.015±0.004      <0.0001    0.031±0.002      <0.0001  0.20 
Log lateral wall e’  *       0.37±0.13    <0.005       0.005±0.002       <0.005     0.014±0.001       <0.0001  0.47 
Log lateral wall e’  * +LVMI+RWT   0.38±0.13    <0.005       0.005±0.002       <0.005     0.013±0.001       <0.0001  0.48 
Log lateral wall a’ *        0.41±0.12    <0.0005      0.007±0.002        <0.001    0.017±0.001       <0.0001  0.21 
Log lateral wall a’  * +LVMI+RWT   0.40±0.12    <0.0005      0.007±0.002        <0.001    0.017±0.001       <0.0001  0.22 
Log lateral wall e’/a’ *        0.33±0.13    <0.005       0.008±0.003         <0.01     0.024±0.002       <0.0001  0.54 
Log lateral wall e’/a’  * +LVMI+RWT   0.31±0.13    <0.01       0.007±0.003        <0.005    0.024±0.002       <0.0001  0.54 
__________________________________________________________________________________________________________________ 
See table 5.5 for abbreviations. * Additional adjustments include age, sex, brachial systolic blood pressure (except e’/a’ where diastolic blood 
pressure was employed), body mass index, and heart rate (see Tables 5.2 to 5.4 for justification of the inclusion of these adjustors).
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Table 5.10 Multivariate adjusted heritability estimates of several indices of left ventricular diastolic function derived from septal wall tissue 
Doppler measurements. 
Adjustments     h2±SEM      p-value         Genetic            p value      Total variance    p-value     Proportion attributed 
                   variance ±SEM        ±SEM          to covariates (r2) 
_________________________________________________________________________________________________________________ 
Log septal wall E/e’ *        0.55±0.11    <0.0001     0.018±0.004        <0.0001      0.033±0.002      <0.0001  0.18 
Log septal wall E/e’  * +LVMI+RWT   0.54±0.11    <0.0001     0.017±0.004        <0.0001      0.032±0.002      <0.0001  0.20 
Log septal wall e’  *       0.22±0.13    <0.05      0.004±0.002          =0.05        0.016±0.001      <0.0001  0.45 
Log septal wall e’  * +LVMI+RWT   0.19±0.13    =0.07      0.003±0.002          =0.08        0.016±0.001      <0.0001  0.46 
Log septal wall a’ *        0.45±0.13    <0.0005     0.006±0.002         <0.001       0.013±0.001      <0.0001  0.20 
Log septal wall a’  * +LVMI+RWT   0.43±0.13    <0.0005     0.006±0.002         <0.001       0.013±0.001      <0.0001  0.21 
Log septal wall e’/a’ *        0.12±0.12    =0.16      0.003±0.003          =0.16        0.025±0.002      <0.0001  0.52 
Log septal wall e’/a’  * +LVMI+RWT   0.10±0.12    =0.21      0.002±0.003          =0.21        0.024±0.002      <0.0001  0.52 
__________________________________________________________________________________________________________________ 
See table 5.5 for abbreviations. * Additional adjustments include age, sex, brachial systolic blood pressure (except e’/a’ where diastolic blood 
pressure was employed), body mass index, and heart rate (see Tables 5.2 to 5.4 for justification of the inclusion of these adjustors). 
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Table 5.11 Multivariate adjusted heritability estimates of left ventricular diastolic function derived from the average of lateral and septal wall 
tissue Doppler measurements with additional adjustments for central aortic systolic blood pressure (SBPc) or aortic backward wave pressures 
(Pb). 
Adjustments     h2±SEM     p-value           Genetic          p value     Total variance     p-value     Proportion attributed 
          variance±SEM                          ±SEM                     to covariates (r2)  
______________________________________________________________________________________________________________ 
Log mean E/e’    * +SBPc      0.50±0.11    <0.0001      0.014±0.004     <0.0001     0.029±0.002       <0.0001  0.22 
Log mean E/e’    * +Pb     0.49±0.11    <0.0001      0.014±0.004     <0.0001     0.029±0.002       <0.0001  0.22 
Log mean e’      *+ SBPc      0.28±0.14    <0.05       0.003±0.002       <0.05       0.010±0.001       <0.0001  0.56 
Log mean e’       * +Pb     0.30±0.14    <0.05       0.003±0.002       <0.05       0.0011±0.001     <0.0001  0.54 
Log mean a’   *+ SBPc      0.60±0.11    <0.0001      0.007±0.002      <0.0001    0.011±0.001       <0.0001  0.26 
Log mean a’    *+Pb    0.60±0.11    <0.0001      0.007±0.002      <0.0001    0.011±0.001       <0.0001  0.26 
Log mean e’/a’  * +SBPc      0.33±0.13    <0.01       0.006±0.003        <0.01      0.018±0.001       <0.0001  0.60 
Log mean e’/a’   * +Pb      0.33±0.13    <0.01       0.006±0.003        <0.01      0.018±0.001       <0.0001  0.59 
______________________________________________________________________________________________________________ 
See table 5.5 for abbreviations and *table 5.8 for additional adjustments with brachial systolic or diastolic blood pressure being replaced with 
the blood pressure value as indicated. Left ventricular mass index and relative wall thickness were also included as confounders.
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As noted in the present study, significant heritability of E/e’ has been 
described in Koreans (Noh et al 2015), and in Europeans (Kloch-Badelek et al 2014). 
Hence, the present findings corroborate the notion that E/e’ is in-part genetically 
determined and that this effect extends across ethnic groups. However, the present 
findings suggest that the genetic contribution to E/e’ may be markedly higher in 
groups of black African descent, as compared to other ethnic groups. In this regard, 
we show heritability estimates for E/e’ (h2±SEM=0.52±0.11, p<0.0001) which are 
markedly greater than that noted in Europeans (h2=0.30, p<0.0001) (Kloch-Badelek 
et al 2014) or Koreans (h2±SEM=0.33±0.05, p<0.05) (Noh et al 2015). This is despite 
similar heritability estimates for the index of relaxation, E/A in the present study 
(h2±SEM=0.29±0.12, p=0.01) as compared to other ethnic groups (h2±SEM, 
Europeans=0.30, p<0.0001, Koreans=0.25±0.04, p<0.05) (Noh et al 2015; Kloch-
Badelek et al 2014). Moreover, this is also despite lower heritability estimates for the 
preload-independent index of relaxation e’, in the present study (h2±SEM=0.30±0.14, 
p<0.0001) as compared to other ethnic groups (h2±SEM, Europeans=0.40, 
p<0.0001, Koreans=0.41±0.05, p<0.05) (Noh et al 2015; Kloch-Badelek et al 2014). 
These results therefore suggest that as compared to other ethnic groups, groups of 
black African ancestry may be predisposed to adverse genetic effects on LV filling 
pressures. Whether this translates into a greater chance of developing heart failure 
with a preserved ejection fraction requires further study. 
 An important aspect of the present study not previously addressed (Jin et al 
2011; Noh et al 2015; Kloch-Badelek et al 2014) is whether genetic influences on E/e’ 
are through an impact of LV remodelling or aortic function. In this regard, LVMI, RWT 
and aortic function are now well recognised as being inherited, a finding previously 
reported in the present community sample (Peterson et al 2015; Redelinghuys et al 
2012). As LVMI, RWT and aortic function are also associated with LV diastolic 
function, the possibility arises that the heritability of E/e’ is by virtue of genetic 
influences on LVMI, RWT or aortic function. This question has important implications 
as LV remodelling and LV loading conditions can be modified by conventional 
therapy, whereas there is currently no known therapy that directly influences diastolic 
function. In the present study we show significant intra-familial correlations and 
heritability for E/e’ after adjustments for LVMI, RWT and aortic function. Thus, the 
present results suggest that the genetic effects responsible for E/e’ are unlikely to be 
attributed to the impact of LVMI, RWT or aortic function. The present findings 
therefore provide the first evidence that the genetic determinants of E/e’ are likely to 
produce direct effects on LV diastolic function. The present results therefore support
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genetic studies being conducted to assess potential molecular targets responsible for 
increases in LV filling pressures and that these studies may be particularly important 
in groups of African ancestry. 
 In the present study, as compared to E/e’, we report on significant, but 
weaker heritability estimates for E/A, an index of diastolic function determined by LV 
relaxation, by filling pressures and several other factors (including heart rate which 
was adjusted for, P-R interval and the diameter of the mitral annulus, which were not 
adjusted for). Although these data support the notion that genetic factors also 
contribute to LV relaxation with similar effects across ethnic groups, E/A may not be 
the best index of LV relaxation to detect intra-familial aggregation and heritability. 
Indeed lateral wall e’ (h2±SEM=0.37±0.12, p<0.0005),(but not septal wall e’), a 
preload-independent index of LV relaxation, showed stronger heritability estimates 
than E/A (h2±SEM=0.29±0.12, p=0.01). However, the dependence of E/A on preload 
may not be the only explanation for the relatively low heritability estimates for E/A in 
the present study, as the heritability of lateral wall e’/a’, which may also be less 
dependent on preload than E/A (Sohn et al 1997), similarly showed lower heritability 
estimates (h2±SEM=0.31±0.13, p<0.005) than E/e’. The heritability estimates for e’/a’ 
in the present study are indeed lower than those reported in Europeans (h2=0.40, 
p<0.0001) where heritability estimates for E/A (h2=0.30, p<0.0001) were lower than 
for e’/a’ (Kloch-Badelek et al 2014). 
 In addition to a markedly greater heritability of E/e’ noted in present as 
compared to prior studies conducted in groups of European or Asian ancestry (Jin et 
al 2011; Noh et al 2015; Kloch-Badelek et al 2014), we also show a significantly 
greater heritability of E and A considered separately (h2±SEM=0.49±0.11 and 
0.52±0.11, p<0.0001) than in other ethnic groups (h2=0.11 to 0.29) (Noh et al 2015; 
Kloch-Badelek et al 2014). However, the physiological and clinical significance of E 
and A assessed independent of each other, is unclear and several factors could 
explain the differences between studies including differences in preload. The 
limitations of the present study are first because of the young age of the siblings 
studied, a low prevalence of DD was noted in sibling pairs. Therefore, we could not 
assess the intra-familial aggregation and heritability of DD considered as a discrete 
trait. In this regard, a comprehensive assessment of a number of variables is 
required to appraise diastolic function and analysis of variables independent of each 
other may give an incomplete picture of the genetic determinants of diastolic 
function.
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Second, we assessed the intra-familial aggregation and heritability of E/e’ in one 
ethnic group only. Although our data are consistent with that obtained in Koreans 
(Noh et al 2015), and Europeans (Kloch-Badelek et al 2014), whether E/e’ shows 
intra-familial aggregation and heritability independent of LVMI, RWT or aortic function 
in other ethnic groups nevertheless requires further study. Moreover, TDI 
measurements were only available in around two-thirds of the sample studied and 
this may have limited our ability to show intra-familial aggregation or heritability. 
In conclusion, in the present study we demonstrate that in a group of African 
ancestry that E/e’, an index of LV filling pressures, and a measure employed to 
identify moderate-to-severe LV diastolic dysfunction thus predicting the onset of 
heart failure with a preserved ejection fraction (Kane et al 2011; Lam et al 2011), 
aggregates in families and shows robust heritability, independent of LVMI, geometric 
LV remodelling and aortic function. Discovering the genes associated with E/e’, 
particularly in groups of African ancestry may cast further light on the genetic 
mechanisms responsible for the progression to heart failure with a preserved ejection 
fraction. 
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CHAPTER 6 
 
 
 
 
Contextual Narrative and Conclusion 
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6.1 Introduction 
 
In the present thesis, in chapters 2 to 5 I provide detailed discussion of the 
findings of my research. In the present chapter I will nonetheless provide a 
contextual narrative for chapters 2 to 5 and discuss the general limitations as well as 
possible clinical implications of my research. The increasing prevalence of 
cardiovascular risk factors in both developed and developing countries is contributing 
toward higher rates of heart failure worldwide (Bradshaw et al 2003; Bhatia et al 
2006; Borlaug & Redfield 2011; WHO, 2015). Heart failure is a condition that from 
the time of diagnosis, was thought to subsequently result in survival rates that are 
comparable to those of malignancies with the worst possible outcomes (Cowie et al 
2000, Stewart et al 2001). Because of the appalling outcomes in patients with heart 
failure, and the marked burden to health care systems and patients alike produced 
by heart failure, over the past three-to-four decades there has been a considerable 
number of studies that have been performed to attempt to improve that situation. In 
this regard there is now substantial evidence to support the use of neurohumoral 
blockers, biventricular pacing, assist devices, valve replacements, coronary artery 
bypass grafts, stents and several other interventions in improving survival rates in 
patients with heart failure. Although more modern and highly technical approaches to 
heart failure have subsequently considerably improved outcomes in heart failure, the 
prognosis from the time of diagnosis is nonetheless still poor. This is particularly 
notable for heart failure with a preserved or normal ejection fraction. 
As indicated in chapter 1 of the present thesis, each year the prevalence of 
heart failure with a preserved ejection fraction or diastolic heart failure increases by 
approximately 1% compared to heart failure with a reduced ejection fraction or 
systolic heart failure (Federmann & Hess 1994; Owan et al 2006; Fonarow et al 
2007; Borlaug & Redfield 2011; Borlaug & Paulus 2011; Scantlebury & Borlaug 
2011). The increased prevalence of heart failure with a preserved ejection fraction is 
possibly because more persons are surviving other disorders to old age and ageing 
is the most important risk factor for heart failure with a preserved ejection fraction. In 
addition the prevalence rates of obesity are increasing world-wide and as discussed 
in chapters 1 and 2 of the present thesis obesity, in specific circumstances, is also an 
important risk factor for heart failure. Furthermore, there may be increased physician 
recognition of the syndrome of heart failure with a preserved ejection fraction (Owan 
et al 2006). Importantly, heart failure with a preserved or normal ejection fraction 
carries just as poor a prognosis as heart failure with a reduced ejection fraction 
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(Senni et al 1998; Owan et al 2006; Paulus & van Ballegoij 2010; Borlaug & Paulus 
2011; Borlaug & Redfield 2011; Li et al 2013; McMurray et al 2012; Burke et al 2014; 
Pitt et al 2014). However, as reviewed in chapter 1 of the present thesis, despite the 
increasing prevalence of heart failure with a preserved ejection fraction in 
populations worldwide, heart failure treatment strategies as applied to patients with 
this form of heart failure have generally been shown to be unsuccessful and novel 
approaches targeting the pathophysiological mechanisms thought to be responsible 
for this form of heart failure have failed (Borlaug & Paulus 2011; Borlaug & Redfield 
2011; Pitt et al 2014). Although there are ongoing studies attempting to improve 
outcomes in patients with heart failure with a preserved ejection fraction, in the 
present thesis I have argued that it is possible that we could do better at targeting 
those at risk and hence preventing this form of heart failure. How have the findings of 
the present thesis extended our knowledge of how best to identify those at risk of 
heart failure with a preserved ejection fraction and do these findings suggest better 
preventative approaches?  
 
6.2 Left ventricular diastolic dysfunction as a cause of heart failure with a 
preserved ejection fraction 
 
The presence of preclinical LV diastolic dysfunction is known to predict the 
progression to heart failure with preserved ejection fraction (Wan et al 2014). The 
obvious question is therefore what are the currently recognised risk factors for LV 
diastolic dysfunction which may be targeted early and hence prevent the progression 
to heart failure with a preserved ejection fraction? In both European and American 
populations, the risk factors known to predict the development of heart failure with 
preserved ejection fraction include hypertension, diabetes mellitus, and obesity 
(Kenchaiah et al 2002; Bahrami et al 2008; Lee et al 2009; Mozaffarian et al 2015). 
Although additional risk factors such as age and female gender are often even more 
important in mediating the development of heart failure with a preserved ejection 
fraction, there are no obvious approaches that can be employed to modify these risk 
factors. All of these conventional risk factors (age, female gender, hypertension, 
diabetes mellitus and obesity) are independently associated with LV diastolic 
dysfunction which may present with or without heart failure (Aurigemma et al 2001; 
Kane et al 2011; Lam et al 2011). In association with these risk factors, there is 
frequently LVH and/or an increased LV relative wall thickness, an index of concentric 
LV remodelling, which may also contribute toward the development of LV diastolic 
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dysfunction and ultimately heart failure with a preserved ejection fraction (Chahal et 
al 2010). As the presence of LV diastolic dysfunction predicts the development of 
heart failure with preserved ejection fraction (Wan et al 2014), it therefore may be 
important to better understand exactly how modifiable risk factors determine LV 
diastolic dysfunction. In this regard, it is not expected that every hypertensive, 
diabetic or obese patient will develop LV diastolic dysfunction and heart failure with a 
preserved ejection fraction. In other words not every hypertensive, diabetic or obese 
individual should be screened for LV diastolic dysfunction (the cost and resources 
required would be too great). Waiting for symptoms of heart failure to develop before 
screening for LV diastolic dysfunction is counter intuitive to an appropriate 
preventative strategy. However, in those with the known risk factors for LV diastolic 
dysfunction and hence heart failure with a preserved ejection fraction, additional 
measures may be employed to identify those most at risk. What has the present 
thesis identified with respect to the possibility of better identifying those at risk of LV 
diastolic dysfunction and hence possibly heart failure with a preserved ejection 
fraction? 
 
6.3 Obesity and obesity-related insulin resistance and LV diastolic 
dysfunction? 
 
 As highlighted in chapters 1 and 2 of the present thesis, obesity and obesity-
related insulin resistance are risk factors for the development of heart failure 
(Kenchaiah et al 2002; Ingelsson et al 2005; Bahrami et al 2008) and the presence of 
LV diastolic dysfunction (Bajraktari et al 2006; Libhaber et al 2009; Tsioufis et al 
2008; Dinh et al 2010; Russo et al 2011; AlJaroudi et al 2012; Çil et al 2012; Cuspidi 
et al 2014). The obvious solution to this problem is to institute weight loss programs 
in obese individuals. However, weight reduction programs seldom result in obese 
individuals reaching target body weights (Latner et al 2002, Anderson et al 2001) and 
often result in an inability to maintain decreases in body weight (Jordan et al 2012, 
Hedayati et al 2011, Aucott et al 2009, Weiss et al 2007, The Trials of Hypertension 
Prevention Collaborative Research Group 1997). In this regard adherence to lifestyle 
changes decrease from as early as 6 months after the initiation of weight reduction 
programs (Elmer et al 2006). Thus, those obese individuals most at risk for LV 
diastolic dysfunction should be identified and in these individuals, if weight reduction 
programs do not achieve the desired goals, it may be necessary to introduce 
alternative approaches to prevent the transition from overweight and obesity to heart 
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failure. Do we have sufficient evidence to suggest that it is only in specific obese 
individuals that the risk for LV diastolic dysfunction exists and is there evidence to 
suggest alternative preventative strategies? 
As reviewed in chapter 1 of the present thesis (section 1.5.1.3), there is some 
evidence for a role of insulin resistance as a mediator of obesity-associated LV 
diastolic dysfunction. However, as pointed out in this section of the thesis, this 
evidence is controversial.  In chapter 2, I argue that because obesity is associated 
with increased LVH and concentric LV remodelling (Cuspidi et al 2014; Woodiwiss & 
Norton 2015) and that these structural changes in the LV are also associated with LV 
diastolic dysfunction, that the impact of obesity or insulin resistance on LV diastolic 
dysfunction may be in-part determined by the extent of the LV remodelling process. 
In chapter 2 of the present thesis, I have shown in 737 participants from a randomly 
recruited community-based study of African ancestry with a high prevalence of 
obesity and LV diastolic dysfunction, that in those with a more concentrically 
remodelled LV, insulin resistance, as indexed by HOMA-IR, is strongly and 
independently associated with several indices of LV diastolic function. In contrast 
however, in those with a less concentrically remodelled LV neither adiposity indices 
nor HOMA-IR were independently associated with LV diastolic function. Importantly, 
LV remodelling failed to modify age or blood pressure-LV diastolic function relations. 
How do these results change our current understanding of obesity effects on LV 
diastolic function? 
Although several cross-sectional and intervention studies have demonstrated 
independent associations between adiposity indices and abnormalities of LV diastolic 
dysfunction (Tsiousfis et al 2008; Libhaber et al 2009; Russo et al 2011; Çil et al 
2012; AlJaroudi et al 2012; Cuspidi et al 2014), our group have recently reported that 
even in a community with a high prevalence of obesity, this effect is modest at best 
as compared to the impact of blood pressure and age (Millen et al 2015). Similarly, in 
the present study, I was unable to show anything but a modest relation between 
indices of excess adiposity or insulin resistance and LV diastolic function when 
considered in the sample as a whole. Importantly, in this community sample there 
was no independent association between indices of adiposity, or insulin resistance 
and the presence of moderate to severe LV diastolic dysfunction. Hence, these data 
suggest that neither obesity nor insulin resistance, when considered in isolation are 
likely to make as significant a contribution to LV diastolic dysfunction at a community 
level as other risk factors such as age or blood pressure. However, the present 
findings also suggest that obesity effects on LV diastolic function are likely to be as 
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important as blood pressure or other risk factor effects if a patient’s LV has a more 
concentric geometry and if insulin resistance exists. These data therefore provide a 
possible explanation as to why studies exploring relations between insulin resistance 
and LV diastolic function have produced controversial results (see section 1.5.1.3). In 
this regard, it is unknown whether relations between indices of insulin resistance and 
LV diastolic function in these studies (see section 1.5.1.3) were assessed in 
participants with a more concentrically remodelled LV. Moreover, the present findings 
suggest that to best identify those overweight or obese individuals who are likely to 
develop LV diastolic dysfunction and hence possibly heart failure with a preserved 
ejection fraction, the degree of insulin resistance should be defined and if insulin 
resistant, then the degree of LV remodelling should be determined. If these patients 
have a more concentrically remodelled LV, then intense weight loss programs should 
be instituted in these individuals, whilst those without insulin resistance or who have 
a less concentrically remodelled LV may not require as intensive weight loss 
programs or at least may not require repeated echocardiograms to monitor for LV 
diastolic dysfunction. Moreover, the present study suggests that if weight loss 
programs are unsuccessful, targeting the degree of insulin resistance may be an 
option to prevent the development of LV diastolic dysfunction. Further studies are 
required to investigate whether therapeutic strategies designed to increase insulin 
resistance improve LV diastolic function and possibly heart failure with a preserved 
ejection fraction in individuals who have obesity related concentric LV remodelling 
and insulin resistance. 
 
6.4 Blood Pressure: the effect of aortic backward wave pressures on LV 
diastolic function. 
  
As reviewed in chapter 1 (section 1.5.2) and chapter 3, although hypertension 
is a well-recognised risk factor for the development of heart failure with a preserved 
ejection fraction and a reduced LV diastolic function, the fundamental haemodynamic 
change responsible for these afterload-induced effects on the heart are at present 
not entirely clear. In this regard, hypertension may be associated with increases in 
various loading conditions, including a resistance afterload which increases diastolic 
blood pressure (and hence load at the end of isovolumic contraction), and an 
increased pulsatile afterload induced by increases in the aortic forward wave 
pressure (produced by and increased stroke volume and aortic stiffness and hence 
load at the end of the ejection period) and an increased pulsatile afterload induced by 
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increases in the aortic backward wave pressure (produced by wave reflections and 
hence load at the peak of systole). The debate as to the relative contribution of each 
of these afterloads to chronic changes in LV diastolic function is ongoing. Although it 
is most likely that all three forms of loading conditions contribute to myocardial 
damage and hence diastolic LV function, the timing of these effects is far less well 
understood. In other words, at what age do these loading conditions contribute to LV 
diastolic dysfunction? The most commonly held misconception is that a resistance 
afterload is more important in mediating myocardial damage and dysfunction in 
young-to-middle-aged persons, whereas pulsatile afterload only contributes in the 
elderly. In this regard, although this approach applies well when considering brachial 
blood pressure effects, it is not the case for aortic blood pressure. Indeed, from 
young adulthood, aortic backward waves begin to increase (Booysen et al 2015) and 
these increases impact more on aortic than on brachial pulse pressure (see section 
1.5.2.3 for the explanation). Only from 50-60 years of age, when aortic stiffness 
begins to dramatically increase do increases in the forward wave pressure contribute 
to any substantial extent to age-related increases in aortic pulsatile load. Hence, 
while aortic pulsatile afterload increases from youth, brachial pulse pressure 
increases to a lesser extent. Hence, damage to the LV mediated by pulsatile 
afterload effects may begin to occur from young adulthood and these effects may not 
be adequately indexed by brachial blood pressure measurements. 
As argued in chapter 3, although several studies have identified associations 
between aortic stiffness (which influences aortic forward wave magnitude) or 
reflected waves and aspects of LV diastolic function in those without heart failure 
(Kawaguchi et al 2003, Weber et al 2006; Weber et al 2008; Borlaug et al 2007), the 
relative role of aortic stiffness versus aortic reflected waves at the time of these 
publications was unclear. As marked age-related increases in backward wave 
pressures precede significant age-related increases in aortic stiffness by several 
decades (Booysen et al 2015) and increases in aortic backward wave pressures are 
a fundamental mechanism responsible for increases in aortic stiffness (Sibiya et al 
2015), aortic backward waves may be the initial (primary) target in preventing the 
progression to LV diastolic dysfunction and consequently heart failure with a 
preserved ejection fraction. However, whether the impact of backward wave 
pressures on LV diastolic dysfunction antedates the effects of aortic stiffness was 
until the present thesis, unclear. In this regard, prior studies assessing relations 
between aortic and LV diastolic function evaluated patients with average ages of 60-
77 years (Mohammed et al 2012; Hundley et al 2001; Kawaguchi et al 2003; Weber 
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et al 2006; Weber et al 2008; Fernandes et al 2008; Kang et al 2010; Desai et al 
2009; Kitzman et al 2013), age ranges when large vessel stiffness is already 
markedly increased (Booysen et al 2015). In the present thesis I therefore 
determined whether the impact of aortic backward wave pressure on LV diastolic 
dysfunction antedates the effects of aortic stiffness in a predominantly young-to-
middle–aged community-based sample with an average age where increases in 
aortic backward wave pressures are well established, but prior to an age when 
striking increases in aortic stiffness are noted. 
In chapter 3, I have shown in 524 participants from a randomly recruited 
community-based study of African ancestry with an age in the predominantly young-
to-middle-aged range, and with a high prevalence of moderate-to-severe pre-clinical 
LV diastolic dysfunction (10.9%), aortic backward wave pressures (Pb derived from 
wave separation analysis and Pa) consistently showed independent relations with 
E/e’, an index of filling pressures, and the presence of moderate-to-severe LV 
diastolic dysfunction; whilst neither forward wave pressures, aortic stiffness (aortic 
PWV), nor the timing of the forward or backward waves were consistently associated 
with E/e’ and moderate to severe LV diastolic dysfunction. Moreover, aortic backward 
wave pressures, but not aortic forward wave pressures, aortic stiffness or the timing 
of forward and backward wave pressures accounted for independent relations 
between aortic pulse pressure and increases in E/e’ or moderate-to-severe LV 
diastolic dysfunction. There are several implications to these findings that warrant 
consideration. 
To predict the risk of developing LV diastolic dysfunction and hence the 
possibly heart failure with a preserved ejection fraction, blood pressure is measured 
at the brachial artery. However, brachial blood pressure may not adequately index 
the pulsatile afterload that determines LV diastolic dysfunction. In this regard, the 
results of chapter 3 suggest that the aortic backward wave, which appears as a 
second and lower systolic shoulder, rather than as the peak systolic pressure at the 
peripheral pulse, is the main component of pulsatile load which contributes toward 
LV diastolic dysfunction over a young-to-middle age range. Hence, in the 
management of blood pressure, it is possible that targeting the aortic backward wave 
or aortic systolic pressure may produce a more robust effect on preventing the 
transition to heart failure with a preserved ejection fraction. In this regard, whilst there 
is little evidence to support a therapeutic approach to modify age-related increases in 
aortic stiffness, there is significant evidence to suggest that aortic backward wave 
pressures may be targeted by conventional antihypertensive therapy (Agabiti-Rosei 
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et al 2007). However, this may only be adequately achieved if the aortic backward 
wave pressure or aortic systolic pressure is measured. In this regard commercially 
available devices to assess aortic pressures are often no more expensive than a well 
validated oscillometric device to measure brachial blood pressure and these devices 
are now easy to use taking only 5-10 minutes to acquire all of the data. The present 
thesis therefore provides sufficient evidence to support a longitudinal study being 
conducted where antihypertensive therapy is titrated against aortic backward wave 
pressures (or aortic systolic pressures) as well as brachial blood pressure versus just 
brachial blood pressure alone and the effect on LV diastolic function and possibly the 
development of heart failure with a preserved ejection fraction assessed.  
 
6.5 Genetic effects on LV diastolic function and the determinants thereof? 
 
When assessing the risk for the development of LV diastolic dysfunction and 
ultimately the progression to heart failure with a preserved ejection fraction, it is 
important to be able to account for all rather than a fraction of the risk. As highlighted 
in chapter 1 of the present thesis (section 1.5), the well-recognised demographic and 
clinical risk factors for heart failure with a preserved ejection fraction, which include 
age, female gender, obesity, hypertension and diabetes mellitus, fail to account for 
all of the inter-individual variation in LV diastolic function (Bielin et al 1991; Fox et al 
2010; Jin et al 2011; Kloch-Badelek et al 2014; Noh et al 2015; Swan et al 2003; 
Tang et al 2002). However, ethnicity is reported to impact on the prevalence of LV 
diastolic dysfunction and ultimately heart failure with preserved ejection fraction 
(Bhatia et al 2006; Yancy et al 2006; Fonarow et al 2007; Lam et al 2007; 
Scantlebury & Borlaug 2011; Chirinos et al 2012; Nichols et al 2014; Mozaffarian et 
al 2015). Although a significant proportion of these ethic effects may be attributed to 
differences in well-recognised risk factors for LV diastolic dysfunction, other 
possibilities must be considered. Hence, independent of well-recognised 
demographic and clinical risk factors for heart failure with a preserved ejection 
fraction, it has been proposed that the inter-individual variation in LV diastolic 
function may be explained to some extent by genetic factors that influence either the 
LV remodelling process, and hence indirectly affect LV diastolic function (and hence 
whether heart failure with a preserved ejection fraction occurs), or LV diastolic 
function through direct effects. In this regard, as reviewed in chapter 1, section 
1.5.3.1, of the present thesis several studies have demonstrated that LV relative wall 
thickness, which is associated with LV diastolic dysfunction and as demonstrated in 
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chapter 2, is a strong modifier of the impact of insulin resistance on LV diastolic 
function, is inherited (Arnett et al 2001; Bella et al 2004; Fox et al 2010; Kuznetsova 
et al 2003). Moreover, as reviewed in chapter 1, section 1.5.3.2, of the present 
thesis, several studies have demonstrated heritability or intra-familial aggregation of 
LV diastolic function identified from trans-mitral blood flow velocity measurements 
(Bielen et al 1991; Swan et al 2003, Tang et al 2002, Fox et al 2010, Jin et al 2011; 
Kloch-Badelek et al 2014). Furthermore, some studies have demonstrated significant 
heritability of tissue Doppler indices of LV diastolic function (Noh et al 2015, Kloch-
Badelek et al 2014). It may therefore be argued that the next step in the process of 
identifying the genetic determinants of LV diastolic function is to perform high 
throughput multi-loci gene screening using currently available sophisticated genetic 
approaches. However, in the present thesis I have argued that the genetic 
determinants of LV diastolic function or the LV structural determinants thereof are not 
entirely clear. What have the studies conducted in the present thesis therefore added 
to our understanding of the possible inheritance of LV diastolic function or the LV 
structural determinants thereof? 
 
6.5.1 Possible genetic effects on LV geometric remodelling 
 
There is considerable uncertainty as to the role of genetic factors in 
determining LV relative wall thickness independent of LV mass. In this regard LV 
mass is a major determinant of LV wall thickness and hence it may be argued that 
the same genetic factors that determine LV mass will also determine the geometric 
remodelling process. However, an increased LV relative wall thickness may be 
determined not just by the extent of LVH, but by several other cellular factors 
(Badenhorst et al 2003). Hence, if LV relative wall thickness is inherited, and LV 
remodelling is a major determinant of LV diastolic function, then the genetic 
determinants of LV diastolic dysfunction are not only going to be regulated by those 
factors which influence only the extent of hypertrophy of the heart, but rather those 
that determine the remodelling process itself. Is there some evidence prior to the 
study conducted in the present thesis to suggest that the LV geometric remodelling 
process is inherited independent of LV mass? 
Siblings of those with LVH have a greater risk of concentric LVH as compared 
to age- and sex-matched controls (Schunkert et al 1999). In that study (Schunkert et 
al 1999), the siblings of those with LVH had no greater risk of eccentric LVH than the 
age- and sex-matched controls. Hence, from that study (Schunkert et al 1999) the 
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possibility arose that the intrafamilial clustering of concentric LVH was in-part driven 
by the LV remodelling process. However, whether these siblings had a greater risk of 
concentric LV remodelling was not reported. Hence, it is also possible that the 
increased risk of concentric LVH in that study (Schunkert et al 1999) may have been 
largely a consequence of LV mass effects. In the Framingham Heart Study although 
the risk of concentric LVH was markedly greater in related as compared to unrelated 
individuals; the risk of concentric LV remodelling was reported to be only modestly 
greater in related compared to unrelated individuals (Lam et al 2010). These data 
(Lam et al 2010) therefore point toward the possibility that the inheritance of LV mass 
explains the inheritance of concentric LVH. Importantly, in all of the studies which 
have reported on intrafamilial clustering or the inheritance of LV relative wall 
thickness (Arnett et al 2001; Bella et al 2004; Fox et al 2010; Kuznetsova et al 2003), 
none have adjusted for LV mass. In the present thesis as described in chapter 4, I 
nevertheless demonstrate that LV relative wall thickness shows strong intrafamilial 
aggregation and heritability beyond LV mass and several confounding variables. 
Indeed, independent of confounders, I showed that 56% of the variation in relative 
wall thickness was heritable (h2±SEM=0.56±0.09, p<0.0001) and this persisted with 
further adjustments for LV mass (h2±SEM=0.48±0.09, p<0.0001). There are several 
important implications of these findings. 
As highlighted in chapter 2, geometric LV remodelling, as indexed by LV 
relative wall thickness, markedly influences whether insulin resistance impacts on LV 
diastolic function. The more concentric the LV geometry the greater the chance that 
LV diastolic dysfunction will occur. Moreover, whilst concentric LV remodelling has 
little influence on the chances of heart failure occurring, whether LVH progresses to 
heart failure with a preserved or reduced ejection fraction is strongly determined by 
the LV geometric remodelling process. As this LV remodelling process shows 
marked heritability, there may be an equally strong genetic basis, and hence 
identifying the genetic determinants thereof could enhance our ability to identify 
those who are at risk of developing heart failure with a preserved ejection fraction 
and may identify novel molecular mechanisms responsible for heart failure with a 
preserved ejection fraction. In this regard, as the intrafamilial aggregation and 
heritability of LV relative wall thickness occurred independent of LV mass, the 
present thesis suggests that genetic factors that influence the LV remodelling 
process beyond hypertrophy need to be sought. Hence, the results of the findings 
reported in chapter 4 contribute to forming the foundation of future genetic studies on 
this topic. 
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6.5.2 Possible genetic effects on LV diastolic function beyond geometric LV 
remodelling 
 
Despite consistent evidence for the heritability of E and A waves across 
various populations, the genetic influence on contemporary measures employed to 
evaluate LV diastolic dysfunction, such as e’ or E/e’ (as discussed in section 1.4.1), 
is nevertheless unclear. This is an important issue as E/e’ is an index of LV filling 
pressures, and a measure employed to identify moderate-to-severe LV diastolic 
dysfunction thus predicting the onset of heart failure with a preserved ejection 
fraction (Kane et al 2011; Lam et al 2011). In this regard, prior studies that have 
reported on the heritability of E/e’ have provided conflicting data, with a Korean study 
showing significant heritability (33%) for E/e’ (Noh et al 2015), but an alternative 
study conducted in European families failed to show significant heritability (Jin et al 
2011). However, subsequent analysis in an expanded data set showed significant 
heritability (31%) (Kloch-Badelek et al 2014). However, these previous studies (Jin et 
al 2011; Kloch-Badelek et al 2014; Noh et al 2015) failed to determine whether E/e’ is 
inherited independent of LV mass and relative wall thickness. Hence, until the time of 
the work performed in the present thesis, whether significant heritability of E/e’ 
occurred independent of LV remodeling was unknown. Moreover, although previous 
studies have reported on the inheritance of E/e’ independent of brachial blood 
pressure (Kloch-Badelek et al 2014; Noh et al 2015), whether heritability of E/e’ was 
independent of aortic BP was also unknown. In this regard, central aortic blood 
pressure has been reported to show stronger heritability estimates than brachial 
blood pressure (Redelinghuys et al 2012). Therefore, how has the work performed in 
the present thesis added to our understanding of the possible genetic basis of LV 
diastolic function? 
In chapter 5 of the present thesis, I report on heritability estimates for E/e’ 
(h2±SEM=0.52±0.11, p<0.0001) which are markedly greater than that noted in 
Europeans (h2=0.30, p<0.0001) (Kloch-Badelek et al 2014) or Koreans 
(h2±SEM=0.33±0.05, p<0.05) (Noh et al 2015). This is despite similar heritability 
estimates for the index of relaxation, E/A in the present study (h2±SEM=0.29±0.12, 
p=0.01) as compared to other ethnic groups (h2±SEM, Europeans=0.30, p<0.0001, 
Koreans=0.25±0.04, p<0.05) (Noh et al 2015; Kloch-Badelek et al 2014). Moreover, 
this is also despite lower heritability estimates for the preload-independent index of 
relaxation e’, in the present study (h2±SEM=0.30±0.14, p<0.0001) as compared to 
other ethnic groups (h2±SEM, Europeans=0.40, p<0.0001, Koreans=0.41±0.05, 
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p<0.05) (Noh et al 2015; Kloch-Badelek et al 2014). In addition, these heritability 
estimates and the intrafamilial correlations of E/e’ were independent of LV mass or 
the degree of concentric LV remodelling. These results therefore suggest that as 
compared to other ethnic groups, groups of black African ancestry may be 
predisposed to the adverse genetic effects on LV filling pressures and that in this 
ethnic group these effects are even beyond the effect of LV remodelling. Clearly, 
these data provide strong evidence in favor of identifying the genetic factors which 
contribute toward filling pressures in the LV in this ethnic group and assessing 
whether these genetic factors determine the progression to heart failure with a 
preserved ejection fraction.  Hence, the results of the findings reported in chapter 5 
also contribute to forming the foundation of future genetic studies on this topic.  
 
6.6 Limitations 
 
Throughout the present thesis I have highlighted the potential limitations of 
the studies conducted. However, there are some limitations that are worthy of 
emphasis. In the definition of diastolic dysfunction, I did not include changes in mitral 
inflow with the Valsalva maneuver as this measurement is not feasible in all patients 
and needs to be carefully standardised in order for accurate interpretations to be 
made (Nagueh et al 2016). Indeed, this measurement is not incorporated in the 
updated diagnostic algorithm for diastolic dysfunction (Nagueh et al 2016). In 
addition, this measurement is not used to define the presence versus absence of 
diastolic dysfunction, but only to assist together with E/A and average E/e’, in the 
separation of mild diastolic dysfunction from moderate-to-severe diastolic 
dysfunction. In the definition of diastolic dysfunction, I also did not include the time 
difference between the duration of pulmonary venous flow and mitral inflow during 
atrial contraction (A wave) (Ar-A duration), and E wave velocity deceleration time; 
however these measurements were also not included in the updated diagnostic 
algorithm for diastolic dysfunction (Nagueh et al 2016). Moreover, I did include 
tricuspid regurgitation velocities and hence may have missed some participants with 
LV diastolic dysfunction. Importantly however, potential participants were excluded if 
significant valve abnormalities were present. Lastly, as the data presented in chapter 
3 of this thesis were analysed prior to the publication of the 2016 algorithm (Nagueh 
et al 2016), LA volume assessments were not included in the definition of diastolic 
dysfunction, and the thresholds for septal e’, E/e’ and E/A were according to the 
2009 algorithm (Nageuh et al 2009). In chapter 5 of the present thesis, a major 
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limitation of the intra-familial aggregation and heritability analysis was the young age 
of the siblings that were recruited for this study. Indeed, because of the low 
prevalence of diastolic dysfunction in younger individuals, I could not assess the 
intra-familial aggregation and heritability of diastolic dysfunction as a discrete trait. 
This could influence the conclusions drawn regarding the genetic determinants of 
diastolic dysfunction. 
 
6.7 Conclusions 
 
In conclusion, the findings from the present thesis provide further evidence to 
potentially assist in the identification of individuals at risk of LV diastolic dysfunction 
and in addition, add to our understanding of the pathophysiological mechanisms that 
may play an important role in the development of LV diastolic dysfunction. In this 
regard I show that the relationship between insulin resistance and not alternative risk 
factors and LV diastolic function is significantly altered by the presence of an 
increase in the degree of LV concentricity. Second, I show that the impact of 
backward wave pressures on LV diastolic dysfunction precedes the effects of aortic 
stiffness, the time to wave reflection or forward wave pressures. Third, I show 
significant intra-familial aggregation and strong heritability in LV filling pressures as 
indexed by E/e’, independent of LV remodelling and aortic function as well as the 
geometric LV remodelling process that makes a strong contribution to the 
development of LV diastolic dysfunction. The findings of the present thesis argue in 
favour of a need to identify the genetic basis of LV diastolic function and for 
conducting several prospective longitudinal or intervention studies guided by genetic 
markers, measures of insulin resistance and aortic backward wave or aortic systolic 
pressures in attempting to prevent the progression to heart failure with a preserved 
ejection fraction.  
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